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vAbstractHomeodomains (HDs) are a large family of DNA>binding domains contained intranscription factors that are most notable for regulating body development andpatterning in metazoans. HDs consist of three alpha helices preceded by an N>terminal arm, where the third helix (the recognition helix) and the N>terminal armare responsible for defining DNA>binding specificity. Here we attempted toengineer the HDs by fully randomizing positions in the recognition helix to specifyeach of the 64 possible 3’ triplet sites (i.e. TAANNN). We recovered HD variants thatpreferentially recognize or are compatible with 44 of the possible sites, a dramaticincrease from the previously observed range of specificities. Many of these HDvariants contain combinations of novel specificity determinants that are uncommonor absent in extant HDs, where these determinants can be grafted into alternate HDbackbones with an accompanying alteration in their specificity. The identifieddeterminates expand our understanding of HD recognition, allowing for the creationof more explicit recognition models for this family. Additionally, we demonstratethat HDs can recognize a broader range of DNA sequences than anticipated, thusraising questions about the fitness barrier that restricts the evolution HD>DNArecognition in nature. Finally, these new HD variants have utility as DNA>bindingdomains to direct targeting of customizable sequence>specific nuclease asdemonstrated by site>specific lesions created in zebrafish. Thus HDs can guidesequence>specific enzymatic function precisely and predictably within a complexgenome when used in engineered artificial enzymes.
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1CHAPTER I
INTRODUCTION
2Molecular Biology Perpetuates LifeLife, along with its beauty (a subjective value of living as perceived by theindividual), is the motivation that perpetuates our existence (the objective state ofliving as perceived by a society). It is this positive feedback cycle that permits us tostudy life, to further molecular biology, thereby creating a greater understanding oflife’s beauty. Nonetheless, from a biologically scientific standpoint, life is merely anobject that contains in itself an innate selfDsustained system; although it’s exactdefinition is debatable (Koshland 2002). From a purely reductionist interpretation,where the cell is regarded as the basic unit of life, life is the result of genetic materialand how that genetic material is regulated. For cells to exist as live entities,genomes must be regulated for biological processes to occur, which permits for thenecessary dynamics in molecular biology that allow for our lives to thrive.To manipulate individual cells, and thus whole organisms, to study livingentities, they must be fully understood through the molecular parts that drive it.Doing so allows for the further understanding of how life functions, enablingdiseases and illnesses to be cured and even prevented, thus allowing for theperpetuation of life. Life requires that genomes be regulated, where transDactingfactors act on cisDregulatory elements. These two distinct cis and trans componentsare intertwined as dynamic constituents that permit the processes of cell growth,cell division, cell differentiation, and even cell death.The transDacting factors encompass general transcription factors and geneDspecific transcription factors that regulate gene expression by interacting on cisDregulatory elements, which permits cells to function and survive. General
3transcription factors are those factors that regulate a basal level of transcription toalmost all genes (Thomas and Chiang 2006). GeneDspecific transcription factors acton specific genes to regulate a particular biological process (Brivanlou and Darnell2002). As the complexity of an organism increases, the number of transcriptionfactors increase, which further increases the gene regulatory network complexity(van Nimwegen 2003). The evolution of transcription factors (and cisDregulatoryelements (Schmidt et al. 2010), and the complexity that is created by this expansionenables biological diversity to occur. Consequently, the molecular progression oftranscriptionDfactor evolution can give rise to the intense yet subtle beauty oforganismal evolution (Babu et al. 2004).
DNA?binding DomainsSequenceDspecific transcription factors contain at least one DNADbindingdomain (DBD) to facilitate target recognition within the genome. DBDs discerndifferent DNA sequences through reversible intermolecular proteinDDNAinteractions read from the sequence, shape, and inherent complexities contained indoubleDstranded DNA (Rohs et al. 2010). DBDs are grouped into families of relatedstructures that are utilized for recognition, where DBDs within a given familyrecognize DNA with similar mechanisms (Ades and Sauer 1995). The three mostcommon DBD families constitute 80 percent of human transcription factors.Starting with the most common, they are: C2H2 zinc fingers domains (ZFs),homeodomains (HDs), and basicDhelixDloopDhelix domains (bHLHs) (Vaquerizas etal. 2009). ZFs, each of 30 amino acids, fold into a beta beta alpha motif around a zinc
4ion to recognize a three to four base pair sequence, where ZFs can be fused in anaverage of 8.5 tandem arrays as a zinc finger protein (ZFP) to recognize longersequences (Enuameh et al. 2013b). The HD, of 60 amino acids each, consists of abundle of three alpha helices preceded by an NDterminal arm to recognize a core sixbaseDpair site, however, they typically function with other cofactors/HDs torecognize their targets (Gehring et al. 1994b). bHLHs, each consisting of 60 aminoacids, fold into two helices joined by a variable loop, where it homoD orheterodimerizes into a four helix bundle with another bHLHs to recognize a sixbaseDpair sequence with its basic helix region (Grove et al. 2009). This sample ofstructure and function in proteinDDNA recognition observed in the top three DBDfamilies is only cross section of a greater diversity that is observed in the remainingfamilies.
History and Biology of HomeodomainsHDs were initially discovered in Drosophila as a homeobox contained in ahomeotic gene, which is a gene involved in programming specific cell lineage thatultimately give rise to body parts (McGinnis et al. 1984). Aberrant function ofcertain homeotic genes in flies results in segment transformation duringdevelopment including the incorrect development of legs instead of antennae andthe development of first legs into third legs (Harelrigg and Kaufman 1983). It wassubsequently shown that it was the homeobox (which encodes the HD) within thehometic gene that is responsible for developmental regulation through its DNADbinding properties (Kuziora and McGinnis 1989; Mann and Hogness 1990).
5Moreover, changes in the HD sequence can affect its DNADbinding properties, whichcan lead to differential gene regulation (Otting et al. 1990). HDs have since beenimplicated in a broad spectrum of biological processes and found to be broadlyrepresented across eukaryotes.The HD is best known to be encoded by genes of the HOX clusters where thegenes within the cluster regulate anterior and posterior body development.
Drosophila have one HOX cluster while vertebrates have four. The four arose fromthe duplication of a single cluster, and the parologous HD sequences within theseclusters are highly similar (Burglin 2011). A cluster is an evolutionarily conservedtandem arrangement in the genome that spatially parallels the order of where theHDDcontaining genes function in embryo development. This phenomenon is alsoknown as colinearity, and was first demonstrated in Drosophila (NussleinDVolhardand Wieschaus 1980). HDs have since been expanded to various superclasses andclasses grouped by sequence similarity and function from different organisms,where some of these HDDcontaining genes are contained in clusters, while others aredispersed throughout the genome (Gehring et al. 1994a).While the HD was identified as a functional unit responsible for biologicalprocesses through DNA recognition, how HDs regulate these processes can alsorequire other domains or motifs. These associated domains or motifs, including zincfingers or POUDspecific domains, can be located either NDterminal or CDterminal tothe HD itself at variable distances from the HD (Burglin 2011). Additionally, HDscan also require cofactors to bind to the cisDregulatory element the HD is regulating.The yeast HD, MATalpha2, binds DNA cooperatively with either the MATa1 or Mcm1
6to regulate mating type switching of the yeast (Herskowitz 1989). Another wellDstudied example is how HOX proteins recognize their in vivo DNA sites. In
Drosophila, HOX factors require an interaction with the HD Exd for correct anteriorand posterior development (Mann et al. 2009).
General Homeodomain CharacteristicsThe HD typically consists of a sequence of sixty amino acids and binds to acore six baseDpair binding site where an invariant adenine is observed at base 3.The exact binding site length, however, may range from five to eight base pairsdepending on the HD. Residues 1D8 are part of an NDterminal arm, 10D22 are part ofthe first helix, 28D38 part of the second helix, and 43D57 is part of the third helix, alsoknow as the recognition helix. It is the recognition helix and the NDterminal armthat dictates the DNADbinding specificity of the HD, where the NDterminal armgenerally directs specificity of the 5’ part of the site and the recognition helix directs3’ specificity. Particular to the fold of the HD are 7 positions that are observed tocontain the same amino acids more than 95 percent of the time (Gehring et al.1994a). The HD sequence contains a hydrophobic core of amino acids, whichincludes: L16, F20, and mostly the invariant W48 and F49. Additionally, an almostinvariant N51 and well conserved residues R5 and R53 are involved in direct DNArecognition. The N51 is of particular importance to specifying the adenine at base 3.When base 3 is mutated to N7Ddeazaadenine to abolish only a single hydrogen bondwithin the binding site a greater than 100Dfold reduction in binding affinity to theHD is observed (Ades and Sauer 1995).
7Molecular Interactions Between the Homeodomain and DNAOriginal structures of the HDDDNA complex determined by NMR and XDraycrystallography elucidated how the gross structure of the HD interacted with DNAand showed some of the specific residues that interact with the binding site. The HDconsist of an NDterminal arm followed by a bundle of three alpha helices with thethird helix perpendicular to the first two (Figure 1D1), where the HD bearsresemblance to the helixDturnDhelix domain found in prokaryotes. To direct DNADbinding specificity, the recognition helix docks in the major groove of DNA, while theNDterminal arm interacts with in the minor groove. Contacts observed in theoriginal structure by NMR of Antp bound to the site TAATGG are residues I47, N50,and M54, which contact the bases. Residues R5 and Y8 of Antp were observed tomake contacts with the DNA backbone (Otting et al. 1990).The first XDray structure of a HDDDNA complex of Engrailed (En) to itscognate site, TAATTA, further identified critical contacts and revealed the moredetailed set of sideDchain interactions (Figure 1D2A) (Kissinger et al. 1990). Themost prominent interaction identified involved in HDDDNA recognition is theinvariant N51, where a bidentate hydrogen bond is made with the N7 and N6 of theadenine at base 3. The non sequenceDspecific interaction made by hydrogenbonding R53 to two phosphate groups of the DNA backbone was also identified.Greater details to interactions by the recognition helix identified by this crystalstructure include I47 making a hydrophobic contact with base 4, Q50 with van derWaals interaction with the complement of base 6, and the Q50 is observed to be in a
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9Figure 1?2
Figure 1?2: Cartoons of the multiple En variantDDNA structures show differentpossible interactions between the HD and DNA.Residue 47, 50, and 54 within the recognition helix are shown and the same coloringscheme is used from figure 1D1. (A) The first wildDtype En with its cognate site(TAATTA) structure (1HDD)(Kissinger et al. 1990), (B) higher resolution structureof wildDtype En with its cognate site (3HDD)(Fraenkel et al. 1998), (C) Q50A Envariant with the wildDtype En cognate site (1DUO)(Grant et al. 2000), (D) and Q50KEn variant with the site TAATCC (2HDD)(TuckerDKellogg et al. 1997).
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proximity where small changes in DNA conformation would allow intermolecularinteraction to occur with sugarDphosphate backbone contacts. The NDterminal armshows fewer, yet critical base specific interactions, which includes hydrogen bondsof R5 to base 1 and R3 to the complement of base 2.Since the original studies, numerous structures with greater resolution havefurthered the understanding of the intermolecular interactions between the HD andDNA. Multiple structures of En mutants with different residues at position 50 havedefined different intermolecular contributions to different binding site. While thewildDtype En Q50 shows additional waterDmediated contacts to base 4 and 5 to itscognate site (Figure 1D2B) (Fraenkel et al. 1998), a Q50A mutation imparts littleoverall rearrangement in interactions with the binding site, implying a modest rolefor Q50 in recognition (Figure 1D2C) (Grant et al. 2000). The structure of En withQ50K complex to the binding site TAATCC, however, demonstrates the importanceof residue 50 with a pair of hydrogen bonds from the lysine to the complementaryguanines of base 5 and base 6 (Figure 1D2D) (TuckerDKellogg et al. 1997). Thesecollective structures of En variants demonstrate that the interactions for a givenresidue in the HD to a binding site are contingent on the residue and basecombination present.Crystal structures of other HDs have further validated critical residues in theHD to interact with its binding site. Within the recognition helix, residues 47 and 54have also been show to interact with the bases 4 through 6 (Wolberger et al. 1991;Grant et al. 2000; Hovde et al. 2001), while residue 55 can interact with base 2(Passner et al. 1999; Piper et al. 1999). Within the NDterminal arm residues 2, 3, 5,
11
6, and 8 have been observed to interact with base 1 through 3 (Fraenkel et al. 1998;Hovde et al. 2001). Moreover, the NDterminal arm can specify a binding sitethrough the recognition of the minor groove shape as demonstrate by HDDDNAcomplexes comparing binding to two related DNA sequences that have differentminor grove shapes (Joshi et al. 2007). The structures of these HDDDNA complexestaken together with mutational analysis illustrate the specificity determinant setswithin the HD that can dictate its binding specificity to different binding sites.
Functional Residues for DNA?binding SpecificityAlongside solved structure of HDDDNA complexes, mutational analysis of HDshas clarified the functional role of a specific residue or groups of residues within theHD (Figure 1D3). These studies have shown that there is rarely a simple oneDtoDoneinteraction between a residue and base. Substituting key residues in a HD, either inthe recognition helix or the NDterminal arm, can change its binding specificity torecognize a site other than the HD’s cognate site. Early mutational analysis focusedon the role of residues in the recognition helix, where the S50K mutation in Prdallowed the mutated HD to recognize an alternate promoter (Treisman et al. 1989).Similarly, mutating Q50K within Ftz and Antp allowed these HDs to prefer adifferent binding site all together, switching from TAATTG to TAATCC (PercivalDSmith et al. 1990; Hanes and Brent 1991). Overlapping residues can also affect thespecificity of a given base position. Mutating I47N and A54R in En changes itspreference from TAATTA to TAACA, however, when either single mutation is made
12
in isolation only a subtle difference from the original binding preference is observed(Noyes et al. 2008a).The complexity of overlapping residues affecting specificity of a given baseposition and a residue affecting multiple bases is not strictly limited to therecognition helix. Mutating the residues 3, 6, and 7of Ubx to that of AbdDb changesthe preference of the homeodomain from TAATGG to TTATGG (Ekker et al. 1994).Likewise, mutating residues 6D8 of TTFD1 to those found in Antp changes thepreference from CAAGTG to TAAGTG (Damante et al. 1996). Moreover, an A8F inCaup can strengthen the specificity at base 1 and subtly change the specificity atbase 2 (Noyes et al. 2008a). A combination of mutations in both the NDterminal armand recognition helix of R3K and K55R changes the specificity of the En site formTAATTA to TGATTA (Noyes et al. 2008a). A total of R3K, 147N, Q50A, A45R, andK55R can dramatically change the specificity of En to TGACA, illustrating theflexibility in binding site specification of En (Noyes et al. 2008a). Collectively, thesestudies reveal the overall complexity and interdependence within the HD for whatare thought to be the general determinants of specificity (Figure 1D3).
Exploring the Recognition Potential of HomeodomainsWith the information present above one would speculate that the HD is ascaffold that is amenable to recognize a broader range of sites. This is, however, notwhat is observed of naturally occurring HDs that have had their DNADbindingspecificity measured. Moreover, some previous attempts at radical specificity
13
Figure 1?3
Figure 1?3: Previously published chart that catalog HD specificity determinants(Noyes et al. 2008a).The numbers with the boxes are amino acid positions that most likely influence thesequence preference at a particular base position (solid line, major groove; dottedline, minor groove), where an arrow points from the box of the potentialinteractions to the base within each described base pair.mple e sh ft t an n l e spec cit ( AATTA) is observ d. Ib Iition the b s spe ified by Arg54 i most atyp c l homeomains is reveal d T us hree di ferent potential specific i g speci c ty d mons r e that En s a r bust caf olde v d g ti ( ghe e re ul s h ghl g t h w th impact of anete minan (i.e., G
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alteration have not proven successful, possibly owning to the technology limitationsin creating large libraries at the time.HD specificity has not been observed to deviate far frommeasured ATDrichsequences (Figure 1D4). Specificities of characterized HDs have been shown totypically recognize a core TAAT site (Gehring et al. 1994b). Recent studiescharacterizing HD specificity in humans, mice, and flies have measured thecomprehensive HD DNADbinding specificities. The HDs measured for humans (146HDs) (Jolma et al. 2013), mice (168 HDs) (Berger et al. 2008), and flies (84 HDs)(Noyes et al. 2008a) grouped HD specificity into 14, 33, and 11 specificity groups,respectively, where the majority of HDs within these groups are recognizing ATDrichsequences (Figure 1D4).With the plethora of studies to understand the HDDDNA binding interface,there still appears to be difficulties in reengineering the HDs to recognize a broadrange of specific DNA sequences. This is demonstrated in a number of studies: Fullrandomization of residue 47 and 51 of the POU HD can only give rise to limiteddifferential HD binding of DNA sequences (Pomerantz and Sharp 1994).Reengineering the Mata alpha2 HD through substitutions at residue 50 did notresult in any variants with equal affinity to the parent HD or sequencediscrimination against its cognate DNA (Mathias et al. 2001). A study that tested 19En HD combinations of amino acids at residues 50 and 54 against 4 DNA sequencesonly resulted in moderate changes in DNADbinding specificity. Only one HD variantin this study showed different sequence discrimination than the parent HD, wherethe affinity of that HD variant was not as strong as the parent HD to its cognate site
15
Figure 1?4
Figure 1?4: Previously published clustering of sequence specificity groups based onfly HD sequence specificity appears limited (Noyes et al. 2008a).(A) While fly HDs are clustered in eleven specificity groups, (B) group specificitymotifs still appear very similar and limited.
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(Connolly et al. 1999). These studies imply that the HD is not amenable toreengineering that would expand the range of DNA sequences a HD could recognize.Nonetheless, the possible feasibility of the HD being amenable toward globalreengineering for recognition of a new DNA sequences was demonstrated whenlarger combinatorial alterations within the recognition helix were utilized.Reengineering En to recognize a DNA duplex containing an unnatural nucleotideshowed that a HD could be selected to recognize a different DNA sequence otherthan the HD’s cognate site with equivalent affinity and specificity resembling that ofthe natural HDDDNA interactions by randomizing residues 43D52 and 54 (Simon andShokat 2004). This particular study implies that a larger combinatorial approach toselecting HD variants may prove successful to broadly reengineer the HD torecognize a diverse range of sites.Here we challenge the view that the HD can only recognize such limited DNAsequences as demonstrated by previous literature. By doing so, we can examine ifthe HD scaffold is amenable to recognizing new DNA sequences if a larger, morecomplex library is utilized or if the HD sequence specificity will somehow still beconstrained. Moreover, exploring the recognition potential of the HD will examinethe degree to which the HD DNADbinding potential can be expanded and thediversity of protein sequence within the HD that can be obtained. By expanding theDNADrecognition potential of HDs, we can then catalog the novel specificitydeterminants to further predict HD binding specificity. Additionally, HDs with novelspecificity may be utilized in customizable sequenceDdirected nucleases fortargeting specific DNA sequences (see Chapter 3).
17
SummaryWe assert that HDs may have broader recognition potential than observedpreviously based on the large specificity analyses of naturallyDoccurring HDs. Thelimited recognition diversity observed in naturally occurring HDs is likely areflection of the limited diversity of residues that are contained within keyspecificity determinants of the characterized HDs. To test if the HD can recognize abroader range of sequences we attempted to globally reengineer the HD torecognize all TAANNN sites. By randomizing a combination of five residues withinthe recognition helix in En we selected HD variants to all 64 possible 3’ binding sites.Our study identified HD variants that preferentially bind to 44 of the 64 possible 3’binding sites, where the novel specificity determinants created a catalog of newspecificity determinants to further the understanding of HDDDNA specificity. Asubset of these HD variants showed similar affinity and specificity to the naturallyoccurring EnDbinding site combination. The specificity determinants were tested tobe robust in combination with 5’ specificity determinants and thus would be usefulto engineer HDs with a combination of 3’ and 5’ specificity. Our results expand theHD to specify a broader range of sequences than ever previously observed andshows that the HD is indeed a flexible scaffold amenable to broad reengineering.
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CHAPTER II
EXPLORING THE DNA?RECOGNITION POTENTIAL OF HOMEODOMAINS
Chapter II has been publish previously as:Stephanie W. Chu, Marcus B. Noyes, Ryan G. Christensen, Brian G. Pierce, Lihua J.Zhu, Zhiping Weng, Gary D. Stormo, and Scot A. Wolfe (2012). Exploring the DNADrecognition potential of homeodomains. Genome Research 22, 1889D1898 
Marcus B. Noyes performed the selections of HDs. Ryan G. Christensen created theimproved prediction model. Brian G. Pierce created the models of interactions.Lihua J. Zhu performed the statistical analysis.
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INTRODUCTIONHomeodomains (HDs) play a prominent role in regulating a multitude ofbiological processes in eukaryotes ranging frommating type switching in yeast toembryonic patterning in metazoans (Kornberg 1993; Gehring et al. 1994a).Emblematic of their central role in gene regulation, HDs are broadly representedacross eukaryotic species; in humans they are the second most common family ofDNADbinding domains (Vaquerizas et al. 2009). Consistent with their abundance,HDs display a diverse array of functions in development and cellDtype specification,and they can be subdivided into a number of distinct families based on commonsequence features and recognition motifs (Burglin 2011). SequenceDspecific DNArecognition is central to many aspects of the regulatory function of HDs and as aconsequence this characteristic has been extensively studied through genetic,biochemical, and structural analyses (Wolberger et al. 1991; Ades and Sauer 1994;Ekker et al. 1994; Gehring et al. 1994a; Damante et al. 1996; Fraenkel et al. 1998;Grant et al. 2000; Hovde et al. 2001; Babu et al. 2004; Joshi et al. 2007; Rohs et al.
2010; Slattery et al. 2011). HDs are typically composed of a ~60 amino acid motifthat folds into a threeDhelix bundle preceded by an NDterminal arm. SequenceDspecific recognition is mediated by the third (recognition) helix docking in the majorgroove and the NDterminal arm docking in the minor groove (Figure 2D1A) where aHD typically specifies a site of three to eight base pairs.Many specificity determinants central to sequenceDspecific DNA recognitionby HDs have been defined. A subset of these determinants function semiDautonomously, such that the transfer of a single residue between HDs can result in a
20
Figure 2?1
Figure 2?1: Structure of the engrailed HD and distribution of HD recognitionresidues.A) Structure of the engrailed HDDDNA complex (Fraenkel et al. 1998), which servesas the framework for library construction. The numbers (white) on the HDrecognition helix (yellow) indicate amino acid positions (green side chains) thatwere randomized, where the primary strand of the core 6 base pair binding site ishighlighted (green) to emphasize the proximity of these residues to the 3’ end of therecognition sequence. Asn51 (orange), which is highly conserved within thehomeodomain family is shown for reference. B) Frequency logo displaying thediversity of residues (circled in red are the residues randomized in the HD library)at various positions in the N51Dcontaining HDs in the genomes of humans, mice, D.
rerio, C. elegans, D. melanogaster, and S cerevisiae.
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predictable alteration in specificity. This is demonstrated by seminal studiesinvestigating the role of position 50 in the recognition preference of PRD, BCD andFTZ (Treisman et al. 1989; PercivalDSmith et al. 1990; Hanes and Brent 1991). Thecritical features determining sequence specific recognition by the NDterminal armremain nebulous and consequently achieving alterations in specificity typicallynecessitates the substitution of multiple residues between HDs (Ekker et al. 1994;Damante et al. 1996).Recent comprehensive analysis of HDs specificity in the mouse and fruit fly(194 and 84, respectively) have somewhat clarified the breadth of DNA sequencesHDs recognize in natural systems (Berger et al. 2008; Noyes et al. 2008a). Whilethese studies used different approaches for determining DNADbinding specificity,they are in general concordance on the core DNADbinding specificity of homologousHDs. Limited sequence diversity is observed in the residues at the criticalrecognition helix positions within most eukaryotes (Figure 2D1B), and there is acorresponding paucity in the diversity of preferred recognition sequences observedfor the characterized HD population (Berger et al. 2008; Noyes et al. 2008a). Thisfocused sequence preference is similar to many other families of DNADbindingdomains (Deppmann et al. 2006; Wei et al. 2010; De Masi et al. 2011), and could bethe result of a general constraint of the domain architecture on its recognitionpotential. Consistent with this conjecture, previous attempts to select HDs withnovel specificity have not succeeded in achieving dramatic alterations in recognitionpotential (Pomerantz and Sharp 1994; Connolly et al. 1999). These attempts,however, allowed variation at only a modest number of recognition positions. Thus,
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it remains possible that HDs can recognize a broader range of DNA sequences thanis currently observed.Here we describe radically reengineering the DNADbinding specificity of the
engrailed homeodomain to clarify the general recognition properties of this family.We systematically selected HD variants from a randomized library against all 64possible combinations of the target site TAANNN. From these selections we wereable to recover HDs that preferentially recognize 44 of the 64 sites, far more thananticipated based on the characterized set of extant HDs. The majority of these HDsharbor distinct combinations of specificity determinants, many of which appear tobe uncommon or absent in extant HDs. These determinants expand ourunderstanding of HD recognition, allowing the creation of more explicit recognitionmodels for this family. The potential for this domain to recognize a broader range ofDNA sequences raises questions about the fitness barrier that restricts the evolutionof more diverse recognition properties for this family in natural systems.
RESULTS
Selection of homeodomains with novel DNA?binding specificity.To explore the DNADrecognition potential of homeodomains (HDs), weinvestigated their ability to specify all possible TAANNN sites by selectingcompatible HDs from a randomized library. These selections were performed usingour bacterial oneDhybrid (B1H) system (Noyes et al. 2008a; Noyes et al. 2008b),where the HD library is expressed as a fusion to two zinc fingers that position thelibrary over the preferred target site (Figure 2D2). The engrailed (en) HD was
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chosen as the library backbone because it is amenable to substitutions that changeits DNADbinding specificity (Ades and Sauer 1994; TuckerDKellogg et al. 1997; Noyeset al. 2008a).Recognition of the 3’ region (bases 4, 5, & 6) of the HD binding site ismediated by specificity determinants within the recognition helix. To select HDvariants with altered sequence recognition preferences, residues 43, 46, 47, 50, & 54were fully randomized (Figure 2D1). These positions, which all point toward themajor groove in the ENDDNA complex, were chosen based on their potential functionas primary or secondary recognition determinants within the 3’ region of the targetsite. Direct baseDspecific contacts have been observed between residues 47 and 54and base 4, as well as between residue 50 and bases 5 and 6 (Wolberger et al. 1991;TuckerDKellogg et al. 1997; Fraenkel et al. 1998; Passner et al. 1999; Piper et al.1999; Grant et al. 2000; Joshi et al. 2007), where sequence alteration at thesepositions has a direct influence on specificity (Treisman et al. 1989; PercivalDSmithet al. 1990; Hanes and Brent 1991; Damante et al. 1996; Noyes et al. 2008a).Residues at positions 43 and 46 play a more subtle role in recognition (Kissinger etal. 1990; Fraenkel et al. 1998; Mahony et al. 2007; Noyes et al. 2008a). Oneadditional prominent determinant, position 51, is almost exclusively asparaginewithin the extant HD population, where it specifies adenine at base 3. This positionwas held constant in our library, in anticipation that our selected HDs could be usedto inform a predictive recognition model for extant HDs.
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Selections employing the HD library were performed separately against eachof the 64 TAANNN sites to recover interacting HDs. We observed variability in theselection stringency required to cull the population down to 1000 to 2000 survivingclones for each target site (Figure 2D3). Overall, selections employing the HD libraryyielded a 20 to 200Dfold increase in surviving colonies when compared to a negativecontrol entirely lacking the homeodomain. Sequencing the recovered clones fromeach target site yielded a catalog of approximately 4.4 x 104 HDs (Online ProcessedIlumina Supplemental Table S3*), and revealed striking amino acid preferences atsome randomized positions within populations recovered from different target sites(Figure 2D4). Some of these preferences were anticipated based on prior studies ofHD specificity (Wolberger et al. 1991; Ades and Sauer 1994; Passner et al. 1999;Noyes et al. 2008a), but many appear to represent novel determinants.
Analysis of selected homeodomains.Prominent HD positions influencing base preference were identified byMutual Information analysis on the catalog of selected HDs for each target site(Mahony et al. 2007). This analysis identified positions 47, 50 and 54 as strongcontributors to 3’ specificity, whereas positions 43 and 46 appeared to have littleglobal influence on the 3’ site preference (Table 2D1). Significant covariation wasobserved between residues 47 and 54, and base 4. In addition, a moderate degree ofcovariation is observed between both of these residue positions and base 5.Moderate covariation is also observed between residue 50 and all of the 3’ basepositions but is most pronounced with base 6. The most significant relationships
26
Figure 2?3
Figure 2?3: Stringency used to select HDs for different target sites.Chart indicating the stringency used to select HDs for each of the 64 TAANNN sites.The bases present at positions 4, 5 (left of rows) & 6 (above each column) areindicated, where the number in each cell represents the concentration of 3DAT (mM)used for selection against that target site.
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Figure 2?4
Figure 2?4: Logos representing the sequences of the recovered HDs from eachtarget site selection.Frequency logos representing the top 200 unique HDs sequences recovered for eachof the 64 target sites from Illumina sequencing. Red circles indicate the randomizedpositions in the HD library.
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Table 2?1. Mutual Information analysis of the selected homeodomainDbinding sitecombinations Base Position 4 Base Position 5 Base Position 6Residue 43 0.06 0.02 0.02Residue 46 0.08 0.06 0.09Residue 47 0.71 0.31 0.10Residue 50 0.31 0.40 0.53Residue 54 0.77 0.37 0.07Mutual Information analysis indicates strong (bold) and moderate contributors to 3’specificity from residues 47, 50 and 54, indicating they are the primarydeterminants that influence specificity at base positions 4, 5 and 6. All values withinthe table are significant with pDvalue < 0.001.
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identified between HD position and binding site position are consistent withpreviously published structural and biochemical data (Treisman et al. 1989;PercivalDSmith et al. 1990; Hanes and Brent 1991; Wolberger et al. 1991; Damanteet al. 1996; Noyes et al. 2008a).
Defining the specificity of selected homeodomains.In an attempt to distinguish selected HD variants that can preferentially bindto each of the 64 TAANNN sites from those that can merely associate favorably witha target site, we determined the DNADbinding specificity for 151 HD variants (Figure2D5, and Online Processed Illumina Supplemental Table S6*). HDs variants werechosen for analysis based on their overlap with the consensus sequence recoveredin each selected population or the presence of combinations of recognition residuesthat were deemed interesting (Figure 2D4 and Online Processed IlluminaSupplemental Table S3*). For example, in anticipation of identifying a HD variantthat specifies TAACGG, we characterized a clone containing residues R47, E50, andR54 that reflects the predominant consensus sequence recovered for this target site.Preferential DNADbinding specificity for each HD was determined using the B1Hsystem (Noyes et al. 2008a) where the entire population of hundreds to thousandsof recovered binding sites was sequenced to construct a recognition motif (Figure 2D5). Based on this analysis, we are able to identify HD variants that preferentiallybind to or are compatible with 44 out of the 64 target sites (Figure 2D6), which
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Figure 2 5.1
1_RTVAA 2_RTVSA 4_VRVSA
5_TRVAA 6_VRVAA 7_RVLRA
8_RVVSQ 9_KTTQD 10_KSVMQ
11_KSVAQ 12_RGVAA 13_ATVKA
14_KGTQM 15_RMIKS 17_TRVSA
18_RLTQA 19_RMVSA 20_QRVSA
21_ERVSV 22_RITAA 23_GTRAY
24_HLIQY 25_YTRQV 26_ALKNM
27_LTKDQ 28_RSKER 29_TLKNQ
30_LAKDQ 31_KITKF 32_VRLKY
33_ALRQQ 34_RTMRY 35_VMRWY
36_ATRRF 37_RFQKF 38_LHYAK
Sup lem n
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Figure 2?5.2
39_IFNAK 40_STRER 41_RVMSR
42_TFYAA 43_MTNGK 44_RGDSK
45_RCYEK 46_RLDSK 47_KMTQK
48_EHNAK 49_LSQSR 51_MSHWR
52_LGMRR 53_ERVSR 54_LMYQR
55_LHYVR 56_HRVQA 57_LTYQW
58_RVYQW 59_TRMAF 60_KTVQV
61_KGKEW 62_SHKEY 63_QSRNV
64_AFRAH 65_GSRWY 66_KTSHM
67_MKYEK 69_VKYER 70_KTSHM
71_MTNNR 72_KMSNF 73_KLTAF
74_STSAH 75_SISRF 76_RAQWF
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Figure 2?5.3
77_KEYVH 168_SRYDR 201_VRVSQ
202_NAREF 203_VQKRF 204_RTDRY
205_TQRQW 207_ITYGK 208_HFNRK
209_PRDSR 210_RSNQK 211_TKNQN
212_RVTNA 213_KMKES 215_KRLAA
216_NRVMM 217_KSKEG 218_KQNQK
219_KVYER 220_LTYQK 221_RLYQK
222_SKYGK 223_RTFGK 224_IMNSK
225_SLQRF 226_KMISA 227_YRIAA
228_KMLQA 229_GRISA 230_ERISQ
232_IKNQM 233_VMNQQ 234_AMVQR
235_RAVSV 236_KSTQM 237_YAVNA
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Figure 2?5.4
238_QRISV 239_RTVRA 240_SSRGF
241_GLRAF 242_LQRGA 243_ATKSM
244_KMKSV 245_RAVKW 246_ISVKY
247_RTDRS 249_QLKQS 250_AGKTF
251_VGYSR 252_LRYSK 253_VANSR
255_RADGK 256_RLYQK 257_KLCSR
258_RTVQQ 259_KMYAW 260_KAYNA
261_KSKEA 262_QFRAW 263_VRFAA
264_KVYHV 265_WYSKY 266_KACHS
267_RVSHT 268_KLQAF 269_KVTNF
270_RAQWF 271_KLQRF 272_VAQRC
301_RSQWH 302_LRWNS 303_VMNRK
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Figure 2?5.5
Figure 2?5: DNADbinding specificity of selected HD variants.The calculated recognition motifs (bit scale) determined for each HD variant usingthe randomized 10Dbase pair library. The clone ID numbers and the amino acidsthat are present at the randomized recognition positions (43,46,47,50 & 54) areindicated above each motif.
304_TTNQK 305_VGRLY 306_RHDRA
307_RYDRA 308_RLDRF 309_RLDRY
310_YRRGA 311_YRRGF 12En_AKIQA
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Figure 2?6
Figure 2?6: Selected HDs with favorable recognition preferences for each targetsite.A grid illustrating the selected HD variants that preferentially recognize or arecompatible with particular 3’ binding site sequences. The amino acids that arepresent at the randomized recognition positions (43,46,47,50 & 54) are indicatedabove each motif. Sequences in red indicated those that are present in more thanone grid position (i.e. are compatible with 2 different sites). Empty boxes indicatedthe absence of quality HD recognizing these sequences.
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represents a sizeable expansion of the 3’ specificities observed in characterizedextant HDs (Figure 2D7). Our analysis of specificities further clarifies the significantassociation of specificity determinants with certain sequence preferences (AppendixTable AD1) and validates many novel specificity determinants (Figure 2D8 andAppendix Table AD2). Although, this analysis expands the number of primarydeterminants that can dictate recognition preferences, it is not possible to codifyDNA recognition as a set of independent determinants because of the overlappinginfluence of neighboring determinants. Moreover, specifying some sequencefeatures, such as T at base 6, appears challenging in any sequence context with thisHD backbone and randomization scheme.
Sequence discrimination by homeodomain variants.We determined the affinity and specificity of a subset of HD variants fordifferent binding sites in vitro using electrophoretic mobility shift assays. For thisanalysis, a subset of seven HDs were chosen that span members with both wellDdefined and novel specificity determinants (Table 2). In all cases, the apparentequilibrium dissociation constant of each HD for its cognate site was similar to theaffinity of Engrailed for its cognate site (Figure 2D9). Cold competition assays wereemployed to determine the degree of discrimination of each HD variant between itscognate site and the parent Engrailed binding site (Figure 2D10). The difference inthe free energy of binding the cognate and parent site ranged from 0.8 to 2.2kcal/mol, where binding the cognate site was always favored (Table 2D2). Thedegree of discrimination determined for En between its preferred site, TAATTA, and
37
Figure 2?7
Figure 2?7: Diversity in the specificity of extant HDs.A grid illustrating the different 3’ specificities found in previously measured extantHDs from Noyes M.B and colleagues (Noyes et al. 2008a), Berger M.F. and colleagues(as denoted by *) (Berger et al. 2008), Steadman D.J and colleagues (as denoted by@) (Steadman et al. 2000), and Jauch R. and colleagues (as denoted by #) (Jauch etal. 2008).
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Figure 2?8
Figure 2?8: Robust specificity determinants observed in the selected HDs.(A) Canonical recognition pattern for HDDDNA interaction At the 5’ end of thebinding site (bases 1, 2 and 3), positions on the recognition helix (solid boxes) andthe NDterminal arm (dashed boxes) contribute to specificity, where the position(s)of the contributing determinants are indicated to the left of the base pair. At the 3’end of the binding site (bases 4, 5 and 6), homeodomain specificity is primarilydefined by positions 47, 50 & 54, where these determinants have overlappingregions of influence. Solid arrows indicate primary positions of interaction anddotted arrows indicate secondary influences on specificity. (B) New specificitydeterminants (blue) and previously described specificity determinants (black) forHDs containing the conserved N51 are broken down by position and trends in basepreference within the three basepairs at the 3’ end of the target site. Note: there areexceptions within our characterized HDs to these specificity preferences, likelyreflecting the overlapping influence of these determinants.
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Table 2?2. Equilibrium dissociation constants of homeodomain variantsHD variant(Cognatesite) Kd,app a (nM) hb Kc,app c (nM),Cognate site Kc,app c (nM),engrailed site RelativeAffinityd ΔΔG(kcal/mol)ATVKA(taaTCC) 4.40 ± 2.09 1.51 ±0.19 3.17 ± 0.51 41.87 ± 4.25 13.22 1.52HLIQY(taaGTG) 1.52 ± 0.08 1.57 ±0.09 1.04 ± 0.11 16.64 ± 0.61 16.06 1.64ERVSR(taaCAC) 19.09 ± 4.56 2.04 ±0.11 14.00 ± 4.15 66.37 ±22.40 4.74 0.91TRMAF(taaATC) 4.03 ± 1.00 1.61 ±0.22 1.74 ± 0.37 6.78 ± 1.65 3.90 0.80TQRQW(taaGTA) 3.71 ± 1.31 1.99 ±0.22 4.87 ± 0.21 193.72 ±9.63 39.75 2.17RSNQK(taaCCA) 9.83 ± 1.18 1.75 ±0.12 8.92 ± 1.30 37.13 ± 7.33 4.16 0.85LAKDQ(taaGGA) 5.69 ± 1.91 1.61 ±0.21 3.50 ± 2.62 85.23 ±26.52 24.37 1.89EngrailedAKIQA(taaTTA) 2.34 ± 0.15 1.44 ±0.08 0.74 ± 0.18 15.93 ± 4.73* 21.59** 1.81
aApparent equilibrium dissociation constant as determined by EMSA. bHillcoefficient (h) as determined by EMSA. c Apparent equilibrium dissociation constantas determined by cold competition with indicated sequence. d Relative affinity(Kc,app engrailed site/Kc,app Cognate site). * The Kc,app measured for the Engrailed HDis with the TAATCC site. ** The relative affinity for Engrailed (Kc,app TAATCCsite/Kc,app Cognate site) is similar to that which was previously reported (Ades andSauer 1994).
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Figure 2?9
Figure 2?9: Determination of the dissociation constant for each HD variant.Apparent equilibrium dissociation constant as measured by EMSA for the HDvariant TQRQW.
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Figure 2?10
Figure 2?10: Determination of the dissociation constant for different binding sitesthrough cold competition.Apparent equilibrium dissociation constants were measured by cold competition forthe HD variant TQRQW. The degree of competition achieved by titration of a coldcompetitor duplex containing (A) its preferred binding site, TAAGTA, or (B) the
engrailed binding site, TAATTA, was measured by the decrease in complexformation with the labeled preferred binding site as a function of increasingconcentration of the competitor.
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TAATCC (22Dfold), which served as our internal control, was nearly identicalto the difference previously reported by Sauer and colleagues (Ades and Sauer1994). The TQRQW HD variant (selected HD variants are identified by the 5 aminoacids selected at the randomized positions) has the greatest discrimination againstthe Engrailed site, displaying a 40Dfold preference, while the TRMAF HD variantdisplays a modest 4Dfold preference for its target sequence. Thus, our selected HDsdisplay a consistent preference for their identified cognate site outside the B1Hsystem.
Robust behavior of new specificity determinants.To determine if the newly observed specificity determinants are able todefine similar DNA sequence preferences in the context of other HD backbones wegrafted the 5 key residues, residues 43, 46, 47, 50, and 54, from each of the seven HDvariants within the sample set into three other D. melanogaster HD backbones: Dfd,Scr, and Ubx. These HDs share 53%, 51%, and 46% identity with Engrailed,respectively. We then determined the DNADbinding specificity of all these variantsusing the B1H system (Figure 2D11 and Figure 2D12). In almost every instance thegrafted residues altered the DNADbinding specificity of each Hox factor in apredictable manner, in agreement with the previously defined DNADbindingspecificity in the Engrailed backbone. In a few instances, such as HLIQY, theintroduction of these residues into the Hox backbone slightly altered 5’ sequencepreference. This alteration may indicate weak indirect effects of these altered
43
Figure 2?11
Figure 2?11: Robust function of the new specificity determinants.Grafting key residues (43, 46, 47, 50 & 54) selected from the Engrailed library intothe HD backbone of the Hox factor Deformed transforms its sequence preference toresemble the corresponding selected HD mutant.
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Figure 2?12
Figure 2?12: Robust function of these New specificity determinants.Grafting key residues (43, 46, 47, 50 & 54) selected from the engrailed HD libraryinto the HD backbone of the Hox factor Dfd, Scr or Ubx results in a factor with asimilar binding preference to that observed when the key residues are present inEngrailed.
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determinants on the 5’ base preference, potentially through interactions withresidues 51 and 55, which can influence 5’ specificity.We also examined the influence of different 5’ specificity determinants on the3’ specificity of our selected HDs. Previous studies have shown that residues 3 and55 influence the specificity at base 2, where the presence of K3 and R55 willpreferentially recognize G over A (Passner et al. 1999; Piper et al. 1999; Noyes et al.2008a). We introduced the mutations R3K and K55R into the Engrailed backbonefor three HD variants (STRER, KVYER, and NRVMM) and determined their DNADbinding specificity (Figure 2D13). In all cases we observe a shift in specificity from Ato G at position 2 without substantial alteration in base preference at the otherrecognition positions. The robust behavior of our new specificity determinantssuggests that they will serve as useful parameters for the prediction of DNADbindingspecificity in extant HDs.
Computational models of the interactions mediating sequence?specific DNA
recognition.We utilized the Rosetta molecular modeling package, which has recentlyundergone significant revision for proteinDDNA complexes (Yanover and Bradley2011), to predict the baseDspecific interactions between our sample set of seven HDsand their cognate sites. These structural calculations used a high resolutionEngrailedDDNA coDcrystal complex as a starting model (Grant et al. 2000). In anumber of instances, the calculated structural models yielded determinant – baseinteractions that are consistent with the correlated sequence preferences observed
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Figure 2?13
Figure 2?13: Supplemental Figure 9. New specificity determinants function with5’ specificity alterations.Mutating the 5’ specificity determinants R3K and K55R specifically alters 5’ bindingpreference from TAANNN to TGANNN while the 3’ binding preference remainsunchanged.
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Figure 2?14
Figure 2?14:Modeling of HD variants.(A) Cocrystal structure of Engrailed bound to TAATTA (Fraenkel et al. 1998). (B)Model of HD variant STRER bound to its cognate site taaCGG. (C) Model of HDvariant LAKDQ bound to its cognate site taaGGA. (D) Model of HD variant RSNQKbound to its cognate site taaCCA. Dotted lines indicate interactions between theprotein and DNA (either hydrogen bonds or van der Waals interactions) where thenumerical values indicate the distance in angstroms.
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Figure 2?15
Figure 2?15: Additional modeling of HD variants.(A) Model of HD variant ATVKA bound to its cognate site taaTCC. (B) Model of HDvariant ERVSR bound to its cognate site taaCAC. (C) Model of HD variant TRMAFbound to its cognate site taaATC. (D) Model of HD variant RVSHT bound to itscognate site taaACA. (E) Model of HD variant TQRQW bound to its cognate sitetaaGTA. (F) Model of HD variant HLIQY bound to its cognate site taaGTG. (G) Modelof HD variant KLTAF bound to its cognate site taaGTA. (H) Model of HD variantRTMRY bound to its cognate site taaGAC. (I) Model of HD variant RSKER bound toits cognate site taaGGC. (J) Model of HD variant MSHWR bound to its cognate sitetaaCAG. Dotted lines indicate interactions of less than 4 Å between the protein andDNA (either hydrogen bonds or van der Waals interactions).
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within our dataset of selected HDs allowing the potential roles of thesedeterminants to be inferred (Figure 2D14 and Figure 2D15). For example, K47 in theLAKDQ – TAAGGA structural model positions the primary amine of this lysinebetween the O6 carbonyls of G4 and G5, mimicking the observed interaction of K50with a pair of guanines on the complementary strand in the Q50K En – DNAstructure (TuckerDKellogg et al. 1997).
Improved predictive models of homeodomain specificity.Previous efforts to predict the DNADbinding specificity of HDs based on theiramino acid sequence have focused on nearest neighbor estimates of specificity(Noyes et al. 2008a; Alleyne et al. 2009). We have recently shown that when highquality alignments of recognition motifs can be obtained, improved recognitionmodels of HD specificity can be achieved using Random Forest based methods(Christensen et al. 2012). This recognition model, which is trained on the existingdata for extant HDs, is a poor predictor of DNADbinding specificity for our selectedHDs (MSE = 0.053; Appendix Table AD3). This deficit in predictive accuracy wasexpected given the increased diversity of recognition residues that are present inour selected HDs (Figure 2D16). Reassuringly, we found that a new recognitionmodel trained only on the selected HDs performed reasonably well in the predictionof the extant HD set (MSE = 0.025; Supplemental Table S9), suggesting that much ofthe recognition repertoire that is present in the extant set is found in our selectedHDs (Figure 2D17). In a 10Dfold cross validation analysis, a joint recognition modelbetween the selected and extant HDs provides excellent accuracy in the prediction
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Figure 2?16
Figure 2?16: Limited diversity at the key recognition positions is observed in extantHDs.(A) Frequency logo displaying the diversity of residues (circled in red are theresidues randomized in the HD library) at various positions in the N51DcontainingHDs of humans, mice, D. rerio, C. elegans, D. melanogaster, and S. cerevisiae. (B)Frequency logo representing the diversity of residues found in our selected HDs thatwere characterized using the ZF10 library.
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of HD specificity within our mutant set (MSE = 0.014; Appendix Table AD3). Tofacilitate the prediction of HD specificity, we have constructed a website(stormo.wustl.edu/PreMoTF.v2) that incorporates our improved recognition model.Users can enter the amino acid sequence of a protein containing one or more HDs,and the algorithm will extract each HD sequence and generate a predictedrecognition motif and representative Position Frequency Matrix (PFM). Whentested on mouse HDs the predicted PFMs were very similar to those obtained byanalysis of PBM data using BEEMLDPBM (Pabo and Sauer 1992). Using this modelwe have also populated a page that displays predicted recognition motifs for themajority of the human HDs to facilitate the use of this data in constructingtranscription regulatory networks within the human genome (Appendix Table AD4).
DISCUSSIONIn this study we performed an unbiased assessment of the breadth ofsequences that HDs can specify by selecting variants of Engrailed that wouldpreferentially recognize each of the 64 possible TAANNN binding sites. Using ourselection system, we recovered HDs that preferentially recognized 44 of these sites(Figure 2D6); a dramatic increase in the diversity of described recognitionsequences. Many of these new sequence preferences are mediated by novel 3’specificity determinants that are functional when incorporated into independent HDscaffolds (Figure 2D11, Figure 2D12, and Figure 2D13).Consistent with prior studies on HDs, Mutual Information analysisdemonstrates critical overlapping roles for the residues at positions 47, 50, and 54
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for 3’ base recognition. The overlap between these determinants may representeither direct or indirect effects, however at the level of individual subsites onedeterminant typically dominates base preference at a specific subsite position. Forexample, while strong covariation is observed between residues 47 and 54, and base4 (Table 1), K54 is highly preferred for recognition of CYN subsites whereas therecovered residue at position 47 is more variable. The presence of a positivelycharged residue at positions 43 or 46 is anticorrelated over the entire dataset(Appendix Table AD5) suggesting that these residues tune the overall affinity of theHD by adjusting electrostatic interactions with the phosphodiester backbone. Theseand other positions may also be responsible for more subtle sequence preferencesthat have been observed in Protein Binding Microarray analysis of HD specificity(Berger et al. 2008) that potentially lead to discrimination of TFs between differentbinding sites of moderate affinity (Badis et al. 2009).The diverse and potentially independent assortment of specificitydeterminants within our dataset provides a foundation for constructing moreaccurate predictive models for 3’ DNADrecognition by HDs. While significant prioreffort has been expended on characterizing HD recognition, the functionality ofspecific determinants at critical recognition positions has remained poorly definedand as a consequence past predictive models of HDDDNA recognition have relied onnearestDneighbor type analyses (Noyes et al. 2008a; Alleyne et al. 2009). Thesemodels perform poorly when trying to predict the specificity of our selected HDs,which likely results from a lack of amino acid diversity at the key determinantpositions within their training sets (Figure 2D1). In the context of our improved
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predictive models, we can predict 3’ specificity of a representative set of extant HDswith reasonable accuracy (Appendix Table AD4) and a predictive model combiningall of the available data provides superior performance in predicting HD specificity.Thus, selectionDbased interrogation of HD recognition can inform predictive models,much as it has for Cys2His2 zinc finger proteins (Benos et al. 2002; Koshland 2002;Liu and Stormo 2008; Persikov et al. 2009; Persikov and Singh 2011).Our ability to select HDs with radically different specificity fromcharacterized extant HDs, where novel sets of specificity determinants areemployed, raises questions as to why extant HDs appear to be constrained in theirdiversity at the key recognition positions? Naively, we expect nature to exploit thefull recognition potential of this domain to make a variety of orthogonal regulatorsfor the independent function in transcriptional regulatory networks. Thischaracteristic is observed in the largest family of DNADbinding domains, Cys2His2zinc fingers (Emerson and Thomas 2009), where comparison of zinc finger proteinsacross the mouse and human genomes indicates that this family is rapidly evolving(Myers et al. 2010), which is presumably creating factors with novel specificities.This diversity in ZFP recognition potential is even manifest within the humanpopulation, where differences in the fingers present in PRDM9 and their resultingspecificity leads to difference in the location of meiotic recombination hotspots inindividuals (Baudat et al. 2010). In this regard ZFPs appear to be an outlier, as mostother wellDcharacterized families of DNADbinding domains (Deppmann et al. 2006;Wei et al. 2010; De Masi et al. 2011) DD like HDs DD display limited diversity in theircore recognition motifs and the recognition residues that they employ. It is possible
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that the recognition potential of these other families of DNADbinding domains aresimilarly constrained. For HDs, the source of the selective pressure limiting theemployed diversity of recognition residues is unclear, but understanding its originwould provide insight into the fitness barriers that influence the evolution of noveltranscriptional regulatory networks in organisms.In many instances HDs function as complexes with other DNADbindingdomains to exert their gene regulatory function (Mann et al. 2009). This aspect ofrecognition is critical for the biological function of many of these factors, wherecomplex formation can alter that recognition preference of the component HDs. Themost thoroughly characterized example of the influence of partner association onrecognition is the HoxDPbx heterodimer, where minor groove features play criticalroles in defining sequence preference for this complex (Joshi et al. 2007; Slattery etal. 2011). In general, the role of residues within and neighboring the NDterminal armin DNA recognition remain poorly defined, although there is evidence that sequencepreference may be driven by complementarity to DNA sequenceDdependent minorgroove width (Slattery et al. 2011; Jinek et al. 2013). We have demonstrated thatsome of our selected HDs can tolerate changes that alter 5’ sequence recognition,but the degree of crosstalk between the recognition residues in the 5’ and 3’segments of the binding site remains poorly defined. A selectionDbased analysis ofthe recognition potential of the NDterminal arm could help to clarify the roles ofindividual positions in minor groove recognition.Our archive might present an opportunity to employ these domains ascomponents of artificial transcription factors or endonucleases. The area of
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engineered DNADbinding domains has primarily been the purview of ZFPs (Urnov etal. 2010), however, efforts to engineer ZFPs to recognize a wide variety of targetsites using public archives have been most successful for guanineDrich binding sites(Ramirez et al. 2008; Zhu et al. 2011). HDs provide potential utility in therecognition of ADT rich sequences, and in the context of zinc fingerDHD chimeras(Pomerantz et al. 1995; Rivera et al. 1996) may have utility in expanding thesequences that be efficiently targeted by zinc fingerDbased artificial nucleases.
MATERIAL &METHODS
Construction of the homeodomain (HD) library. A pB1H2ω2D12En (Noyes et al.2008a) (pB1H2ω2D12En(SB)) construct was created with the followingmodifications to the original engrailed (en) sequence: restriction sites SacI & BamHIwere installed for use with cassette mutagenesis of the recognition helix throughintroduction of a synonymous mutation at L38 and a T60G mutation, respectively(Appendix Table AD6). The randomized recognition helix was cloned into the SacIand BamHI sites of pB1H2ω2D12En(SB) by the direct ligation of the followingphosphorylated and annealed three oligonucleotide: EN K55 library, EN Library 5pcomp, and EN Library 3p comp (Appendix Table AD6). Following transformationinto electrocompetent XL1Blue cells, the library was plated on 20 150mm 2xYTplates containing 100ug/ml carbenicillin and incubated at 37oC overnight. Therecovered library size was 1.3x108 where the theoretical library size, 3x107, wasover sampled 3D4 fold.
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Design of the target binding sites for the selection of HDs. The 64 target sites(GGCCGCnnnTTAGCTGGGCGGGACG) for use with the HD Library selections werecloned between the NotI and EcoRI site in pH3U3 (Noyes et al. 2008b). The boldnnnTTA element is the reverse complement of the 6bp HD target site TAANNN,where the NNN represents each of the 64 possible 3bp combinations. The boldTGGGCG element is the Zif12 binding site, which is positioned 10bp upstream the D35 box.
Bacterial?One Hybrid (B1H) selections with the HD library. Each HDlibrary/TAANNN selection in the B1H system was performed basically as previouslydescribed (Noyes et al. 2008b). For each selection at least 1x108 dual transformants(of HD expression vector and binding site reporter vector into the selection strain)were plated on NMmedia supplemented with 1uM IPTG and 200uM uracil. Thestringency of each selection was adjusted such that 1000D2000 colonies wererecovered (Figure 2D3). About 24 colonies were initially sequenced to confirm thesuccess of the HD selections. Subsequently, recovered HD library members wereidentified via Illumina sequencing. Surviving colonies from each selection werepooled and prepared for sequencing as previously described (Gupta et al. 2010). HDclones were amplified using a forward primer(CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTATGCTTGCCCTGTCGAGTCC) andreverse primer (CTTAATGCGCCGCTACAGGGC), where the forward primerincorporated the Illumina P2Dadapter sequence (bold). Each PCR product was thendigested with either BamHI or XbaI for the ligation of barcoded P1 adapters(Appendix Table AD7 & AD8) prior to Illumina library generation and sequencing.
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Mutual Information (MI) and other statistical data analysis. The catalog ofapproximately 44,000 selected HDs identified by Illumina sequencing for the 64target sites was used to calculate MI between the randomized positions within theHD and base positions 4, 5, and 6 in the DNA target site as previously described(Mahony et al. 2007). Significance was determined by calculating the MI for a set ofrandomly associated selected recognition helices to the 64 target sites performedone thousand times followed by a nonDparametric test used to derive a nulldistribution where a pDvalue < 0.001 for each MI value was considered significant.The twoDsided Fisher Exact Test was applied to assess significant associationbetween the positive charge status at position 43 and that at position 46 for HDsrecovered for each of the 64 binding sites and all binding sites combined. The oddsratio and its 95% of confidence interval were computed for each triplet andcombined using the fisher_test function based on conditional maximum likelihoodestimation. These statistical analyses were performed using R, a system forstatistical computation and graphics (Ihaka and Gentleman 1996). To adjust formultiple comparisons for the 64 binding sites, pDvalues were adjusted using BDHmethod (Enuameh et al. 2013a) where sites with adjusted pDvalue < 0.05 wereconsidered significant.
B1H selections of HD variants with the ZF10 library. All HD variantscharacterized from the HD library selections were sequences that were directlyisolated from colonies on the selection plates, either from direct isolation ofindividual clones or the reconstruction of variants identified by Illumina sequencingthrough the ligation of phosphorylated and annealed oligonucleotides into
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pB1H2ω2D12En (Appendix Table AD9). Each ZF10 library/HD variant selection wasperformed as previously described (Noyes et al. 2008a) except that all selectionswere plated on NMmedia supplemented with 5mM 3DAT, 1uM IPTG, and 200uMuracil. Recovered ZF10 library members were identified via Illumina sequencing aspreviously described (Gupta et al. 2010) except that the initial PCR product wasdigested with either BamHI or NcoI for the ligation of barcoded P1 adaptors(Appendix Table AD7 and AD10). Overrepresented sequence motifs were identifiedusing MEME (Bailey and Elkan 1994) from the top 1000 most frequently occurringunique sequences within the Illumina dataset except for the grafted HDs where thetop 500 most frequently occurring unique sequences were used. Additionalsequences were included in cases where they had the same of reads as the oneDthousandth (or fiveDhundredth) sequence in the set. The input parameters used forMEME were zero or one motif per sequence (zoops), 4 bases as the width minimum,10 bases as the width maximum, while all other parameters retained the programdefault settings. Recognition motifs for each HD were then constructed aspreviously described (Zhu et al. 2011) by weighting the number of reads for eachsequence that comprise the most significant motif identified by MEME, where thenumber of sequences input for motif discovery and incorporated into each motif isreported in Supplementary Table 6
Expression and purification of proteins. Each HD variant was expressed inRosetta2(DE3)pLysS cells as CDterminal fusions to a purification tag sequenceconsisting of a HisD6 tag, maltose binding protein (MBP), and Tev protease cleavagesite. Cells were lysed by sonication. Protein was purified from the lysates using
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Amylose Resin (New England Biolabs) and then was eluted from the Amylose Resinin binding buffer without BSA and IGEPAL CAD630 (25mM NaCl, 10mM TrisDHCl pH7.5, 0.1mM EDTA, 1mM DTT, and 5% glycerol) supplemented with 40mMMaltose.Protein concentrations were determined by absorbance at 280 nm. Single usealiquots of protein were stored at D80 prior to use.
Preparation of binding sites for electrophoretic mobility shift assays (EMSAs).Duplex binding sites were prepared by annealing the top oligonucleotide(GGGCAGNNNNNNGGACG) and bottom oligonucleotide (GGCGTCCNNNNNNCTGC)(Invitrogen) for a given binding site in annealing buffer (10mM TrisDHCl, 50mMNaCl, and 1mM EDTA) to the final concentration of 40uM dsDNA, where the N6represents the 6bpDbinding site used in a given EMSA. Initial single strandedoligonucleotide concentrations were determined by absorbance at 260nm. Fordetection, annealed oligonucleotides were radiolabeled with alphaD32P dCTP andKlenow (exoD) (New England Biolabs) followed by a MicroSpin GD25 column (GEHealthcare) purification.
Determination of apparent dissociation constant via EMSAs. Varyingconcentrations of a given purified HD variant were equilibrated with 40pM oflabeled oligonucleotide in binding buffer (25mM NaCl, 10mM TrisDHCl pH 7.5,0.1mM EDTA, 1mM DTT, 5% glycerol, 0.1mg/ml BSA, and 0.1% IGEPAL CAD630) for4 hours at room temperature. Samples were loaded onto a 5% polyacrylamide gelwithout loading dye in 0.5X TBE buffer while running at 300V at 4oC. Gels were runfor 40 minutes following loading. Gels were dried and then exposed onphosphoimaging plates for 8D72 hours. Plates were imaged using a Typhoon FLA
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9000, and quantified using ImageGauge V4.22. The apparent equilibriumdissociation constants (Kd,app) were determined using the modified Hill equation:
where Y is the fraction of bound DNA as determined by the ratio of the bound DNAband to the total (free + bound) bands,m is a normalization factor that represents Ymax, [P]t is the total protein concentration, and h is the Hill coefficient.
Determination of apparent dissociation constant via competition binding
assays. Competition assays were performed under the conditions described for thedetermination of apparent dissociation constant via EMSA except that varyingconcentrations of an unlabeledDannealed oligonucleotide were added to asubsaturating (70D90%) amount of a given purified HD variant and 40pM of labeledoligonucleotide prior to equilibration. The concentration of DNA that disrupts 50%of the bound labeled complex (IC50) was determined using a simplified sigmoidaldoseDresponse curve (Ryder et al. 2008):
where Y is the fraction of bound DNA, C is the concentration of unlabeledcompetitor, and h is the Hill coefficient. The IC50 is then converted into the apparentequilibrium dissociation constant for the competitor (Kc,app) using the Lin and Riggsequation (Lin and Riggs 1972):
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where P is the purified HD variant concentration, R is the concentration of thelabeled oligonucleotide, and Kd,app is the apparent equilibrium dissociation constantof the HD for the labeled oligonucleotide as measured by EMSA.
Computational modeling of HD?DNA complexes. Modeling of mutanthomeodomain structures was performed with RosettaDNA, using the recentlydescribed flexible DNA protocol and scoring function (Yanover and Bradley 2011)(RosettaDNA executable and accompanying parameter sets kindly provided byPhilip Bradley at the Fred Hutchinson Cancer Research Center). Starting with thestructure of the DNADbound engrailed Q50A homeodomain (Grant et al. 2000), 20models were generated by RosettaDNA for each DNADbound mutant homeodomain.Each model was minimized with flexible DNA backbone and bases, and side chainpacking was performed for residues adjacent to the DNA major groove (residues 31,43D44, 46D51, 53D55, 57D58 in the crystal structure). Extended side chain rotamersets were used for buried residues having 15 neighbors within 10 Å (“Dex1 Dex2 Dex1aro::level 6 Dextrachi_cutoff 15”), while extra DNA rotamers were used to samplebase flexibility (“Dexdna::level 2”). DNA backbone flexibility was specified for the 6base pair DNA target site plus 2 base pairs flanking each side of the site. For eachmutant, the 20 models from RosettaDNA were rescored using DDNA, a knowledgeDbased energy potential developed to predict protein/DNA structures and bindingaffinities (Zhao et al. 2010), and the top DDNA score was used to select a structuralmodel reflecting the anticipated interactions at the HDDDNA interface.
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Random Forest (RF) Predictive Modeling. Protein and Position Frequency Matrix(PFM) alignments and relative scaling of the PFMs used as inputs for theconstruction of a RF model were preformed as previously described (Christensen etal. 2012). RF regression was performed as described using the previously identifieddeterminant positions (3, 6, 19, 47, 50, 54 and 55) identified from the adjustedMutual Information assessment of the 264 characterized extant HDs described inour previous study (Christensen et al. 2012). Models to test the utility of the extantHD specificity data from 246 mouse and fruit fly HDs (Thomas and Chiang 2006;Berger et al. 2008; Noyes et al. 2008a; Noyes et al. 2008b) and the selected HDs inthis study were trained as noted in Supplemental Table S9 where the evaluationincorporated 10Dfold cross validation when the training set and prediction setoverlapped. The reported MSE values reflect the MSE per motif parameter in thepredicted motif (Christensen et al. 2012).
DATA ACCESSIllumina Data for the selected and characterized HDs has been deposited with GEO(GSE35806). A website (stormo.wustl.edu/PreMoTF.v2) provides user access to thepredictive model of HD specificity and predictions for all of the annotated HDs in thehuman genome.
* Online Processed Illumina Supplemental Tables can be found at:http://genome.cshlp.org/content/22/10/1889/suppl/DC1
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CHAPTER III
INTRODUCTION TO GENOMIC TARGETING
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Advancing biology, biotechnology, and medicine through targeted genome
editing and targeted gene regulationPrecise targeted genome editing is a strategy that allows for the controlledmodification of an organism’s genome to change it for the needs of biology,medicine, and biotechnology. Targeted genome editing is induced by artificialnucleases that direct (Figure 3D1): 1) nonDspecific nucleotide insertions or deletionsat a specific location, 2) a specific templateDderived substitution to change aparticular nucleotide, or 3) extensive templateDderived alterations such as genereplacement or gene fusion for tagging that spans a large portion of a gene. Theadvent of tools for genome editing has proven to be effective in a variety oforganisms, where the toolbox of engineered nuclease platforms include ZFNs(Carroll 2011), TALENs (Joung and Sander 2013), and most recently, Cas9/CRISPR(Jinek et al. 2012).Genome editing can further both the fields of basic biology andbiotechnology. In basic biology genome editing tool facilitate the interrogation ofgene function in organisms that were previously less tractable or not amenable toother reverse genetics techniques. While making directed genetic changes havebeen established in yeast, bacteria, and mice, such techniques had not beenestablished in most eukaryotes. For example, while the nematode, c.elegans, hasbeen studies for the past forty years to allow for a vast increase of knowledge inbiology (Brenner 1974), gene function has been typically studied through forwardgenetic techniques that induce randommutations. After randommutagenesis, toidentify the genotype responsible for a given phenotype, tedious classical and
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Figure 3?1
Figure 3?1: Possible modes of repair after a DSB is created in the genome bycustomizable sequenceDdirected endonucleasesArtificial nucleases inducing a DSB results in three possible repair outcomes: 1) nonDspecific insertions or deletions at a specific location, 2) specific substitution tochange a particular nucleotide, or 3) extensive alterations such as gene replacementor gene fusion for tagging that spans a large portion of a gene.
NHEJ HDR HDR
+ +
Donor template Donor template
Insertion or deletion Nucleotide substituion Gene replacement
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molecular genetic techniques must be performed. While some reverse genetictechniques are available, such as transient gene knockdown by RNA interference,they do not allow for germ line transmission that propagate progeny with heritablemutations (Zhuang and Hunter 2012). Only recently has gene editing beendemonstrated in c.elegans by TALENs, ZFNs, and the Cas9/CRIPSR system thatinduce siteDspecific mutations resulting in heritable germ line transmission (Woodet al. 2011; Friedland et al. 2013) as well as other organisms.In biology, ZFN have been shown to function in fly, zebrafish, frog, mouse, rat,sea urchin, and hamster (Carroll 2011). While TALENs have been shown to functionin fly, zebrafish, frog, and cricket (Joung and Sander 2013). Even the Cas9/CRIPSRsystem has shown to function in fly (Gratz et al. 2013), zebrafish (Hwang et al.2013), and mice (Hwang et al. 2013). Moreover, genome editing in biotechnology ofplants and livestock can enable improvements in food production and biofuels byincreasing yield and robustness, decreasing pesticide use, and increasing efficiencyof creating genetic modifications in livestock with long reproductive cycles. Similarto the advantages for biology, direct manipulation by genome editing is less timeconsuming than other techniques typically used in biotechnology such as geneticcrossing and randommutagenesis. To date, various organism of agriculturerelevance have been genetically manipulated by ZFNs (tobacco, maize, and pig) andTALENs (pig, cow, silkworm, and rice).Genome editing impacts medicine in both disease modeling and therapeutics.Target genome manipulation in somatic cell lines can further disease modeling, suchis in mammalian cell lines. Furthermore, the therapeutic potential of genome
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editing is significant. Instead of treating symptoms of a given genetic disease, thegenetic defect that the disease arises from can be corrected, thereby curing thedisease all together. ZFNs have targeted genes in humans for therapeutic value andTALEN hold similar potential (PerezDPinera et al. 2012; Wirt and Porteus 2012). Forexample, ZFNs have enabled gene correction in the IL2Rgamma gene providing apotential treatment of XDSCID (Urnov et al. 2005) as well as disrupt the CCR5 gene toprevent the entry of the HIV virus into CD4+ TDcells (Holt et al. 2010), the later ofwhich is currently in phase II clinical trials (SbD728). So far, many uses in cell lineshave been demonstrated, while therapeutics appear more challenging.In addition to gene editing, targeted gene regulation has importantimplication in medicine and biology. Precise control of the regulation of geneexpression is a quality necessary for the use of artificial transcription factors astherapeutic agent. Targeted gene regulation in organisms and cell lines can providea means to control cellular processes for their study. Thus tools to edit the genomeand target gene regulation are vital to furthering many fields of science.
Tools to target specific genomic sitesTo create tools to manipulate the outcome of a cellular process throughregulating gene expression or by editing a genomic location, the function of aparticular protein or enzyme must be directed to a given genomic site precisely andpredictably. Current tools using a DBD or, more recently, a small guide RNA(sgRNA) can direct an enzyme, such as an endonuclease, to edit the genome or aeffector domain, such as an activation or repression domain, to regulate gene
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expression. The sgRNA can be designed and synthesized to direct the endonucleaseto a specific DNA address and thus is potentially easier to reprogram than DBDs.The sgRNA is an artificial component of the bacterial Cas9/CRISPR system thattargets the Cas9 endonuclease to a specific genomic sequence (Figure 3D2)(Jinek etal. 2012; Jinek et al. 2013; Qi et al. 2013) science, doudna 2013 elife, lim wa 2013cell). Since the specificity of Cas9/CRISPR system can be simply modified bychanging the sgRNA, it may be the method for quick reverse genetics in basicbiology where offDtarget effects is of less importance since this system appears tohave high offDtarget effects (Fu et al. 2013) While this technology is gaining traction,it is in its infancy and requires much further exploration, thus details of this systemwill not be further discussed in this chapter. To date, DBDs have been the mostutilized method for directing chimeric proteins to a particular genomic target.The two most commonly utilized DBDs are ZFs and transcription activatorDlike effectors (TALEs), as these two domains can be programmed to recognize avariety of different DNA sequences (Figure 3D3). Each of these DBDs has beenincorporated within artificial transcription factors to alter gene expression orcustomizable sequenceDdirected endonucleases for gene editing. For the past twodecades ZFs have been extensively studied and reengineered to recognize a broadrange of sites, where one ZF module recognizes a three to four base pair site (Klug2010). ZFs, however, appear more suited to recognize guanine rich sequences andcan display contextDdependent modularity (Ramirez et al. 2008; Zhu et al. 2011). AsTALEs have been rapidly characterized over the past four years, they have beenfound to be more modular in nature as compared to ZFs, as one TALE
70
Figure 3?2
Figure 3?2: Cas9/CRISPR utilizes the sgRNA to direct siteDspecific DNA cleavageA single strand of synthetic RNA (the sgRNA) directs the bacterial Cas9endonuclease subunit (blue) to a target DNA site to induce DSB to the DNA, wherethe protospacer adjacent motif (PAM) next to the complementary region of thetarget DNA is also necessary.
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module binds one nucleotide with minimal context dependent effects (Bogdanoveand Voytas 2011). While TALEs are now being used more frequently as targetingdomains for nucleases or regulators their DNADbinding properties have been lessextensively studied than ZFs. For precise genomic targeting to occur, DBDs with abalance between affinity and specificity are necessary (Ptashne 1992), and it iscurrently not clear what artificial nuclease platform will be the most precise forgene therapy applications.
Targeted gene regulation by artificial transcription factorsMultiple routes to direct the regulation of gene expression, either repressionor activation, utilizing the DBDs discussed above have been published. To activategene expression, ZFs and TALEs have been fused to different activation domains,including VP16, VP64, and p65. In order to repress gene expression, ZFs and TALEshave been fused to the KRAB domain or simply used to interfere with transcription.The initial study demonstrating that a DBD could regulate siteDspecific geneexpression showed that a tandem array of ZF modules, typically referred to as azincDfinger protein (ZFP), could be fused to VP16 to activate reporter expression,while at the same time the ZFP alone was able to block transcription in vivo in cellculture (Choo et al. 1994). Since then, a multitude of other studies havedemonstrated that DBDs can regulate gene expression in mammalian cells. Geneactivation by ZFPs can be regulated not only through their fusion to VP16 (Choo etal. 1994; Liu et al. 2001) but also other activation domains such as p65 (Liu et al.2001) or VP64 (Beerli et al. 1998). Similarly, TALEs have been fused the p65 or
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VP64 activation domains to activate gene expression in mammalian cells (Zhang etal. 2011; Joung and Sander 2013). Several of these studies have also demonstratedthat chromosomal location may impact in vivo gene activation and that targetingDNase hypersensitive sites may give greater activation in vivo (Liu et al. 2001; Rebaret al. 2002; Maeder et al. 2013). Moreover, ZFPs fused to VP16 have also beenshown to direct gene activation in mice (Rebar et al. 2002). Alternatively, DBDs alsohave utility to repress transcription as demonstrated by the fusion of a ZFP to aKRAB domain, where using such a chimeric protein results in the inhibition of geneexpression (Choo et al. 1994). While DBDs used to direct gene expression showpromise as possible therapeutic and tools for basic biology, they have yet todemonstrate as much utility as customizable sequenceDdirected endonucleases.
Genome editing by customizable sequence?directed endonucleasesCustomizable sequenceDdirected endonucleases (hereafter referred to asartificial nucleases) are engineered nucleases used to direct siteDspecific DNAcleavage. They must requisitely function to: 1) target a specific DNA location, and 2)create a break in the DNA. As a result, most artificial nuclease consists of two parts,a DBD to recognize a DNA target and a nuclease domain to cleave DNA. Twoexceptions are the Cas9/CRISPR system, as described above, and meganucleases.For meganucleases, the two requisite functional parts are not spatially separate andare encompassed in one large molecule (Silva et al. 2011). They, however, lackflexibility to recognize a broad range of sites and will not be further discussed. Thetwo major types of artificial nucleases that are currently used are ZFNs and TALENs,
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where they consist of a ZFP or TALE domains, respectively fused to the fokI nucleasedomain (Figure 3D2) (Carroll 2011; PerezDPinera et al. 2012).The original artificial nuclease created the general architecture of the firstZFN in 1996, where the fokI domain, belonging to the type IIs restrictionendonuclease FokI, is fused to the CDterminus of the ZFP (Kim et al. 1996). Thisbasic scaffold is still currently in use. For ZFNs and TALENs to function, twomonomers of the fokI nuclease domain must be in close enough proximity for thedomain to dimerize in order to cleave DNA (Figure 3D4). A pair of ZFNs requires 6bps between two monomer sites while a pair of TALENs requires 16 bps betweentwo sites. Current artificial nucleases use engineered obligate heterodimericversions of the fokI nuclease domain to decrease offDtarget activity by precludinghomodimer formation via a single monomer (Miller et al. 2007; Szczepek et al. 2007;Doyon et al. 2011).Artificial nucleases induce siteDspecific DSBs that are then repaired byendogenous cellular mechanisms (Figure 3D1). It is the repair of the DSB, by eithernonhomologous endDjoining (NHEJ) or homologyDdirected repair (HDR), that leadsto gene editing. The NHEJ repair pathway rejoins two broken ends together, andwhen this repair is imprecise, it can lead to the generation of small insertions ordeletions (lesions) at the repair site (Wyman and Kanaar 2006). In this targetedmutagenesis, a lesion creating a frame shift mutation in a coding exon can thuscreate a truncated nonfunctional gene product or gene product destined fornonsenseDmediated decay. HDR is a templateDdirected repair, where the templatecan be exogenously supplied to either change or replace a targeted sequence
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Figure 3?4
Figure 3?4: Cartoon representation of the general architecture of ZFNs and TALENs(Joung and Sander 2013)(A) Representation of a pair of ZFNs, where the ZFP of each ZFN contains three ZF(circle) and the FokI nuclease domain (orange disc) is CDterminally fused to the ZFP.(B) Representation of a pair of TALENs containing 16.5 repeats (multicolored disc)and the necessary NDterminal and CDterminal domain of the TALE where the FokInuclease domains is fused to the CDterminus of the TALE.
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(Porteus and Baltimore 2003; Wyman and Kanaar 2006). Recently, inducing singleDstranded nick by an artificial programmable nickase, where the cleavage activity ofone fokI monomer is inactivated, has shown to restrict the DNA repair pathway toHDR, thereby decreasing the frequency of unwanted indels (Kim et al. 2012;Ramirez et al. 2012; Wang et al. 2012). While nickases show promise, increasingtheir gene correction frequency, which is lower than achieved by a DSB, is needed toshow further utility.ZFNs are the artificial nucleases most thoroughly studied, however, TALENsare rising rapidly in utility by building off the foundational work on ZFNs.Regardless, ZFNs, TALENs, and CRISPRs each have their advantages anddisadvantages (Table 1). Characteristics inherent to the properties of the DBD foreach nuclease system allows each system is best suited for a particular target orfunction. The established methods for ZFN assembly and thorough studies of ZFsallows for them to be widely utilized in a variety of organisms. Several studies havecharacterized the offDtarget effects of ZFNs to understand their in vivo precision,however, similar studies have not been performed with TALENs (Gupta et al. 2011;Pattanayak et al. 2011). However, the ZFs modularity is limited in that each fingercan influence the specificity of the neighboring triplet, thus they are best suited torecognize triplets of GNNs (Ramirez et al. 2008). Moreover, each ZFP is typicallyable to specify from nine to twelve bps, where three to four ZFs, respectively, arejoined together through canoical linkers. TALENs complement these deficiencies ofZFNs in that TALEs can recognize up to sixteen bps and are more modular than ZFs(Reyon et al. 2012a). TALENs have also been shown to be less cytotoxic than ZFNs
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Table 3?1. The advantages and disadvantage of the different types of customizablesequenceDdirected endonucleases.
Advantages Disadvantages
ZFNs D Small DBD, 30 amino acids per3 bp recognitionD OffDtarget effects well definedD Safely used in clinical trials
D DBD has context dependencyof GNND Typical ZFP can recognize 12bpsD Less activity than TALENsD More cytotoxic than TALENs
TALENs D Can theoretically recognize anysiteD Each TALE can recognize up to16 bps or moreD Higher activity than ZFNsD Less cytotoxic than ZFNs
D Has 5’ base requirement of TDLarge DBD, 34 amino acid per 1bp recognitionD OffDtarget less established thanZFNs
Cas9/CRISPR
system
D Ease of target modificationD Can theoretically recognize anysite D Limitations poorly defined dueto recent developmentD High offDtarget rates
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and also have greater activity (Reyon et al. 2012b). Nonetheless, the establishmethodology of ZFNs in the artificial nuclease field has defined their offDtarget effectbetter than other nuclease and their safety has been demonstrated, thus far, inclinical trials. Moreover, the small size of the ZF over TALE, which needs to includeits NDterminal and CDterminal domain, is an advantage for lentiviral delivery(Holkers et al. 2013). While Cas9/CRISPR system is new to the field they holdadvantages over both TALENs and ZFNs. The ability of the Cas9/CRISPR system totarget its site through a synthetic RNA allows quick synthesis of new targets andtheoretically can target any given site. However, both the Cas9 endonuclease andRNA must be introduced into the target organism. Moreover, the system has beenshown to have high offDtarget rates that may limit their use to organisms with quickgeneration times for outcrossing unintentional offDtarget mutations created (Fu etal. 2013).Since initial studies demonstrating in vivo function of ZFNs in fruit flies andmammalian cells (Porteus and Baltimore 2003; Carroll et al. 2010) ZFNs andTALENs have facilitated targeted mutagenesis and gene replacement in a variety oforganisms at different paces (Carroll 2011; Joung and Sander 2013). For example,targeted mutagenesis by ZFNs in zebrafish was first demonstrated five years ago(Doyon et al. 2008; Meng et al. 2008), however, only in the past year has homologymediated repair been demonstrated in zebrafish with exogenous donor DNAsutilizing TALENs (Bedell et al. 2012; Zu et al. 2013). The discrepancy in whether anartificial nuclease can function in a given organism maybe due to different cellularmachinery of different organisms but is also dependent on the particular specificity
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of the given DBD used. Limitations of artificial nucleases still remain that includethe ability of DBDs to target a greater range of sequences and offDtarget effects ofDSBs, where by they can create cytotoxicity to a cell or organism. More stringentDBD to increase the specificity of DNADbinding will alleviate such detrimental effectsof artificial nucleases. Additionally, identifying new DBDs to complement ZFs andTALEs binding specificity can expand the sequences artificial nucleases can target.
Previous gene targeting utilizing homeodomains  The original chimeric nuclease utilizing a HDDFokI fusion was created by theChandrasegaran lab several years prior to the creation of ZFNs, however, it resultedin moderate nonDspecific cutting and such a chimeric molecule has not beenrevisited since (Kim and Chandrasegaran 1994). Attempts to further the utility ofHDs resulted in the engineering of the ZFHD, where it was subsequently used as anartificial transcription factor to recognize a specific DNA site to drive gene activationfor potential use as a therapeutic (Pomerantz et al. 1995; Magari et al. 1997). This,however, also has not resulted in further development of utilizing HDs in chimericproteins. These experiments utilizing HDs were performed prior to our lab’sexpansion of HD specificity. Thus, the ability of the HD to target a broad range ofsiteDspecific genomic regions were limited by the inability of the HDs to beengineered to recognize a variety of different target sites.  
Summary
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To test if HDs can be incorporated as the DBD in customizable sequenceDdirected nucleases to direct sequence specific gene editing, we developed a morestringent ZFHD chimeric framework than the original ZFHD. Thus, HDs can be usedto complement the utility of ZFs to target sequenceDdirected nucleases. We set outto create a functional HDDcontaining nuclease, the nZFHD, where the nucleasedomain is fused to the NDterminus of ZF. We incorporate the use of the HD modulesour lab previously created to demonstrate the feasibility of utilizing HDs as a newDBD in artificial nucleases. To create an nZFHD, we optimized the linkers betweenthe ZF and the HD, as well as the linker between the nuclease and the ZFHD. Thefunctionality of this platform was demonstrated by creating targeted lesions inzebrafish embryos. Thus, nZFHDs can direct targeting in a complex genome.
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CHAPTER IV
UTILIZING ENGINEERED HOMEODOMAINS IN CUSTOMIZABLE SEQUENCE?
SPECIFIC NUCLEASES
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INTRODUCTIONCustomizable sequenceDdirected nucleases, such as zinc finger nucleases(ZFNs), transcription activatorDlike effector nucleases (TALENs), and, most recently,the Cas9/CRISPR system, are important tools to further biology, biotechnology, andmedicine. These tools induce site specific DSBs, which enables repair bynonhomologous endDjoining (NHEJ) or homologyDdirected repair (HDR) to preciselyor imprecisely modify the target of interest (Carroll 2011; Jinek et al. 2012; Joungand Sander 2013). These nucleases have been used in a wide variety of organisms,including flies (Carroll et al. 2010), zebrafish (Meng et al. 2008), plants (Osborn et al.2013), livestock (Carlson et al. 2012), cell culture, and humans (Porteus andBaltimore 2003; Jinek et al. 2013). While artificial nucleases have been studied overthe past twenty years they are still somewhat constrained in the targets they canspecify due to required recognition features for the DBD (ZFNs or TALENs) or guideRNA and PAM sequence (Cas9/CRISPR system).HDs prefer to recognize ATDrich sites and thus complement the ZF preferencefor GDrich binding. Since HD variants from our prior study were selected in thecontext of a ZFHD fusion, HDs have demonstrated function as ZFHDs. While theoriginal ZFHD was published in 1995 (Pomerantz et al. 1995), this construct hasshown limited use in literature (Magari et al. 1997); since then further utility of thisconstruct has not been demonstrated. While the ZFHD has demonstratedfunctionality as a DBD, it recognizes binding sites with limited stringency using alinker of GGRR between the ZF and HD. Furthermore, the linker used in previousstudies by our lab utilizing the ZFHD construct with the linker TGTGR has been
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shown to recognize sequences with different spacings between the ZF and HD.Optimization of the linker for specificity and activity will improve the functionalityof the ZFHD construct as a DBD (Noyes et al. 2008a; Chu et al. 2012).To incorporate a new DBD into customizable sequenceDdirected nuclease, weset out to utilize HDs, within the ZFHD construct, in artificial nucleases (termed thenZFHD). Here we create a functional nZFHD, where we optimize the linker betweenthe ZF and HD to increase stringency and activity. In the commonly usedcustomizable sequenceDdirected nuclease, the ZFN, the FokI nuclease domain isfused to the CDterminus of the zinc finger (ZF) of a ZFN (Figure 4D1). To fuse theZFHD to the FokI nuclease domain, a different fusion point is necessary to create anuclease incorporating ZFHDs. To this end, we identified a linker between the NDterminus of the ZFHD and the CDterminus of the nuclease domain to create afunctional nZFHD. We subsequently show that this architecture is functional in vivo,in zebrafish, to create indels at a given target site.
RESULTS
Optimize linker selected between ZF and HD for specific DNA recognition  To create functional nZFHDs we first optimized the linker that fused the ZF tothe HD to robustly recognize specific binding sites of various spaces between the ZFand HD. ZFHD modules to be used for specific genomic modification would requireprecise DNADbinding specificity (Figure 4D1 and Figure 4D2A). The linker previouslyutilized in our ZFHD (TGTGR) constructs did not constrain the ZF and HD to bind in
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Figure 4?1
Figure 4?1: Schematic of nZFHD, nZF, and ZFN.In the typical ZFN construct the FokI nuclease domain (triangles) is fused to the CDterminus of the ZFs (ovals). In an nZF the nuclease domain is fused to NDterminus ofthe ZFs. In an nZFHD the nuclease domain is fused similarly as the nZF, however, aHD (hexagon) follows the CDterminus of the two ZFs. The arrows represent the twolinkers we optimize: one between the ZFs and the HD (black) and the other betweenthe nuclease domain and ZF (grey). The N and C denotes the N and CDterminus ofthe DBDs.
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specific orientations relative to each other, which leads to an overall reduction inspecificity (Figure 4D2C) (Noyes et al. 2008a). Moreover, the original linker (GGRR)fusing the ZF and HD together used by other labs had not been tested for relativeactivity in our system (Pomerantz et al. 1995; Magari et al. 1997)(Pomerantz et al.1995, Ariad).  Molecular models created by structural superimposition of the ZF and HD atdifferent spacings and orientations between the ZF and HD binding site on a DNAtemplate allowed an estimation of the distance between the CDterminus of the zincfinger and the NDterminus of the HD. Based on this modeling, we estimated (wherethe approximation of an amino acid spanning maximally 3 angstroms was used) thatthe longest linker library (6 amino acids) could possibly span inverse four basepairs through one base pair of spacing (Figure 4D2B and Figure 4D3), where aninverse ZFHD site refers to the ZF and HD binding to its expected sequence onopposite strands. Using the models created, the range of the different linker lengthswere estimated to span 13 angstroms for an inverse two base pairs between the ZFand the HD for the shortest observed length and 25.5 angstroms for an inverse fourbase pair between the ZF and HD for the longest length (Figure 4D3).  We calculated that linker libraries spanning one through six amino acidsbetween the ZF and HD could be exhaustively or nearly exhaustively searched in theBIH system when each amino acid was encoded as NNS; the largest libraryconsisting of the 6 amino acids linker containing 1 x 10^9 possible members. TheB1H system, which was also previously used to characterize the specificity of allhomeodomains in D. melanogaster (Noyes et al. 2008a), allows for very large
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Figure 4?3
Figure 4?3: Models with spacings between the ZF and HDModels created by superimposition with the various spacings we attempted toidentify linkers for with the estimated distance between the ZF and the HD (yellow).
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libraries, up to 1x 10^9 members in diversity, to be conveniently built into thesystem. Resulting growth on selective media implies an interaction between a givenDNADbinding site and protein pair. BIH selections for each of the seven bindingsites, from inverse 4bp through 1bp, were performed with each of the six libraries(Figure 4D2A). Based on its constrained length, the one amino acid library yieldednegligible growth with any of the seven binding sites. Thus this library also servedas a negative control throughout our experiments. Based on the results with thislibrary, we deemed selections yielding over two hundred colonies as successful. Forthe inverse 4bp, inverse 1bp, and inverse 0bp binding site spacings, no viablelinkers were identified. Constructs with high activity were identified for bindingsite spacings of inverse 3bp, inverse 2bp, 0bp, and 1bp. Individual survivingmembers were sequenced from successful selections to identify functional librarymembers for each spacing between the ZF and HD (Table 4D1). Individual linkersdeemed to represent the consensus of selected linkers for a particular binding sitewere characterized in comparison with the original linker, TGTGR, in the BIH systemwith the ZF10 randomized binding site library (Noyes et al. 2008a) (Figure 4D4).Based on this analysis, linkers with improved activity and specificity were identifiedfor binding site spacings of inverse 3bp (CPLLRG), inverse 2bp (KGTCG), 0bp(APKP), and 1bp (LPRLPR) as demonstrated by the recovered binding site from theZF10 library and an activity analysis in comparison with the original linker (Figure4D2A, 4D2C, and Figure 4D4).  
Linker identified between the nuclease and ZF to create a functional nZFHD  
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Table 4?1. Linkers identified between the ZF and HD from B1H selections
Spacing 
between 
the ZF and 
HD: 
inverse 
4bp 
inverse 
3bp 
inverse 
2bp 
inverse 
1bp 
inverse 
0bp 0bp 1bp 
        
Number of 
Amino Acid 
in the 
linker 
library:         
2aa   FS      
  NG      
  FS      
  SG      
  SS      
  GR      
  FG      
        
3aa  MNT    QPK  
  LQP    VPR  
  MPS    LPK  
  EPS    QKR  
  ENT    EQR  
  EPS    SPR  
  FDR    EPR  
  FNL    QPR  
  VNL    QPR  
  SPS    QRR  
  NNP    EKR  
  FNT    LPR  
  FNL    QYR  
  EAS    SPR  
      MPR  
      LPR  
        
4aa  APEW ANGK   LPKP  
  DSNR KPGV   LPKP  
  LPGR RPGW   GPKP  
  VPNR EAGR   FAIS  
  DPDW ERYP   DPKP  
  AWRP EKYP   DPSR  
  APSW VPGR   GPKP  
  SWRP RPGV   NKSG  
  LPGR RPGV   APRP  
  DPGR ARNP   RPKP  
  DPDR MKYP   CPKP  
  DPNP VRNP   MPKP  
  DPDR VPGR   RVQT  
  DPSR SRFP   WATP  
  ASAG VPGK   ELMA  
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  EYNP ERNP   LPNN  
  SPNY VPGH   FKLF  
  APDT    LPNN  
  EPGR    LPNN  
  APGR    LPNN  
  SPER    APRN  
  SPQQ    LPKP  
  SPHW    SPKP  
  EPNR    APKP  
  DVGR      
        
5aa  TRPAG GGKCA VGLPP    
  FPTNS AGKCA VGLPE    
  APWTG AGKCA GGRPH    
  SPIRS RGTCA VGLPA    
  APSTE GGKCG VGLPE    
  APSTV RGQCG     
  DPAAG KGRCG     
  FRLPG KGTCG     
  APTTV GGLCA     
  CDWFA GGACA     
  FWRPG GGKCG     
  MRRPG AGLCG     
  LDWMG KGACG     
  SRPVG AGTCG     
   KGSCK     
   AGRCH     
   EGKCA     
   RGSCG     
   GGHCG     
        
6aa  CPLLRG PCGECG YCGRSG   LPRLPA 
  CPLLRG APRLGP HESPGQ   LPRVKR 
  CPILRG PDGACA DLGPLK   LPKVKR 
  CPALRG PAGSCA SRPGWK   LPRLRR 
  CPLLRG PHGSCR SCWPGK   LPRPRR 
  ALRGQG PNGACV ESGTWK   LPKVRK 
  CPLLRG PRGECG    LPRLPR 
  CPLLRG PCGECR    LPRLPR 
  CPLLRG PAGXCK    LPRLPT 
  CPMLRG PNGVCL    SPRLDG 
  EARARG PAGSCR    APRNWG 
  TPEWRS GPSPLP    LPIAHG 
  EAHRRG PGGSCA    APRLSG 
  SPQWRL PNGECQ    EPRVLP 
   PGGSCG     
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Figure 4?4
Figure 4?4: Stringency of selected linkers between the ZF and HDMotifs of ZF10 selections for selected linker between the ZF and HD showing thebinding specificity for a particular linker (right).
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Figure 4?5
Figure 4?5:Models estimating the distance between fusing the nuclease to the NDterminus of the ZFThe models created by superimposition to estimated the distance between the ZFand nuclease with 8 base pairs and 16 base pairs between the two ZF monomers foran NDterminal fusion to the ZFs.
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Using superimposition, the necessary space between the two ZFHDmonomersites and the length of linker between the nuclease from the ZF were estimated tocreate a functional nZFHD (Figure 4D5). We oriented two ZFPs, Zif268, over doubleDstranded DNA with the NDterminus of each ZFP facing towards each other usingsuperimposition (ElrodDErickson et al. 1996). The FokI nuclease domain dimer,centered between the two ZFPs, was superimposed over the active site of the BamHIcrystal structure as previously describe (Wah et al. 1998). A previous studyexamined the fusion of FokI nuclease domain to the CD terminus of the HD, but thisdisplayed non specific activity (Kim and Chandrasegaran 1994), thus we chose tofuse the nuclease to NDterminus of the ZFHD to create a more specific chimericnuclease. Our molecular models allowed estimation of the distance between the NDterminus of the zinc finger and the CDterminus of FokI in various orientations andspacings. The most favorable spacing appeared to be 8bp and 16bp between the ZFand FokI binding sites (40 and 60 angstroms apart, respectively), which provided astarting point of possible spaces to test between the two monomer sites.  Linker lengths of 14 through 24 amino acids, composed of alanine, serine,and glycine, were fused to optimized ZFHDs, with either the APKP or KCTCG linkerbetween the ZF and HD, to test for activity with spacing of 8, 9, 10, 16, 17, 18, or 19base pairs between the two monomer sites (Figure 4D6 and Table 4D2). These nZFHDconstructs with various spacings were tested using a yeastDbased chromosomalreporter assay (Ryan et al. 1998). Consistent results for the two different linkersbetween the ZF and HD identified the shortest linker tested, 14 amino acids, to be
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Figure 4?6
Figure 4?6: Yeast activity assay showing relative activity for nZFHDsEach nZFHD either contains the APKP or KCTCG linker for nZFHD binding sites of 0base pair or inverse 2 base pair, respectively, alongside the original linker, TGTGR.Various linker lengths between the nuclease domain and the ZFHD were testedagainst different spaces between the two ZFHD binding sites as compared to aninternal ZFN control.
        14aa                 17aa                20aa                  24aa                14aa                 17aa                 20aa                 24aa             control
|-------------------------------APKP--------------------------------| |-------------------------------TGTGR------------------------------| 
        14aa                 17aa                20aa                  24aa                14aa                 17aa                 20aa                 24aa             control
|------------------------------KCTCG-------------------------------| |-------------------------------TGTGR------------------------------| 
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Table 4?2. Sequences tested in the yeast reporter assay
Linker lengths test between nuclease and ZF 
14aa ASGGGSGSSGSGGA  
17aa ASGGGSGASGSGSGGGA  
20aa ASGGGSGASGSGAGSSGGGA  
23aa ASGGGSGAGSGSGAGSGSGSGGA 
    
Spaces between 2 ZF-0bp-HD sites (bolded), the same space is used 
between 2 ZF-inverse2bp-HD sites 
8bp TAAGCCTGGGCGGCGCTCACCGCCCAGGCTTA 
9bp TAAGCCTGGGCGGCGCATCACCGCCCAGGCTTA 
10bp TAAGCCTGGGCGGCGCATCAaCCGCCCAGGCTTA 
16bp TAAGCCTGGGCGGCGCATCAgcgcatcCCGCCCAGGCTTA 
17bp TAAGCCTGGGCGGCGCATCAtgcgcatcCCGCCCAGGCTTA 
18bp TAAGCCTGGGCGGCGCATCAttgcgcatcCCGCCCAGGCTTA 
19bp TAAGCCTGGGCGGCGCATCAttgcgtcatcCCGCCCAGGCTTA 
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the most stringent in activity to the 8 and 16 base pair spacing, with high activitycomparable to an internal ZFN positive control.  
Gene disruption in zebrafish created by an nZFHD  To validate that the nZFHD platform is functional in vivowe sought to targetsix genes in zebrafish to create insertions or deletions (indels) within the targetedregion. Each target site contained 16 base pairs between the two nZFHDmonomerbinding sites. The ZFHD sites tested a range of different spacings (inverse 3bp,inverse 2bp, 0bp or 1bp) and employed the linkers characterized earlier that arespecific for a particular spacing (Figure 4D7A and Table 4D3). ZF and HDmodulesused in the construction of each nZFHD are derived from our previously publishedarchives (Zhu et al. 2011; Gupta et al. 2012). The 14 amino acid linker between thenuclease and the ZFHD was used in all nZFHDs.mRNA for each pair of nZFHDs was transcribed and injected into oneDcellstage embryos. In trpa1a, lesions were inferred by the measurement of toxicityusing a dose response curve, where the ratio of normal morphology, deformedmorphology, or dead embryo at 24 h.p.f. was calculated (Meng et al. 2008). Theother five targets did not yield dose response curves indicative of possible lesions.Of the embryos injected with nZFHDs targeting trpa1a, genomic DNA was isolatedfrom pools of embryos with either visually deformed or normal morphology. Eachpool of DNA was followed by T7E1 digestion of the target locus then ran on a gel tovisualize mismatches (indels) at the target created by injecting the embryos withnZFHDs. At this locus, as the dose of nZFHD increased, the frequency of lesions also
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Figure 4?7
Figure 4?7: Utilizing nZFHDs in zebrafish(A) The six different zebrafish gene targets nZFHDs were tested on. (B) Doseresponse curves for varying doses of trpa1a mRNA showing phenotypes associatedwith increasing doses of injected nZFHDs (C) T7E1 digestion of pooled embryos ofdifferent dosages showing potential lesions created by the trpa1a pair of nZFHDs.Percentages below each lane are the lesion rates measured for each pool of embryos(D) Lesions observed in morphologically normal embryos injected with 150pg ofboth nZFHDmRNAs. Dashes or red letters indicate the positions of deletions orinsertions, respectively.
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Table 4?3. nZFHD constructs used for zebrafish. Amino acid sequences of therecognition helix of the ZFs or residues 43, 46, 47, 50, and 54 of the HDs used for thenZFHD, and the space for the between the ZF and HD in the target gene for a givennZFHD.
 Left 5p ZFHD   
Gene Name: finger 1 finger 2 space  homeodomain 
ppfibp2a RSDHLTR RSDHLTR 1bp VMRWY 
celsr1b RSDALTR RSDALTR inverse 2bp LHYAK 
mrps23 RSDALTR RSDNLSE 1bp MKYEK 
trpa1a RSDNLTR LSFNLTR inverse 2bp RHDRA 
slc8a4a RSDTLKA RSDALRK 0bp KRLAA 
b3galt4 DRSALAR RSDNLTQ 0bp QRISV 
     
 Right 3p ZFHD   
Gene Name: finger 1 finger 2 space  homeodomain 
ppfibp2a DRSALAR RSDNLTR inverse 3bp QRISV 
celsr1b YRQSLTR RSDDLTR inverse 3bp VRLKY 
mrps23 LAHHLTR RSDNLTR inverse 3bp RHDRA 
trpa1a RSDDLTR RSDNLTR 1bp KTTQD 
slc8a4a RSDNLTR RSDNLTQ 1bp HLIQY 
b3galt4 RSDALTR RSDALRK inverse 2bp LGMRR 
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increased as observed in the T7E1 assay, where embryos injected with the range of15 pg of mRNA to 300 pg mRNA resulting in 1.1 percent to 6.7 percent lesionfrequency, respectively (Figure 4D7B and 4D7C).Types of mutations generated by nZFHD at 150 pg, normal embryos, wereidentified by cloning the treated target site into the vector of the LacZalpha blueDwhite assay (Zhu et al. 2013). A frameDshift of a created lesion in the embryo isidentified by white colonies amongst a background of blue wildDtype colonies in thisassay. Thus, we identified short indels created around the nZFHD binding siteindicating that the nZFHDs did create a doubleDstranded break at the target regionto allow for imprecise repair at the target loci (Figure 4D7D).
DISCUSSIONIn this study we were able to create sequenceDdirected genomic lesions inzebrafish by using the ZFHD nuclease platform that we engineered. Thisachievement required the optimization of the linker joining the ZF and HDmodulesand the creation of a functional NDterminal fusion of the FokI nuclease domain tothis DNADbinding platform. Guided by molecular modeling of the ZF and HDmodules on idealized BDDNA, we designed linker libraries to span different spacingsand orientation between the ZF and HDmodules. We selected linkers that definedpreferences for particular binding relationships between the ZF and HDmodulesand these linkers also displayed higher activity within the B1H system implying thatthey may also have improved affinity. Additionally, we identified a linker betweenthe FokI nuclease domain and ZFHD to create a functional nZFHD at a particular
100
spacings between the monomer binding sites. Moreover, the selected linkersbetween the ZF and HD also demonstrated higher activity in a yeast based activityassay as compared to the original linker joining these modules.The four different linkers identified for the four different orientationsbetween the ZF and HD shows that a linker joining two DBD for a fixed spacingbetween two DNA binding sites can be identified. While linkers of approximatespacing have been identified and utilized in ZFs and ZFNs in previous studies(Moore et al. 2001; Soldner et al. 2011), artificial linkers joining two DBDs with goodstringency for a specific spacing and orientation between two DBDs as we haveshown here have not been previously published. This study implies that it ispossible to identify linkers between other DBDs to create a larger toolbox for whatcan be recognized by chimeric DBD combinations to be used in artificial nucleasesor transcription factors. The selections performed here can also be used for otherDBDs, such as ZFs, to expand their flexibility of specificity. Moreover, the linkerbetween the nuclease and ZFHD can potentially be further optimized to functionwith higher stringency of spacing between the two ZFHD binding sites.Using HDs in ZFHDs complement the number of sequences that can berecognized by ZFs because HDs prefer to recognize ATDrich sites while ZFs recognizeGDrich sites. By increasing the number of different orientations between a ZF andHD by three more from the original ZFHD construct, we have increased the numberof targetable 6 bp binding site from four percent to twenty percent of all possible 6bps sites. Taking into account that the 5’ of the HD can recognize TGA, TAA, TTA,CAA, and CGA (triplets that ZFs can not target), this is twenty percent is in addition
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to the possible 6 bp sites that can be recognized by our single fingers ZF modules(18 percent) (Zhu et al. 2011). Additionally the current set of single finger modulesfrom our lab cannot recognize the five 5’ triplet sites recognized by HDs, whichhighlights the complementarity between these module sets.While only one of the six nZFHDs we created for zebrafish resulted in lesions,their failure to function may not be due to the architecture of the nZFHDsthemselves. Properties inherent to in vivo genomic DNA can affect nucleasetargeting of endogenous sequences, such as chromatin architecture and DNAmethylation, which can hinder the access to or recognition of the target site (Reyonet al. 2012a; Valton et al. 2012). To evaluate if the five nZFHD are not functional dueto properties inherent to the in vivo system, they may be tested in a system outsideof the zebrafish, such as the yeastDbased nuclease assay (Zhu et al. 2011). Moreover,the specificity of each ZFHD created for zebrafish can be tested in the B1H system totest the true specificity of each ZFHD once it has been assembled. This has beenperformed for ZFs in ZFNs where assembling finger modules may result inunexpected specificity within the entire array (Gupta et al. 2010; Zhu et al. 2011).By selecting for stringent linkers between the ZF and HD and identifying afunctional linker between the nuclease and ZFHD we successfully used HDs to createsiteDspecific lesions in the complex genome of the zebrafish. By doing so, theexpanded sites ZFHDs can recognize will complement the limitations of ZFNs, whereboth ZFs and ZFHDs have advantages over TALENs due to their small size to beincorporated into gene delivery vectors (Holkers et al. 2013). The advantage overCRISPRs by nZFHDs and ZFNs of being functionally encompassed by one molecule
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may further provide advantageous to simplify delivery of a nuclease to a givensystem. Moreover, studies have CRISPRs have shown they have high offDtargeteffects (Fu et al. 2013). While this study demonstrates that HDs can be used asDBDs in ZFHD, it is possible that HDs can be developed as stand alone DBDs, eitheras individual HDs or tandem HDs fused to an effector domain, for use in generegulation or genome editing. Further engineering to expand the HD bindingspecificity at either the 5’ or 3’ specificity (Chu et al. 2012) will also expand theutility of the ZFHD. Moreover, ZFHDs have additional utility to be used as DBD forartificial transcription factor. Thus ZFHDs have broad utility for genome editing andtargeted gene regulation in organisms of biology, biotechnology, and therapeutics.
MATERIAL ANDMETHODS
Superimposition modeling of ZFHDsZFHDs were built by superimposing the ZFs, finger 1 and 2 of zif268 (ElrodDEricksonet al. 1996), and HD, Msx1 (Hovde et al. 2001) over the respective DNA bindingsites, using Pymol over BDform DNA created by X3DNA (Lu and Olson 2003), withthe different spaces between the ZF and HD sites. Measurements were thenestimated using Pymol’s measurement function.
BIH?linker selectionLinker libraries of 1 through 6 amino acids between the last histidine of the two ZFsin a Zif268 finger 1 and 2 backbone and the glutamate at the beginning of theengrailed HD was encode as NNS for each amino acid in the p1352DomegaDUV2. Therecognition helix of ZF backbone variant was QKGHLTR for finger 1 and DRSDLTR
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for finger 2 while the HD was VRLKY at positions 43, 46, 47, 50, and 54 in theprevious published Engrailed variant (Noyes et al. 2008a). For each linker libraryselection with each binding site was oversample 3 times, with the exception of the 6amino acid linker library, which was covered maximally to 2 x 10^8 combinationsdue to the coDtransformations efficiency of the US0 selection strain. Selections wereplated on NMminimal medium selective plates lacking uracil and containing 25mM3DAT as the competitor and grown at 37o for 60 to 120 hours. Up to 24 individualcolonies for each successful selection were sequenced.
BIH?binding site selection using the ZF10 library  Selections characterizing the DNADbinding specificity of individual ZFHD linkerclones were performed as previously described (Noyes et al. 2008a) except that allselections were plated on NMminimal medium selective plates with 5mM 3DAT,1mM IPTG, and 200mM uracil then grown at 37o for 24 to 32 hours. 24 individualcolonies for each selection were sequenced. The overrepresented sequence motifwas determined with MEME (Bailey and Elkan 1995) and sequence logs created byWeblogo (Crooks et al. 2004).
BIH?based activity assayActivity assay were performed as previously described (Noyes et al. 2008b). 10Dfoldserial dilutions were grown on NMminimal medium selective plates containing10mM 3DAT, 1mM IPTG, and 200mM uracil then grown at 37o for 36 hours.
Yeast?based nuclease assayThe Mel1Dbased yeast activity assay (Ryan et al. 1998) was performed from theintegration of the nZFHD target site to be tested with the ZFN positive control
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through the modified ySSA vector. nZFHDs were cloned into pYLeu containing awildDtype FokI nuclease domain and a modified assay was preformed as previouslydescribed (Gupta et al. 2012).  
Zebrafish husbandry  Zebrafish were handled according to established protocols (Westerfield) and inaccordance with Institutional Animal Care and Use Committee (IACUC) guidelines ofthe University of Massachusetts Medical School.
nZFHDmRNA injections and lesion analysisFor targeting sites in zebrafish, the left 5’ nZFHD and right 3’ nZFHD was cloned intopCS2 vectors containing the DD and RR obligate heterodimer versions of the FokInuclease domain, respectively (Szczepek et al. 2007). pCS2DnZFHD constructs werelinearized with NotI. The mRNA was transcribed, purified and injected as previouslydescribed (Zhu et al. 2013). Pools of 20 injected embryos were collected at 24 h.p.f.for a given dosage and phenotype to be assayed for lesions and lesion rate wascalculated as previously described (Zhu et al. 2013).
LacZalpha blue?white assayTo identify the types of lesions created in zebrafish, the targeted genomic regionswere cloned in pBluescriptDKS(D) vector and assayed for indels as previouslydescribed (Zhu et al. 2013).  
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CHAPTER V
DESCRIPTION OF METHODS
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Bacterial?One Hybrid System For SelectionsThe BacterialDOne Hybrid (B1H) system can be utilized to determine theDNADbinding specificity of a DNADbinding domain (DBD) or identify a DBD thatbinds to a particular DNA sequence (Noyes et al. 2008b). The B1H system consistsof a plasmid with the DBD fused to the omegaDsubunit of RNA polymerase (bait) anda second plasmid with the target site upstream of two reporter genes, HIS3 and
URA3 (prey). To identify DNADbinding specificity of a DBD the library members arecontained within the prey in the form of a randomized binding site library, while toidentify a DBD specific for a target site the library members are contained within thebait in the form of a randomized DBD library. Both the bait and the prey plasmidsare transformed into a bacterial selection strain with bacterial homologs, hisB and
pyrF, of the reporter genes contained on the prey plasmid deleted. Plasmidconcentration in the transformation of the selection strain are titrated to minimizethe opportunity that more than one library member will be transformed into a cell.If the bait interacts with the prey, the recruited RNADpolymerase will activate thetranscription of the reporter genes to allow for growth on selective media. Coloniesthat grow on the selective media can then be isolated and sequenced to identify thelibrary member(s) at either the bait or prey level.The advantages of the B1H system include: 1) It is a quick method that onlyrequires a single round of selection and does not require protein purification. Thisis unlike other techniques such as proteinDbinding microarray where proteinpurification is necessary or SELEX where several rounds of enrichment and proteinpurification are necessary; 2) It allows for a large number of library members (1 x
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10^9) to be searched since the transformation efficiency of bacterial cells are higherthan other cell types such as yeast hybrid systems; 3) Library members can be ateither the target site level or the DBD level; 4) The genome acts as competitor DNAto prevent less specific DNADprotein interactions from being captured.The disadvantages of the B1H system include: 1) It is necessary for theinteraction of the DBD with target to be in the dynamic range of the system torecover a library member, as low affinity binders may not be identified or lowaffinity interaction must be fused to another DBD to increase overall affinity. 2)While this system allows for a large number of library members, the searchablelibrary size is limited by the transformation efficiency of the selection strain. 3)Often different conditions (stringency of selective media) may need to be optimizedto allow for growth of colonies to identify interactions.
Identifying Target Sites or DBDs From the B1H SystemSanger sequencing or Ilumina sequencing is used to identify the selectedlibrary members recovered from the B1H system. Regions of the plasmid containingthe randomized region (either DBD or target site) are PCR amplified for both typesof sequencing. For Sanger sequencing, individual colonies are used for PCRamplification, where multiple colonies are screened. For Illumina sequencing, theplasmids from an entire selection plate of surviving colonies are pooled togetherand the randomized region is PCR amplified. Each pool amplification is preparedwith a barcoded adapter to differentiate individual selection plates. Pooledbarcoded amplicons can then be submitted for an Illumina sequencing run.
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Overrepresented target motifs for the target sites were identified using MEMEfollowed by alignment and visualization by WEBLOGO on a bit scale representinginformation content. DBDs identified were displayed through WEBLOGO asfrequency logos to visualize overrepresented amino acids.Sanger sequencing can identify long stretches of sequences, which wasinitially necessary for our HD library. Since the HD library has residues 43, 46, 47,50, and 54 randomized, which spans 36 base pairs in length, Illumina sequencing atthe time of the experiment did not span the necessary length. The readout length of36 bases pairs would not cover all randomized residues in addition to the barcodeof the adaptor at that time. Nonetheless, Illumina sequencing allows for theupwards of 30 million read, which can allow for over 50 different barcodedselections (for each different target site) to be run in one Illumina flowcell lane toread out greater than 5 x 10^5 reads per barcoded sample. Sanger sequencingnecessitates individual colonies be isolated, thus can be cumbersome if one is tolook at a large number of library members. Since the initial sequencing of HDlibrary member, Illumina sequencing has been expanded to 75D100 base pairs, thusallowing for Illumina sequencing of HD library members.Using WEBLOGO, the frequency of the amino acids identified in therandomized region of the HD variant for each target site is displayed as frequencylogo (Crooks et al. 2004). While frequency logos are used to identify amino acidsthat are overrepresented in the selections for HD variants, the logos can bemisleading. Each amino acid is not equally represented in the HD library. (Eachrandomized residue position was randomized as NNS.) For example, Phe occurs
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once while Ser occurs thrice in NNS, thus if a residue has a higher frequency in thelogo it does not necessarily equate that the residue was enriched during theselection. Nonetheless, taking into account the randomization scheme, frequencylogos are useful to quickly visualize the highest occurring resides at a given position.Sequences for DNADbinding specificity are identified by MEME (Bailey et al.2009) where MEME identifies overrepresented sequences from all sequencessubmitted. For our data, the ZOOPS model was used, as it assumes that either zeroor one motif occurs per each sequence. While this is a simple tool, the output ofMEME is only as good as the selection performed, thus selections should beperformed at a selection stringency that recovers a range of motifs with differentactivities. Moreover, each base is treated as an independent contribution to thebinding motif, thus interdependence between bases cannot be captured.
Mutual Information Analysis of Amino Acid?Base InteractionsMutual Information (MI) identifies covariation between a DBD’s recognitionresidue and a base within the recognition sequence which is a hallmark of aresidue’s influence on DNA recognition at that position. MI compares theprobability of the cooccurrence of a base and an amino acid to the independentoccurrence of the base and the amino acid. Particularly in DBDs that lack priorinformation, such as DNADprotein cocrystal structures or other DNADprotein bindingexperiments, MI analysis can provide information for which residues may influencethe specificity of a given base. The MI calculations can then be used to directstructure and function mutational analysis to ultimately be used in protein
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engineering of binding specificity. MI calculations are dependent on the number ofsamples, thus a small population size (<200 members) will yield high backgroundnoise (Mahony et al. 2007). Moreover, MI can also identify evolutionarily linkedresidues and indirect or subtle effects, thus mutational analysis guided by MIcalculation may not always identify large changes, if any, in binding specificity.
Electrophoretic Mobility Shift Assays & Competition Binding Assays to
Determine Equilibrium Dissociation ConstantsGel mobility shifts are used to visualize proteinDDNA interactions byresolving the differential mobility of free DNA from proteinDbound DNA, whereelectrophoretic mobility shift assays (EMSAs) and competition binding assays aretwo different types of gel shifts used. The equilibrium dissociation constant (Kd)can be calculated from EMSAs when the bound DNA and free DNA are quantifiedwith different protein concentrations mixed with a labeled DNA that is well belowthe Kd. EMSA is the most established and widely used method to determine Kd. Toproperly calculate a Kd, the protein concentrations titrated for an EMSA needs to bedetermined to cover two orders of magnitude over and under the constant. Inaddition, the binding transition is where the greatest number of data points shouldoccur. To fulfill both these requirements, optimization is necessary. In addition,EMSAs can be used to look at cooperative binding of DNADprotein interactions.While it is a sensitive assay, weak interactions may not be detected due to high offrates of a given interaction. Moreover, very strong interactions cannot be identified,as a minimal amount of labeled DNA needs to be detected and quantified.
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Competition binding assays consists of titrating in various concentrations ofunlabeled DNA of the same or mutated sequence into subsaturating proteinDDNAcomplex where the DNA of the starting complex is labeled. The free and bound DNAas compared to the competitor concentration can then be used to calculate theequilibrium dissociation constant of the competitor (Kc). The advantages ofcompetition binding assay includes the lack of need to label the DNA competitor,thus many different DNA sequences can be tested to compare affinities against eachother. Since there is no lower limit of DNA, weak interactions can be measuredunlike EMSA. However, each unlabeled sequence to be tested is performed as anindividual assay.
Superimposition to Estimate Distance Spanning Two DBDsSuperimposition by structurally aligning solved crystal structures onidealized BDform DNA allow for gross estimation of distance between positions ondifferent DBDs aligned over the DNA. This is a quick method that estimates theshortest possible distances between two DBD while at the same time avoidingpossible steric interference between the two DBDs. This is opposed to more preciseenergy minimization methods that require more technical expertise and accurateforce fields to model the complexes, which are still under development (Liu andBradley 2012) Estimations are dependent on crystal structure quality and idealizedBDform DNAmay not be representative of what a built chimeric protein willrecognize, as a DNA in vivo is expected is expected to display sequenceDdependentconformational differences. Estimations are then used as a guide of distance to
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allow for empirical determination of the length of linker needed to join two DBDs.The estimation, however, can be quite different from final determined linker length.
Bacterial?One Hybrid Activity AssayUtilizing the B1H system described above, individual bait and preycombinations are transformed into the selection strain. Each combination can thenbe compared for growth rates on selective media to compare the relative DBDDtarget site activity to each other. While there is a correlation of activity to affinityfor the B1H system, this assay, however, does not allow for absolute quantificationof affinity between the different bait and prey combinations (Noyes et al. 2008b).Nonetheless, the comparison of activity does not require the need for labeled DNAor protein purification, unlike gel mobility shift assays.
Yeast?Based Nuclease AssayThe yeastDbased nuclease assay allows for readout of nuclease function to atarget site. This assay is a chromosomal reporter system where the target site isintegrated between an alphaDgalactosidase gene (MEL1). Expression vector(s)containing the nuclease(s) is transformed into the strain containing the integratedtarget site. If the nuclease(s) is able to target the site to create a doubleDstrandedbreak, it allows for in vivo yeast machinery to resect the intervening target to repairtheMEL1 reporter gene via singleDstrand annealing. The restoredMEL1 gene canthen be assayed in liquid culture by spectrophotometry, where a higher nucleaseactivity gives higher measured readout (Doyon et al. 2008).
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This assay allow nucleases to be tested in a controlled system wheredifferent target sites are integrated into yeast at the same location within the yeastgenome. Thus different combinations of nuclease and target sites can be easilytested and compared against each other. The advantage of first testing nucleases inthis system is that the readout of nuclease activity to a target site can be comparedto each other. For in vivo targets that are first tested in this system, it allows for thenuclease and target site combination to be tested without having to take intoaccount confounding factors inherent to an in vivo systems (such has localchromatin structure and DNA methylation). Just because a nuclease(s)demonstrates activity in the yeast system, however, it does not always correlate tofunction in other organisms, such as zebrafish.
Nuclease Treatment of ZebrafishTo introduce artificial nucleases to zebrafish to create targeted genomiclesions, mRNA of the nucleases are injected into singleDcell stage embryos. ThemRNA is translated in vivo by the zebrafish that will then potentially allow thenucleases to generate lesions (insertions or deletions) at the target site. Theoptimal dose of mRNA that is likely to result in lesions is empirically determined byinjecting various concentrations to identify a dose that yields 30 percent deformedembryo morphology (and the reminder normal morphology). Thus embryos at thedesired dose, both normal and deformed, are then isolated for lesion identification,although this is not an absolute indication that lesions have been create at the targetsite (Meng et al. 2008).
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Nuclease treatment is a reverse genetic technique, thus it has the advantageover forward genetic techniques to direct targeted mutagenesis and does notrequire massive screening followed by cumbersome identification of the geneticvariant. Moreover, nuclease treatment has advantages over other reverse genetictechniques in zebrafish of morpholinos, TILLING, and retroviral/transposonDmediated mutagenesis. Nuclease treatment creates permanent lesion that cancreate founders, unlike morpholinos that only transiently knocks down geneexpression. TILLING requires the identification of a mutagenic event from a largelibrary of mutants, where these mutants have many mutations in addition to themutation in the gene of interest. Random insertions of retroviral/transposonDmediate mutagenesis does not allow for controlled directed mutagenesis that isoften desired in a genetic technique. Overall, nuclease treatment has the advantageto create heterozygous carriers with minimal offDtarget effects.With the advantages over many reverse genetic techniques, artificialnuclease treatment has several limitations. The targets of artificial nuclease arelimited by the ability of the DBD (whether it be HDs, ZFs, TALENs, or CRIPSRs) totarget a site, although there are current efforts to expand targeting by DBDs. Even ifa DBD is theoretically available for a particular site, different nucleases havedifferent success rates due to the DBD properties (affinity and specificity), generalnuclease architecture (specificity and stringency), and local genomic effects(chromatin structure and DNA methylation). Nonetheless, artificial nucleases arebeing more commonly used as a genetic technique in many fields.
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LacZalpha Blue?White Assay for Lesion IdentificationTo identify the types of lesions created by the nuclease, the region that wastargeted by the nuclease is PCR amplified from pooled 24 h.p.f. embryos and clonedinto the LacZalpha gene. The amplified product is designed to be short (60D90 basepairs) and inDframe with the LacZalpha gene to have minimal disruption on thefunction of the LacZ peptide. If a lesion, as a deletion or insertion, is present, it willdisrupt the reading frame of LacZ resulting in a nonDfunctional product. A functionalproduct results in blue colonies plated on XDgal and IPTG, while, a nonDfunctionalproduct, indicative of a lesion, will result in white colonies due to inactive betaDgalactosidase. The white colonies are then isolated and sequence to identify theexact sequence present (Zhu et al. 2011).This assay allows for visual assessment of lesions, instead of shotgun cloning,where wildDtype sequences are also sequenced, thus it decreases unnecessarysequencing. Since a triplet insertion or deletion does not result in a frame shift,these types of lesions will not be detected with this assay. While this method has aquick sample preparation to identify lesion types present as compared to Illuminasequencing, it requires that each pooled sample be prepared, cloned, screened, thenmultiple colonies be sequenced, thus assessing lesions in numerous pools can betime consuming.
116
CHAPTER VI
GENERAL DISCUSSION
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Here we were able to dramatically expand HD 3’ specificity from previouslyobserved specificity in naturally occurring HDs. This raises further questions on theevolutionary implications of the expansion. Moreover, we show that new HDvariants that we identified can be used in the new type of artificial nuclease weengineered, the nZFHD. By optimizing the linker between the ZF and HD as well asthe nuclease and ZFHD, we were able to ultimately create siteDdirected lesions inzebrafish. Thus, we introduce the nZFHD as an additional tool to create siteD specificlesions in a complex genome.
Expanding HD Sequence SpecificityBy attempting to engineer the HD to recognize all 64 3’ triplets sites(TAANNN) by fully randomizing positions in the recognition helix we were able todramatically increase the range of sequences HDs can preferentially recognize. Wewere able to expand the 3’ end of the HD binding site from 14 fo the 64 triplet sitesto 44 of the possible 64 sites. This was accomplished by searching a largerrandomized library of HDs than had been previously described for novel recognitionproperties. Some of the recovered variants contained amino acids not previouslyobserved in naturallyDoccurring HDs at residues 43, 46, 47, 50, and 54 that appear topromote novel recognition properties. These selected HD variants display similarbinding affinity and specificity to that of the parent HD for its cognate site.Moreover, amino acid combinations that specify a particular 3’ sequence are able tofunction in alternative HD backbones or in combination with other 5’ specificitydeterminants.
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The success of our experiments likely originates from our ability toexhaustively randomize five recognition helix residues of the HD that we deemedimportant for 3’ specificity. Each randomized residue was anticipated to contributeto different aspects of specificity based on prior literature studies, and thisexpectation was largely confirmed by our MI analysis of selected clones from eachtarget site. The inability of prior studies to identify HD variants with novel HDspecificity (Pomerantz and Sharp 1994; Connolly et al. 1999; Mathias et al. 2001)may be due to their more limited variation at a subset of these recognition positions,as many of our HDs with new recognition properties contain a diverse set of aminoacids The similarity in binding affinities of the identified HD variants for theircognate sites to the En parent for its cognate site is expected as the HD variantswere selected under similar stringencies (where we have observed a loosecorrelation between affinity and stringency in the B1H system (Noyes et al. 2008b).Moreover, since the strongest contributor to affinity, N51 (Ades and Sauer 1995),was held constant in our study, this result is not unexpected. The favorableaffinities of the HD variants demonstrates that when the HD is fused to zinc fingersin the B1H system, sufficient dynamic range remains within the system to selectvariants with recognition properties similar to the parent HD. It is plausible that HDvariants with different binding affinities can also be selected. This may require thatdifferent HD backbones be used and the affinity of the zinc fingers, which are fusedto the HD in the B1H system be tuned to account for changes in affinity. Grafting thenovel specificity determinants on more dramatically different HD backbones, such
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as an atypical HD (Noyes et al. 2008a), will allow further exploration of theinterdependence between our selected specificity determinants and other backboneresidues.
Limitations of HD Recognition PotentialFor 20 sites, out of the 64 TAANNN interrogated, we could not identify a HDvariant with preferential binding. In particular, we found difficulty in specifyingthymidine at base 6. This may be a result of the lack of inherent flexibility within theHD scaffold to specify this particular base pair. Residue 50 dictates specificity forbase 6 by contacting the complementary base within this base pair. The favorableinteraction of adenine in the complementary base 6 position to residue 50 could belimiting the recognition potential.While we chose residues to randomize in our library that we deemed to bemajor determinants of 3’ specificity, other residues in the HD are in contact with thephosphate backbone of the binding site, which include residues 8, 25, 31, 44, 53, and57 (Fraenkel et al. 1998; Passner et al. 1999; Grant et al. 2000). These contactslikely contribute to binding affinity, but they may also influence specificity inunanticipated ways by indirect readout of the target site. Residues within the HD,those that are not observed to make contacts to the binding site, particularlyresidues in the recognition helix, may also contribute to orienting the majorspecificity determinants to specify a particular site. Mutations to these residuescould broaden HD specificity and additional libraries with different combinations of
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randomized residues in the HD could allow for further expansion of 3’ specificity ofthe HD.
Evolutionary Implications of Expanding HD SpecificityThe broad spectrum of HD specificity observed in this study raises thequestions of why naturally occurring eukaryotic HDs do not fully exploit theirrecognition potential. It is particularly striking when the diversity of DNADbindingspecificity of HDs is compared to ZFPs, where ZFPs appear to be rapidly evolvingwith regards to recognition potential (Myers et al. 2010). This characteristic of ZFPsappears as an outlier compared to other DBD families such as bHLHs, bZIPs, and ETS(Wei et al. 2010; De Masi et al. 2011). Thus extant HDs have limited measuredspecificity (Berger et al. 2008; Noyes et al. 2008a; Jolma et al. 2013) similar to thatobserved for other DBD families.HDs are essential for the early development of embryos and bind to manysites throughout the genome (Mann et al. 2009). Thus, they can be viewed as highlyconnected nodes in a network. Could it be that HDs evolve slower (with lessdiversity of interaction) because each member is so highly connected and vital toembryogenesis? This view parallels that of the high conservation of RNADbindingspecificity (Ray et al. 2013). (A high degree of connectedness is also consistent withthe essential nature of many HDs.) This view of restricted evolution is controversialas essential hubs have also been demonstrated to have more diverse specificity andthan nonDessential hubs (Song and Singh 2013). Moreover, since HDs typicallyrecognize a small hexamer binding site, they can recognize potentially millions of
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sites in a genome with high affinity therefore have evolved to be highly necessarysince they recognize so many sites in a genome. If a larger recognition site isutilized then it occurs less in a genome, therefore less essential and allowed toincrease in diversity.The DNA recognition of HDs also function with a cofactor that extends ormodifies the HD’s recognition potential. For example, in HoxDPbx heterodimercomplex results in more specific binding when the two HD complexes to bind toDNA (Joshi et al. 2007). Thus, to understand how a binding partner of a HD canconstrain the evolution of the HD’s specificity, directed evolution of the HDspecificity can be performed with a given cofactor. This may identify how DNADbinding specificity evolves when a TF binding partner is involved in its specificity.Furthermore, the limited HD specificity brings about the question of how their CRMsevolve compared to CRM regulated by a TF with greater diversity of binding, such asZFPs. While we are able to measure the specificity of HDs in our study it does notrecapitulate the true dynamics of in vivo binding. To further understand thenuances of DNA binding by HDs and their evolution, network interaction studies ofHDs in an organism or several organisms, such as that performed in c.elegans TFs(ReeceDHoyes et al. 2013), would be useful to understand the broader picture of HDevolution. Such a study will build a clearer picture to why we were able to select forsuch expanded specificity of a DBD and how that relates to neofunctionalization ofHDs, or if it does at all. Could it be that HDs have DNA bispecificity (a termed coinedfor secondary specificity) not observed in previously measured HDs therefore only
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allowing for 14 of the 64 possible triplet site to be measured as measured for otherTFs (Nakagawa et al. 2013). Further studies measuring HD specificity, such as HTprotein binding microarrays to more broadly define extant HD specificity will alsoallow a more complete assessment of the extent to which HD DNADbindingspecificity is limited in natural systems as protein binding microarray can captureDNA bispecificity.
Future Directions for Broadening HD SpecificityExpanding HDs to recognize a greater range of target sites demonstrates thatthe HD backbone is amenable to further changes in specificity and thus furtherexpansion of specificity at the 5’ and 3’ end may be possible. Identifying newspecificities through the creation of a library of residues affecting 5’ specificity maygreatly increase the number of sites HDs can recognize. A combination of residuesthat influence 5’ specificity D 2, 3, 6D8, and 55 (Ekker et al. 1994; Damante et al.1996; Noyes et al. 2008a) (Figure 1D2) D could be randomized to create a HD libraryidentifying novel 5’ specificities. Additionally, by understanding 5’ recognitionthrough reengineering, it would allow for more sophisticated predictive models tobe created as we have done with the 3’ specificity of HDs (Chu et al. 2012).Moreover, while residue 51 contains an almost invariant asparagine, other HDs areknown to contain other residues at this position, such as the Lag1 HD (Noyes et al.2008a). Changing this residue would allow exploration of the potential forrecognition of other bases at position 3. However, the lack of studies forunderstanding the affinity of residue L51 in Lag1 may necessitate further
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exploration before utilizing it as a HD backbone for reengineering. New 5’specificities identified will likely be compatible with 3’ specificity to greatly expandthe diversity of hexamer binding by the HD.
HDs in artificial nucleasesBy attempting to optimize the linker between the ZF and HD from theoriginal ZFHD construct used in the B1H system that expanded the HD bindingspecificity we were able to identify more stringent and higher activity DNArecognition by the ZFHD modules. Identifying a linker to join the FokI nucleasedomain to the NDterminus of the new ZFHD allowed us to create an active nZFHD,which ultimately created sequenceDdirected genomic lesions in zebrafish.The four different orientations and spacings that the ZF and the HD can bindrelative to each other increase the number of sites the ZFHD can target. While wecreated six pairs of nZFHD to target six different sites in zebrafish, we onlyidentified lesions in one of the six targets. The lesion rate for this target shows thatnZFHD can be as efficient as ZFNs with the ability to create similar types of smallinsertions and deletions at the target site (Gupta et al. 2012).The ability to incorporate HDs in combination with ZFs broadens their jointtargeting capacity as DBDs as ZFs are better at recognizing guanine rich sequenceand HD are better at recognizing ATDrich sites. Moreover, by increasing the numberof different sites a ZFHD can target from the original ZFHD construct site, we haveincreased the number of targetable 6 bp binding site from four percent to twentypercent of all possible 6 bps sites. Taking into account that the 5’ of the HD can
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recognize TGA, TAA, TTA, CAA, and CGA (triplets that ZFs can not target), this istwenty percent is in addition to the possible 6 bp sites that can be recognized by oursingle fingers ZF modules (18 percent) (Zhu et al. 2011). Additionally, the inabilityof the current set of single finger modules from our lab to recognize the five 5’triplet sites recognized by HDs highlights the complementarity between thesemodule sets.
Limitations of HDs in artificial nucleasesOur current results show that while we have created functional nZFHDs, oursuccess rate is limited, where only one of the six nZFHD used resulted in lesions.Here we have built the ZFHD by combining the expected DNADbinding sequence ofthe ZF with the expected DNADbinding sequence of the HD. We could furthervalidate the DNADbinding specificity of each constructed ZFHD chimera as the fuseddomain (containing our selected linkers) to identify the actual sequence each ZFHDrecognizes to test if modularity of the ZF and HD is preserved. The assembly of whatwere deemed modular ZFs in ZFNs has resulted in unexpected specificity for thefinal ZFP (Zhu et al. 2011). Thus, the specificity of each ZFHD created for nZFHDscan be tested in the B1H system to measure if the expected specificity of eachassembled ZFHD has been preserved.Nonetheless, the nZFHDs failure to function may not be due to thearchitecture of the nZFHDs themselves. Further exploration of the cause of thenZFHD’s inability to create lesions at the other five target sites may identify if it isthe inability of the nZFHD to function properly or if it is factors not inherent to the
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nZFHD. Properties inherent to in vivo genomic DNA can affect nuclease targeting ofendogenous sequences, such as chromatin architecture and DNA methylation, whichcan hinder the access to or recognition of the target site (Reyon et al. 2012a; Valtonet al. 2012). To evaluate if the five nZFHD are not functional due to propertiesinherent to the in vivo system, they can be tested in a system outside of thezebrafish, such as the yeastDbased nuclease assay.What nZFHDs can target is only as good as what the HD (and ZF) canrecognize. Increasing the number of target sites that the HD can recognize viaengineering its 5’ and 3’ specificity will also increase the possible number of targetsa ZFHD can specify. This assumes that the modularity of the 5’ and 3’ of the HDspecificity determinants is preserved if new specificity determinant at either the 5’or 3’are identified.Moreover, the linker between the nuclease and the ZFHD can possibly beimproved by selecting for a more stringent linker with higher activity for aparticular spacing, as we have done with the linker between the ZF and the HD.This, however, will be more technically challenging as the length of the linkerbetween the nuclease and ZFHD is much longer than the linker between the ZF andHD. In addition, these experiments are more complicated due to the need to gaugenuclease activity. A possible system to test for nuclease activity is an E.coli basedsystem that has been utilized for directed evolution of the FokI nuclease domain tocreated a higher activity ZFN.(Guo et al. 2010). This system utilizes a toxic reporterplasmid that is destroyed upon nuclease activity to allow for the evolved nuclease tobe recovered and identified. Identifying a linker between the nuclease domain and
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ZFHD to give the nZFHD higher stringency and activity could provide a versatilenZFHD.
Future Directions of HD VariantsDemonstrating that HDs can be utilized in customizable sequenceDdirectednucleases provides the impetus for further developing different architectures ofchimeric DBDs with ZFs and HDs or even HDs alone. Alternative architectures willallow for even greater flexibility in the toolkit to direct sequence specific activity of aprotein or enzyme, which will complement ZFs. Alternative architectures include:fusing the nuclease directly to the CDterminus of the HD, fusing the ZF and HD asHDZF to then connect the nuclease to either termini of the HDZF, or even designingtandem HDs as chimeric nucleases (or artificial transcription factors). Then a linkercould be identified to connect the nuclease to create a functional chimeric nucleaseusing a yeast based assay, as we have done, or utilizing the E.coli based assaymentioned above (Guo et al. 2010). Increasing the possible architecture of HDs willincrease the utility of ZFs, by broadening the frameworks in which ZFs can beemployed with HDs for targeted DNA recognition.FineDtuning the affinity of the HD may aid in decreasing offDtarget effects ofartificial nucleases or artificial proteins, as this has been explored in a limitednumber of cases in ZFNs (Gupta et al. 2011; Pattanayak et al. 2011). Residueswithin the HD (8, 25, 31, 44, 53, 57) have been observed to make several backbonecontacts implying that these interactions do not contribute to specificity but ratheraffinity (Zhu et al. 2011) (Fraenkel et al. 1998; Passner et al. 1999). Mutating these
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residues to abolish one or more of these interactions may be used to fineDtune theaffinity of the HD.HDs can be fused to other DBDs to increase the complex sequences they canspecify. For example, ZFs have been fused to the leucine zipper to create aheterodimeric functional unit (Wolfe et al. 2003). Thus, the combinations ofchimeric DBDs utilizing HDs are endless where HDs can be seen as parts that can beadded to the toolbox to build chimeric transcription factors or chimeric nucleases.Methods to modulate active DNADbinding of the HD within an in vivo systemhold potential through the phosphorylation of the HD. The DNADbinding activity ofHDs can be modulated by phosphorylation at residue 7, where either a decrease orincrease in affinity is observed after phosphorylation, depending of the particularbinding site (Kapiloff et al. 1991). However, sequences adjacent to the coreDbindingmotif can influence the affect of the phosphorylation, thus further exploration tounderstand the specifics of this phenomenon may be necessary. Nonetheless, theutility of phosphorylation in the HD maybe useful as a switch for turning DNArecognition on or off.
Overall Utility of HDs as DBDBroadening what HDs can specify to then utilize the new variants in chimericnucleases complements the limitation of ZFs in ZFNs. While the field of artificialnucleases is quickly growing with TALENs and CRISPRs, nZFHDs (and ZFNs) haveseveral advantages over TALENs and CRISPRs. The small size of ZFHDs and ZFsprovide an advantage over TALEs to be incorporated into gene delivery vectors
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(Holkers et al. 2013) since the typical TALE molecule can be greater than 900 aminoacids, where ZFs and HDs are less than 200 amino acids. In addition, both nZFHDsand ZFNs is be functionally encompassed by one type of molecule to simplifydelivery of a nuclease to a given system. This can be an advantage over CRISPRssince it requires both the Cas9 protein and sgRNA molecules to generate a DBSwhile the other nuclease systems only require the nuclease protein to function.Moreover, nZFHD may provide advantages over the CRISPR system due to it highoffDtarget effects (Fu et al. 2013). By expanding HD specificity and applying them foruse in artificial nucleases, we have added HDs to the arsenal of DBDs to be used astools to further biological investigation, biotechnology, and therapeutics.
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Appendix A-1: 
Significance of determinat—triplet correlations 
          
 
Helix 
position Residue(s) 
Triplet 
preference 
Residue(s) 
present in 
recovered 
sequences 
for target 
triplets 
Residue(s) 
absent in 
recovered 
sequences 
for target 
triplets 
Residue(s) 
present in 
recovered 
sequences 
for 
excluded 
triplets 
Residue(s) 
absent in 
recovered 
sequences 
for 
excluded 
triplet 
Odds 
ratio 
95% confidence 
interval  P-valuea 
47 IVT Tnn 2430 786 885 8661 30.25 33.66 - 27.18 0 
47 KR Gnn 2182 974 827 8779 23.78 26.41 - 21.41 0 
47 N Ynn 997 5393 293 6079 3.84 4.41 - 3.35 4.61E-99 
50 E nBG 903 1467 259 10133 24.07 28.04 - 20.74 0 
50 H MCn 240 1368 42 11112 46.38 66.31 - 33.13 1.63E-175 
50 K KCC 328 16 499 11919 485.05 851.44 - 294.20 0 
50 R nWC 663 944 672 10483 10.95 12.45 - 9.64 1.44E-283 
50 W nAG 543 261 124 11834 197.94 251.58 - 156.32 0 
54 FY Rnn 2143 4229 77 6313 41.54 52.94 - 32.95 0 
54 K Cyn 1252 314 135 11061 322.92 405.14 - 262.56 0 
54 R CRn 1331 277 1126 10022 42.51 49.23 - 36.77 0 
 
a – Benjamini-Hochberg adjusted P-value is reported to account for multiple hypothesis testing. 
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Appendix A-2: 
List of validated HD variants that associate with novel and previously 
defined specificity determinants 
 
KR47 --> Gnn 
26_ALKNM 
27_LTKDQ 
28_RSKER 
29_TLKNQ 
30_LAKDQ 
61_KGKEW 
62_SHKEY 
23_VQKRF 
213_KMKES 
217_KSKEG 
243_ATKSM 
244_KMKSV 
249_QLKQS 
250_AGKTF 
261_KSKEA 
23_GTRAY 
25_YTRQV 
33_ALRQQ 
35_VMRWY 
36_ATRRF 
65_GSRWY 
202_NAREF 
205_TQRQW 
240_SSRGF 
241_GLRAF 
242_LQRGA 
262_QFRAW 
35_VGRLY 
310_YRRGA 
311_YRRGF 
 
 
IVT47 --> Tnn 
15_RMIKS 
226_KMISA 
227_YRIAA 
229_GRISA 
230_ERISQ 
238_QRISV 
9_KTTQD 
14_KGTQM 
18_RLTQA 
22_RITAA 
212_RVTNA 
236_KSTQM 
1_RTVAA 
2_RTVSA 
4_VRVSA 
5_TRVAA 
6_VRVAA 
8_RVVSQ 
10_KSVMQ 
11_KSVAQ 
12_RGVAA 
13_ATVKA 
17_TRVSA 
19_RMVSA 
20_QRVSA 
21_ERVSV 
56_HRVQA 
60_KTVQV 
201_VRVSQ 
216_NRVMM 
235_RAVSV 
237_YAVNA 
239_RTVRA 
258_RTVQQ 
 
 
N47 --> Ynn 
39_IFNAK 
43_MTNGK 
48_EHNAK 
71_MTNNR 
210_RSNQK 
211_TKNQN 
218_KQNQK 
224_IMNSK 
232_IKNQM 
233_VMNQQ 
253_VANSR 
303_VMNRK 
304_TTNQK 
 
 
R50 --> nWC 
52_LGMRR 
225_SLQRF 
272_VAQRC 
36_ATRRF 
308_RLDRF 
271_KLQRF 
203 _VQKRF 
 
W50 --> nAG 
51_MSHWR 
76_RAQWF 
270_RAQWF 
301_RSQWH 
35_VMRWY 
65_GSRWY 
 
 
H50 --> MCn 
267_RVSHT 
70_KTSHM 
264_KVYHV 
66_KTSHM 
266_KACHS 
 
E50 --> nBG 
28_RSKER 
213_KMKES 
217_KSKEG 
40_STRER 
261_KSKEA 
61_KGKEW 
62_SHKEY 
 
 
K50 --> KCC 
15_RMIKS 
32_VRLKY 
13_ATVKA 
265_WYSKY 
246_ISVKY 
245_RAVKW 
 
 
F54 --> Rnn 
59_TRMAF 
75_SISRF 
36_ATRRF 
308_RLDRF 
203_VQKRF 
31_KITKF 
241_GLRAF 
73_KLTAF 
202_NAREF 
240_SSRGF 
311_YRRGF 
37_RFQKF 
250_AGKTF 
72_KMSNF 
225_SLQRF 
271_KLQRF 
76_RAQWF 
270_RAQWF 
268_KLQAF 
269_KVTNF 
 
 
K54 --> CYn 
210_RSNQK 
46_RLDSK 
44_RGDSK 
67_MKYEK 
45_RCYEK 
43_MTNGK 
224_IMNSK 
207_ITYGK 
222_SKYGK 
38_LHYAK 
252_LRYSK 
48_EHNAK 
47_KMTQK 
220_LTYQK 
221_RLYQK 
304_TTNQK 
218_KQNQK 
 
 
R54 --> CRn 
52_LGMRR 
49_LSQSR 
53_ERVSR 
55_LHYVR 
51_MSHWR 
54_LMYQR 
253_VANSR 
40_STRER 
168_SRYDR 
251_VGYSR 
257_KLCSR 
209_PRDSR 
 
 
Y54 --> Gnn 
305_VGRLY 
309_RLDRY 
35_VMRWY 
65_GSRWY 
34_RTMRY 
32_VRLKY 
265_WYSKY 
246_ISVKY 
204_RTDRY 
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Appendix A 3:  
Construction and assessment of RF models for predicting HD specificity.  
 
  
 
Supplement              
pe ifici y    
 
 
Trial 
Model 
Assessment Training Set Prediction Set 
MSE per 
parameter 
A Full 100% extant HDs 100% en mutant HDs 
0.053 
B 10-fold CV 90% en mutant HDs 10% of en mutant HDs 
0.015 
C 10-fold CV 90% en mutant HDs + 100% extant HDs 
10% of en mutant 
HDs 
0.014 
D Full 100% en mutant HDs 100% extant HDs 0.025 
E Positive control 100% extant HDs 100% extant HDs 
0.003 
F Positive control 100% en mutant HDs 
100% en mutant 
HDs 
0.004 
 
Extant HDs indicated the set of 246 mouse and fruit fly HDs previously used for 
modeling (Christensen et al. 2012).  En mutant HDs indicates the 151 characterized 
selected HDs from this study.  CV, cross-validation; MSE, mean squared error.  
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Appendix A-4: 
Human HD Predictions 
                 y  y   p   y p  p )
Name ▾ Logo PFM Mat r i x
A1L4G3_HUMAN/200..257
A |  0.2008 0.1962 0.0212 0.9709 0.9865 0.1785 0.1144 0.5041 0.2028
C |  0.2465 0.2269 0.0088 0.0065 0.0084 0.0788 0.1435 0.0106 0.2671
G |  0.2883 0.1034 0.0043 0.0053 0.0019 0.0565 0.2367 0.4559 0.3203
T |  0.2644 0.4735 0.9656 0.0173 0.0032 0.6862 0.5054 0.0294 0.2098
A4D0Z1_HUMAN/161..221
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
A4D127_HUMAN/185..245
A |  0.2344 0.1869 0.0226 0.9033 0.9814 0.0073 0.0113 0.7340 0.1894
C |  0.2384 0.2464 0.0173 0.0095 0.0072 0.0342 0.0514 0.0071 0.3376
G |  0.2724 0.1015 0.0038 0.0480 0.0035 0.0164 0.4441 0.2224 0.2769
T |  0.2548 0.4652 0.9563 0.0392 0.0080 0.9421 0.4932 0.0365 0.1961
A4D182_HUMAN/32..92
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
A6NLG4_HUMAN/10..70
A |  0.2216 0.1799 0.0271 0.9614 0.9876 0.0035 0.0280 0.4998 0.2551
C |  0.2672 0.2974 0.0107 0.0123 0.0082 0.0037 0.0568 0.0421 0.2260
G |  0.2853 0.1350 0.0018 0.0161 0.0018 0.0203 0.0898 0.3923 0.3507
T |  0.2259 0.3877 0.9605 0.0102 0.0024 0.9725 0.8254 0.0657 0.1682
A8MWF9_HUMAN/55..115
A |  0.2344 0.1869 0.0226 0.9033 0.9814 0.0073 0.0113 0.7340 0.1894
C |  0.2384 0.2464 0.0173 0.0095 0.0072 0.0342 0.0514 0.0071 0.3376
G |  0.2724 0.1015 0.0038 0.0480 0.0035 0.0164 0.4441 0.2224 0.2769
T |  0.2548 0.4652 0.9563 0.0392 0.0080 0.9421 0.4932 0.0365 0.1961
ADNP_HUMAN/763..815
A |  0.2437 0.2375 0.0837 0.5709 0.9766 0.2939 0.2199 0.2667 0.1464
C |  0.2498 0.1752 0.0459 0.0343 0.0052 0.5463 0.5009 0.3620 0.2379
G |  0.2272 0.1584 0.0869 0.1296 0.0054 0.1422 0.0216 0.1255 0.4717
T |  0.2793 0.4289 0.7835 0.2651 0.0128 0.0175 0.2575 0.2458 0.1440
ALX1_HUMAN/131..191
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
ALX3_HUMAN/152..212
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
ALX4_HUMAN/213..273
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
ARGFX_HUMAN/77..137
A |  0.2261 0.2432 0.0659 0.8778 0.9851 0.1996 0.4513 0.2747 0.1693
C |  0.2579 0.2110 0.0199 0.0110 0.0071 0.0000 0.1487 0.4981 0.2496
G |  0.2701 0.1098 0.0243 0.0595 0.0027 0.3692 0.0479 0.0000 0.4634
T |  0.2460 0.4361 0.8899 0.0517 0.0051 0.4312 0.3521 0.2272 0.1176
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 y  y   p   y p  p )
Name ▾ Logo PFM Mat r i x
A1L4G3_HUMAN/200..257
A |  0.2008 0.1962 0.0212 0.9709 0.9865 0.1785 0.1144 0.5041 0.2028
C |  0.2465 0.2269 0.0088 0.0065 0.0084 0.0788 0.1435 0.0106 0.2671
G |  0.2883 0.1034 0.0043 0.0053 0.0019 0.0565 0.2367 0.4559 0.3203
T |  0.2644 0.4735 0.9656 0.0173 0.0032 0.6862 0.5054 0.0294 0.2098
A4D0Z1_HUMAN/161..221
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
A4D127_HUMAN/185..245
A |  0.2344 0.1869 0.0226 0.9033 0.9814 0.0073 0.0113 0.7340 0.1894
C |  0.2384 0.2464 0.0173 0.0095 0.0072 0.0342 0.0514 0.0071 0.3376
G |  0.2724 0.1015 0.0038 0.0480 0.0035 0.0164 0.4441 0.2224 0.2769
T |  0.2548 0.4652 0.9563 0.0392 0.0080 0.9421 0.4932 0.0365 0.1961
A4D182_HUMAN/32..92
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
A6NLG4_HUMAN/10..70
A |  0.2216 0.1799 0.0271 0.9614 0.9876 0.0035 0.0280 0.4998 0.2551
C |  0.2672 0.2974 0.0107 0.0123 0.0082 0.0037 0.0568 0.0421 0.2260
G |  0.2853 0.1350 0.0018 0.0161 0.0018 0.0203 0.0898 0.3923 0.3507
T |  0.2259 0.3877 0.9605 0.0102 0.0024 0.9725 0.8254 0.0657 0.1682
A8MWF9_HUMAN/55..115
A |  0.2344 0.1869 0.0226 0.9033 0.9814 0.0073 0.0113 0.7340 0.1894
C |  0.2384 0.2464 0.0173 0.0095 0.0072 0.0342 0.0514 0.0071 0.3376
G |  0.2724 0.1015 0.0038 0.0480 0.0035 0.0164 0.4441 0.2224 0.2769
T |  0.2548 0.4652 0.9563 0.0392 0.0080 0.9421 0.4932 0.0365 0.1961
ADNP_HUMAN/763..815
A |  0.2437 0.2375 0.0837 0.5709 0.9766 0.2939 0.2199 0.2667 0.1464
C |  0.2498 0.1752 0.0459 0.0343 0.0052 0.5463 0.5009 0.3620 0.2379
G |  0.2272 0.1584 0.0869 0.1296 0.0054 0.1422 0.0216 0.1255 0.4717
T |  0.2793 0.4289 0.7835 0.2651 0.0128 0.0175 0.2575 0.2458 0.1440
ALX1_HUMAN/131..191
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
ALX3_HUMAN/152..212
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
ALX4_HUMAN/213..273
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
ARGFX_HUMAN/77..137
A |  0.2261 0.2432 0.0659 0.8778 0.9851 0.1996 0.4513 0.2747 0.1693
C |  0.2579 0.2110 0.0199 0.0110 0.0071 0.0000 0.1487 0.4981 0.2496
G |  0.2701 0.1098 0.0243 0.0595 0.0027 0.3692 0.0479 0.0000 0.4634
T |  0.2460 0.4361 0.8899 0.0517 0.0051 0.4312 0.3521 0.2272 0.1176
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CDX4_HUMAN/172..232
A |  0.2142 0.0729 0.0985 0.3510 0.9785 0.0091 0.0977 0.5420 0.1289
C |  0.1734 0.0712 0.0209 0.0000 0.0069 0.0815 0.0094 0.0154 0.4211
G |  0.2170 0.0543 0.0111 0.0622 0.0046 0.0305 0.2840 0.4209 0.2441
T |  0.3954 0.8016 0.8696 0.5868 0.0101 0.8790 0.6089 0.0217 0.2060
CERS2_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
CERS3_HUMAN/69..128 No prediction made
The extracted domain has residue (S) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
CERS4_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
CERS5_HUMAN/81..137 No prediction made
The extracted domain has residue (H) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
CERS6_HUMAN/78..128 No prediction made
The extracted domain has residue (Q) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
CRX_HUMAN/38..98
A |  0.2271 0.2000 0.0400 0.9635 0.9883 0.0002 0.0349 0.0327 0.1395
C |  0.2471 0.2969 0.0041 0.0098 0.0085 0.0051 0.9108 0.7577 0.3630
G |  0.3047 0.1251 0.0091 0.0116 0.0013 0.0741 0.0043 0.0403 0.2830
T |  0.2211 0.3780 0.9468 0.0151 0.0019 0.9206 0.0500 0.1693 0.2146
CUX1_HUMAN/1243..1303
A |  0.1438 0.1791 0.0787 0.3598 0.9711 0.3373 0.1969 0.3645 0.2414
C |  0.3657 0.1971 0.0998 0.0277 0.0085 0.1734 0.6559 0.2860 0.2789
G |  0.2819 0.1291 0.0358 0.5008 0.0031 0.0466 0.0000 0.1814 0.2782
T |  0.2085 0.4947 0.7857 0.1117 0.0172 0.4428 0.1472 0.1682 0.2015
CUX2_HUMAN/1167..1227
A |  0.1438 0.1791 0.0787 0.3598 0.9711 0.3373 0.1969 0.3645 0.2414
C |  0.3657 0.1971 0.0998 0.0277 0.0085 0.1734 0.6559 0.2860 0.2789
G |  0.2819 0.1291 0.0358 0.5008 0.0031 0.0466 0.0000 0.1814 0.2782
T |  0.2085 0.4947 0.7857 0.1117 0.0172 0.4428 0.1472 0.1682 0.2015
D2CFI5_HUMAN/61. .121
A |  0.2526 0.2040 0.0570 0.6844 0.9728 0.0078 0.0988 0.0385 0.1443
C |  0.2412 0.2275 0.0675 0.0265 0.0092 0.0189 0.8379 0.7140 0.3504
G |  0.2737 0.1581 0.0113 0.2183 0.0024 0.0344 0.0177 0.0715 0.2837
T |  0.2324 0.4103 0.8642 0.0707 0.0156 0.9389 0.0456 0.1761 0.2217
D6R955_HUMAN/88. .114 No prediction made
The extracted domain has a gap at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
D6R9U1_HUMAN/88. .131 No prediction made
The extracted domain has a gap at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
D6RAR5_HUMAN/45. .105
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
D6RBB8_HUMAN/180..240
A |  0.2524 0.1439 0.0520 0.9014 0.9711 0.0836 0.1018 0.3286 0.2510
C |  0.2238 0.3478 0.0234 0.0054 0.0061 0.0148 0.0343 0.0514 0.2630
G |  0.3062 0.1284 0.0219 0.0829 0.0057 0.1413 0.3529 0.5412 0.2866
T |  0.2176 0.3800 0.9027 0.0104 0.0171 0.7603 0.5110 0.0789 0.1994
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CDX4_HUMAN/172..232
A |  0.2142 0.0729 0.0985 0.3510 0.9785 0.0091 0.0977 0.5420 0.1289
C |  0.1734 0.0712 0.0209 0.0000 0.0069 0.0815 0.0094 0.0154 0.4211
G |  0.2170 0.0543 0.0111 0.0622 0.0046 0.0305 0.2840 0.4209 0.2441
T |  0.3954 0.8016 0.8696 0.5868 0.0101 0.8790 0.6089 0.0217 0.2060
CERS2_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
CERS3_HUMAN/69..128 No prediction made
The extracted domain has residue (S) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
CERS4_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
CERS5_HUMAN/81..137 No prediction made
The extracted domain has residue (H) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
CERS6_HUMAN/78..128 No prediction made
The extracted domain has residue (Q) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
CRX_HUMAN/38..98
A |  0.2271 0.2000 0.0400 0.9635 0.9883 0.0002 0.0349 0.0327 0.1395
C |  0.2471 0.2969 0.0041 0.0098 0.0085 0.0051 0.9108 0.7577 0.3630
G |  0.3047 0.1251 0.0091 0.0116 0.0013 0.0741 0.0043 0.0403 0.2830
T |  0.2211 0.3780 0.9468 0.0151 0.0019 0.9206 0.0500 0.1693 0.2146
CUX1_HUMAN/1243..1303
A |  0.1438 0.1791 0.0787 0.3598 0.9711 0.3373 0.1969 0.3645 0.2414
C |  0.3657 0.1971 0.0998 0.0277 0.0085 0.1734 0.6559 0.2860 0.2789
G |  0.2819 0.1291 0.0358 0.5008 0.0031 0.0466 0.0000 0.1814 0.2782
T |  0.2085 0.4947 0.7857 0.1117 0.0172 0.4428 0.1472 0.1682 0.2015
CUX2_HUMAN/1167..1227
A |  0.1438 0.1791 0.0787 0.3598 0.9711 0.3373 0.1969 0.3645 0.2414
C |  0.3657 0.1971 0.0998 0.0277 0.0085 0.1734 0.6559 0.2860 0.2789
G |  0.2819 0.1291 0.0358 0.5008 0.0031 0.0466 0.0000 0.1814 0.2782
T |  0.2085 0.4947 0.7857 0.1117 0.0172 0.4428 0.1472 0.1682 0.2015
D2CFI5_HUMAN/61. .121
A |  0.2526 0.2040 0.0570 0.6844 0.9728 0.0078 0.0988 0.0385 0.1443
C |  0.2412 0.2275 0.0675 0.0265 0.0092 0.0189 0.8379 0.7140 0.3504
G |  0.2737 0.1581 0.0113 0.2183 0.0024 0.0344 0.0177 0.0715 0.2837
T |  0.2324 0.4103 0.8642 0.0707 0.0156 0.9389 0.0456 0.1761 0.2217
D6R955_HUMAN/88. .114 No prediction made
The extracted domain has a gap at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
D6R9U1_HUMAN/88. .131 No prediction made
The extracted domain has a gap at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
D6RAR5_HUMAN/45. .105
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
D6RBB8_HUMAN/180..240
A |  0.2524 0.1439 0.0520 0.9014 0.9711 0.0836 0.1018 0.3286 0.2510
C |  0.2238 0.3478 0.0234 0.0054 0.0061 0.0148 0.0343 0.0514 0.2630
G |  0.3062 0.1284 0.0219 0.0829 0.0057 0.1413 0.3529 0.5412 0.2866
T |  0.2176 0.3800 0.9027 0.0104 0.0171 0.7603 0.5110 0.0789 0.1994
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DPRX_HUMAN/15. .75
A |  0.2271 0.2000 0.0400 0.9635 0.9883 0.0002 0.0349 0.0327 0.1395
C |  0.2471 0.2969 0.0041 0.0098 0.0085 0.0051 0.9108 0.7577 0.3630
G |  0.3047 0.1251 0.0091 0.0116 0.0013 0.0741 0.0043 0.0403 0.2830
T |  0.2211 0.3780 0.9468 0.0151 0.0019 0.9206 0.0500 0.1693 0.2146
DRGX_HUMAN/32. .92
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
DU4L2_HUMAN/18. .78
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
DU4L2_HUMAN/93. .151
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
DU4L3_HUMAN/18. .78
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
DU4L3_HUMAN/93. .151
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
DU4L4_HUMAN/18. .78
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
DU4L4_HUMAN/93. .151
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
DU4L5_HUMAN/18. .78
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
DU4L5_HUMAN/93. .151
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
DU4L6_HUMAN/18. .78
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
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DU4L6_HUMAN/93. .151
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
DU4L7_HUMAN/18. .78
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
DU4L7_HUMAN/93. .151
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
DUX1_HUMAN/18. .78
A |  0.2265 0.1816 0.0601 0.6776 0.9747 0.0048 0.0678 0.4547 0.1994
C |  0.2534 0.1976 0.0334 0.0264 0.0107 0.0404 0.0530 0.0196 0.2876
G |  0.2514 0.1495 0.0219 0.2362 0.0028 0.1046 0.1838 0.4796 0.3219
T |  0.2687 0.4713 0.8846 0.0598 0.0118 0.8502 0.6954 0.0461 0.1911
DUX1_HUMAN/93. .153
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
DUX2_HUMAN/18. .78
A |  0.2265 0.1816 0.0601 0.6776 0.9747 0.0048 0.0678 0.4547 0.1994
C |  0.2534 0.1976 0.0334 0.0264 0.0107 0.0404 0.0530 0.0196 0.2876
G |  0.2514 0.1495 0.0219 0.2362 0.0028 0.1046 0.1838 0.4796 0.3219
T |  0.2687 0.4713 0.8846 0.0598 0.0118 0.8502 0.6954 0.0461 0.1911
DUX3_HUMAN/120..179
A |  0.2376 0.1579 0.0475 0.4023 0.9878 0.0000 0.0415 0.5208 0.2469
C |  0.2587 0.2934 0.0112 0.0000 0.0074 0.1044 0.0252 0.0000 0.2071
G |  0.2690 0.1306 0.0089 0.5639 0.0019 0.0542 0.1060 0.4368 0.3747
T |  0.2348 0.4181 0.9324 0.0338 0.0029 0.8414 0.8273 0.0424 0.1713
DUX3_HUMAN/45. .105
A |  0.2265 0.1816 0.0601 0.6776 0.9747 0.0048 0.0678 0.4547 0.1994
C |  0.2534 0.1976 0.0334 0.0264 0.0107 0.0404 0.0530 0.0196 0.2876
G |  0.2514 0.1495 0.0219 0.2362 0.0028 0.1046 0.1838 0.4796 0.3219
T |  0.2687 0.4713 0.8846 0.0598 0.0118 0.8502 0.6954 0.0461 0.1911
DUX4C_HUMAN/18. .78
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
DUX4C_HUMAN/93. .151
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
DUX4_HUMAN/18. .78
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
DUX4_HUMAN/93. .151
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
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DUX5_HUMAN/120..180
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
DUX5_HUMAN/45. .105
A |  0.2265 0.1816 0.0601 0.6776 0.9747 0.0048 0.0678 0.4547 0.1994
C |  0.2534 0.1976 0.0334 0.0264 0.0107 0.0404 0.0530 0.0196 0.2876
G |  0.2514 0.1495 0.0219 0.2362 0.0028 0.1046 0.1838 0.4796 0.3219
T |  0.2687 0.4713 0.8846 0.0598 0.0118 0.8502 0.6954 0.0461 0.1911
DUXA_HUMAN/100..158
A |  0.2373 0.1721 0.0590 0.3934 0.9851 0.0159 0.0457 0.4718 0.2404
C |  0.2499 0.2761 0.0165 0.0000 0.0078 0.0205 0.0541 0.0177 0.2336
G |  0.2633 0.1473 0.0076 0.5528 0.0026 0.0432 0.1387 0.4779 0.3471
T |  0.2495 0.4045 0.9169 0.0537 0.0045 0.9204 0.7615 0.0326 0.1788
DUXA_HUMAN/14. .72
A |  0.2371 0.1566 0.0529 0.3194 0.9859 0.0145 0.0000 0.4186 0.2301
C |  0.2461 0.2671 0.0052 0.0000 0.0071 0.0016 0.0644 0.0416 0.2563
G |  0.2763 0.1503 0.0110 0.6414 0.0029 0.0433 0.1249 0.5346 0.3358
T |  0.2405 0.4260 0.9309 0.0392 0.0042 0.9406 0.8107 0.0052 0.1778
E0YMI7_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E0YMJ3_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E0YMJ4_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E0YMJ5_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E0YMJ8_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E0YMJ9_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E5RGZ2_HUMAN/266..341
A |  0.2260 0.2126 0.1212 0.6215 0.9503 0.0503 0.1019 0.5213 0.2296
C |  0.2767 0.2221 0.1232 0.0477 0.0000 0.8548 0.3955 0.1597 0.1796
G |  0.2235 0.1424 0.0738 0.1213 0.0130 0.0000 0.0753 0.1542 0.4496
T |  0.2738 0.4229 0.6818 0.2096 0.0367 0.0949 0.4273 0.1648 0.1413
E7EMR0_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E7EN04_HUMAN/129..189
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
E7EQ07_HUMAN/86..146
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
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E7ER53_HUMAN/2112..2172
A |  0.2351 0.1770 0.0755 0.8644 0.9854 0.1264 0.6189 0.1422 0.1215
C |  0.2654 0.2520 0.0169 0.0187 0.0060 0.0136 0.1701 0.6182 0.2285
G |  0.2370 0.1027 0.0337 0.0968 0.0036 0.7031 0.0000 0.0275 0.5260
T |  0.2625 0.4683 0.8739 0.0200 0.0050 0.1570 0.2109 0.2121 0.1240
E7ER53_HUMAN/2209..2269
A |  0.2519 0.1819 0.0275 0.8227 0.9853 0.0203 0.0536 0.6569 0.2579
C |  0.2418 0.2492 0.0408 0.0045 0.0075 0.0334 0.0530 0.0141 0.2140
G |  0.2715 0.1199 0.0276 0.1135 0.0019 0.0237 0.3889 0.2931 0.3775
T |  0.2348 0.4490 0.9041 0.0594 0.0052 0.9226 0.5044 0.0359 0.1507
E7ER53_HUMAN/2588..2648
A |  0.2342 0.1668 0.0273 0.5568 0.9874 0.0101 0.0138 0.4708 0.2177
C |  0.2530 0.3389 0.0029 0.0000 0.0079 0.0084 0.0216 0.0118 0.2707
G |  0.2909 0.1231 0.0049 0.4184 0.0017 0.0107 0.0940 0.4760 0.3289
T |  0.2220 0.3711 0.9649 0.0247 0.0030 0.9708 0.8706 0.0414 0.1826
E7ER53_HUMAN/2912..2972
A |  0.2399 0.1483 0.0321 0.9435 0.9809 0.0210 0.0287 0.5619 0.2547
C |  0.2461 0.3280 0.0106 0.0110 0.0072 0.0028 0.0488 0.0140 0.2428
G |  0.2837 0.1082 0.0044 0.0325 0.0037 0.0484 0.1220 0.3763 0.3085
T |  0.2304 0.4155 0.9529 0.0129 0.0083 0.9279 0.8005 0.0478 0.1940
E7ETP3_HUMAN/159..219
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
E7EUQ4_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E7EUW9_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E7EVZ1_HUMAN/2102..2162
A |  0.2351 0.1770 0.0755 0.8644 0.9854 0.1264 0.6189 0.1422 0.1215
C |  0.2654 0.2520 0.0169 0.0187 0.0060 0.0136 0.1701 0.6182 0.2285
G |  0.2370 0.1027 0.0337 0.0968 0.0036 0.7031 0.0000 0.0275 0.5260
T |  0.2625 0.4683 0.8739 0.0200 0.0050 0.1570 0.2109 0.2121 0.1240
E7EVZ1_HUMAN/2199..2259
A |  0.2519 0.1819 0.0275 0.8227 0.9853 0.0203 0.0536 0.6569 0.2579
C |  0.2418 0.2492 0.0408 0.0045 0.0075 0.0334 0.0530 0.0141 0.2140
G |  0.2715 0.1199 0.0276 0.1135 0.0019 0.0237 0.3889 0.2931 0.3775
T |  0.2348 0.4490 0.9041 0.0594 0.0052 0.9226 0.5044 0.0359 0.1507
E7EVZ1_HUMAN/2578..2638
A |  0.2342 0.1668 0.0273 0.5568 0.9874 0.0101 0.0138 0.4708 0.2177
C |  0.2530 0.3389 0.0029 0.0000 0.0079 0.0084 0.0216 0.0118 0.2707
G |  0.2909 0.1231 0.0049 0.4184 0.0017 0.0107 0.0940 0.4760 0.3289
T |  0.2220 0.3711 0.9649 0.0247 0.0030 0.9708 0.8706 0.0414 0.1826
E7EVZ1_HUMAN/2902..2962
A |  0.2399 0.1483 0.0321 0.9435 0.9809 0.0210 0.0287 0.5619 0.2547
C |  0.2461 0.3280 0.0106 0.0110 0.0072 0.0028 0.0488 0.0140 0.2428
G |  0.2837 0.1082 0.0044 0.0325 0.0037 0.0484 0.1220 0.3763 0.3085
T |  0.2304 0.4155 0.9529 0.0129 0.0083 0.9279 0.8005 0.0478 0.1940
E9PB27_HUMAN/159..222
A |  0.2331 0.1862 0.0329 0.1150 0.9785 0.0256 0.3941 0.2947 0.2436
C |  0.2117 0.1101 0.0141 0.0001 0.0070 0.4410 0.0780 0.1906 0.2202
G |  0.1937 0.1722 0.0228 0.8471 0.0034 0.0585 0.3485 0.2694 0.3604
T |  0.3615 0.5314 0.9302 0.0378 0.0111 0.4749 0.1794 0.2454 0.1758
The extracted domain has residue (Q) at position 51 but residue (N)
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E9PB55_HUMAN/22..80 No prediction made
The extracted domain has residue (Q) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
E9PCM7_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
E9PEK5_HUMAN/154..212
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
E9PEK5_HUMAN/79..139
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
E9PFV9_HUMAN/216..276
A |  0.2275 0.2398 0.0596 0.7268 0.9881 0.0157 0.1254 0.2813 0.2523
C |  0.2571 0.2797 0.0096 0.0030 0.0072 0.0173 0.2354 0.2483 0.1896
G |  0.3102 0.1459 0.0148 0.2523 0.0021 0.0099 0.1297 0.3206 0.4273
T |  0.2052 0.3345 0.9160 0.0179 0.0026 0.9571 0.5094 0.1498 0.1307
E9PG50_HUMAN/273..331 No prediction made
The extracted domain has residue (D) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
E9PG50_HUMAN/390..447 No prediction made
The extracted domain has residue (E) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
E9PGE3_HUMAN/214..274
A |  0.2345 0.1541 0.0242 0.5016 0.9882 0.0068 0.0121 0.5322 0.2058
C |  0.2632 0.3621 0.0023 0.0019 0.0075 0.0041 0.0125 0.0084 0.2960
G |  0.3123 0.1258 0.0047 0.4749 0.0018 0.0058 0.0753 0.4280 0.3341
T |  0.1900 0.3580 0.9688 0.0216 0.0025 0.9833 0.9001 0.0314 0.1641
E9PGG2_HUMAN/137..196
A |  0.2383 0.1722 0.0787 0.3269 0.9818 0.0000 0.6108 0.4070 0.2617
C |  0.2370 0.2267 0.1101 0.0141 0.0065 0.7438 0.1118 0.1451 0.2381
G |  0.2454 0.1740 0.0319 0.5116 0.0044 0.0896 0.0554 0.2006 0.3084
T |  0.2793 0.4271 0.7792 0.1474 0.0073 0.1666 0.2221 0.2474 0.1918
E9PIN6_HUMAN/234..294
A |  0.2473 0.3513 0.1233 0.7905 0.9802 0.0121 0.0171 0.6505 0.3667
C |  0.2127 0.2208 0.0182 0.0067 0.0049 0.0036 0.0486 0.2373 0.0974
G |  0.3243 0.1216 0.0152 0.0176 0.0043 0.0067 0.4954 0.0479 0.4528
T |  0.2158 0.3063 0.8433 0.1853 0.0105 0.9775 0.4389 0.0643 0.0831
E9PIX4_HUMAN/8. .68
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
E9PLE6_HUMAN/55..115
A |  0.2184 0.2379 0.0271 0.9604 0.9834 0.0366 0.0387 0.4661 0.1915
C |  0.2319 0.2329 0.0092 0.0105 0.0081 0.1007 0.1784 0.0222 0.2702
G |  0.3183 0.1328 0.0103 0.0124 0.0025 0.0358 0.3706 0.4677 0.3421
T |  0.2314 0.3965 0.9534 0.0167 0.0060 0.8269 0.4122 0.0439 0.1962
E9PNC9_HUMAN/280..340
A |  0.2670 0.3899 0.1107 0.7971 0.9786 0.0187 0.0316 0.6638 0.3870
C |  0.2142 0.1971 0.0113 0.0073 0.0029 0.0003 0.0657 0.2101 0.0997
G |  0.3053 0.1073 0.0149 0.0115 0.0060 0.0103 0.4403 0.0463 0.4244
T |  0.2135 0.3057 0.8630 0.1841 0.0126 0.9707 0.4624 0.0798 0.0889
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E9PQ94_HUMAN/37..97
A |  0.2184 0.2379 0.0271 0.9604 0.9834 0.0366 0.0387 0.4661 0.1915
C |  0.2319 0.2329 0.0092 0.0105 0.0081 0.1007 0.1784 0.0222 0.2702
G |  0.3183 0.1328 0.0103 0.0124 0.0025 0.0358 0.3706 0.4677 0.3421
T |  0.2314 0.3965 0.9534 0.0167 0.0060 0.8269 0.4122 0.0439 0.1962
E9PQI0_HUMAN/65..125
A |  0.2473 0.3513 0.1233 0.7905 0.9802 0.0121 0.0171 0.6505 0.3667
C |  0.2127 0.2208 0.0182 0.0067 0.0049 0.0036 0.0486 0.2373 0.0974
G |  0.3243 0.1216 0.0152 0.0176 0.0043 0.0067 0.4954 0.0479 0.4528
T |  0.2158 0.3063 0.8433 0.1853 0.0105 0.9775 0.4389 0.0643 0.0831
E9PS79_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
EMX1_HUMAN/158..218
A |  0.2385 0.1178 0.0427 0.9530 0.9872 0.0316 0.1208 0.6349 0.2395
C |  0.2516 0.3932 0.0122 0.0128 0.0076 0.0070 0.0419 0.0228 0.2576
G |  0.2701 0.1232 0.0157 0.0231 0.0021 0.0417 0.2768 0.2853 0.2980
T |  0.2398 0.3659 0.9294 0.0112 0.0030 0.9196 0.5605 0.0570 0.2049
EMX2_HUMAN/153..213
A |  0.2385 0.1178 0.0427 0.9530 0.9872 0.0316 0.1208 0.6349 0.2395
C |  0.2516 0.3932 0.0122 0.0128 0.0076 0.0070 0.0419 0.0228 0.2576
G |  0.2701 0.1232 0.0157 0.0231 0.0021 0.0417 0.2768 0.2853 0.2980
T |  0.2398 0.3659 0.9294 0.0112 0.0030 0.9196 0.5605 0.0570 0.2049
ESX1_HUMAN/138..198
A |  0.2358 0.1569 0.0261 0.9545 0.9880 0.0037 0.0363 0.6063 0.2790
C |  0.2586 0.3220 0.0092 0.0137 0.0070 0.0069 0.0317 0.0163 0.2085
G |  0.2918 0.1103 0.0025 0.0196 0.0025 0.0095 0.0772 0.3350 0.3569
T |  0.2139 0.4108 0.9622 0.0123 0.0025 0.9798 0.8549 0.0425 0.1556
EVX1_HUMAN/182..242
A |  0.2350 0.1336 0.0185 0.9687 0.9862 0.0056 0.0284 0.7018 0.1918
C |  0.2644 0.3754 0.0073 0.0092 0.0076 0.0315 0.0744 0.0197 0.3114
G |  0.2964 0.1184 0.0071 0.0189 0.0024 0.0112 0.4242 0.2305 0.3153
T |  0.2042 0.3725 0.9672 0.0032 0.0038 0.9517 0.4731 0.0480 0.1814
EVX2_HUMAN/187..247
A |  0.2350 0.1336 0.0185 0.9687 0.9862 0.0056 0.0284 0.7018 0.1918
C |  0.2644 0.3754 0.0073 0.0092 0.0076 0.0315 0.0744 0.0197 0.3114
G |  0.2964 0.1184 0.0071 0.0189 0.0024 0.0112 0.4242 0.2305 0.3153
T |  0.2042 0.3725 0.9672 0.0032 0.0038 0.9517 0.4731 0.0480 0.1814
F2Z381_HUMAN/33. .93
A |  0.3019 0.2505 0.0874 0.8705 0.9843 0.0063 0.0581 0.5512 0.3071
C |  0.2338 0.2215 0.0037 0.0060 0.0059 0.0072 0.0558 0.2614 0.1645
G |  0.2729 0.0959 0.0303 0.0190 0.0029 0.0265 0.5642 0.0837 0.4177
T |  0.1914 0.4321 0.8786 0.1044 0.0068 0.9600 0.3218 0.1038 0.1108
F5GWW6_HUMAN/282..342
A |  0.2473 0.3513 0.1233 0.7905 0.9802 0.0121 0.0171 0.6505 0.3667
C |  0.2127 0.2208 0.0182 0.0067 0.0049 0.0036 0.0486 0.2373 0.0974
G |  0.3243 0.1216 0.0152 0.0176 0.0043 0.0067 0.4954 0.0479 0.4528
T |  0.2158 0.3063 0.8433 0.1853 0.0105 0.9775 0.4389 0.0643 0.0831
F5GXB4_HUMAN/44. .104
A |  0.2526 0.2040 0.0570 0.6844 0.9728 0.0078 0.0988 0.0385 0.1443
C |  0.2412 0.2275 0.0675 0.0265 0.0092 0.0189 0.8379 0.7140 0.3504
G |  0.2737 0.1581 0.0113 0.2183 0.0024 0.0344 0.0177 0.0715 0.2837
T |  0.2324 0.4103 0.8642 0.0707 0.0156 0.9389 0.0456 0.1761 0.2217
F5GZ66_HUMAN/154..212
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0 2650 0 1353 0 0085 0 6468 0 0024 0 0131 0 0804 0 5029 0 3823
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G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
F5GZ66_HUMAN/79. .139
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
F5GZI2_HUMAN/70. .130
A |  0.2184 0.2379 0.0271 0.9604 0.9834 0.0366 0.0387 0.4661 0.1915
C |  0.2319 0.2329 0.0092 0.0105 0.0081 0.1007 0.1784 0.0222 0.2702
G |  0.3183 0.1328 0.0103 0.0124 0.0025 0.0358 0.3706 0.4677 0.3421
T |  0.2314 0.3965 0.9534 0.0167 0.0060 0.8269 0.4122 0.0439 0.1962
F5H0K0_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
F5H1R1_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
F5H2R1_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
F5H3E7_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
F5H401_HUMAN/28. .88
A |  0.2256 0.2329 0.0320 0.9445 0.9838 0.0132 0.0465 0.4633 0.2032
C |  0.2579 0.2875 0.0050 0.0096 0.0080 0.0087 0.1394 0.0207 0.3161
G |  0.3030 0.1898 0.0023 0.0331 0.0024 0.0090 0.2441 0.4508 0.2789
T |  0.2135 0.2899 0.9607 0.0128 0.0058 0.9691 0.5701 0.0652 0.2018
F5H4I8_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
F5H4U9_HUMAN/232..295
A |  0.2331 0.1862 0.0329 0.1150 0.9785 0.0256 0.3941 0.2947 0.2436
C |  0.2117 0.1101 0.0141 0.0001 0.0070 0.4410 0.0780 0.1906 0.2202
G |  0.1937 0.1722 0.0228 0.8471 0.0034 0.0585 0.3485 0.2694 0.3604
T |  0.3615 0.5314 0.9302 0.0378 0.0111 0.4749 0.1794 0.2454 0.1758
F5H5U3_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
F5H7Y3_HUMAN/118..197
A |  0.2263 0.1863 0.0979 0.7678 0.9589 0.0180 0.0739 0.4643 0.2794
C |  0.2852 0.2552 0.0582 0.0348 0.0002 0.9122 0.4205 0.1100 0.1861
G |  0.2565 0.0930 0.0324 0.0615 0.0116 0.0068 0.0680 0.2258 0.4069
T |  0.2320 0.4655 0.8115 0.1358 0.0293 0.0631 0.4375 0.1999 0.1275
F5H820_HUMAN/495..553 No prediction made
The extracted domain has residue (D) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
F5H820_HUMAN/612..669 No prediction made
The extracted domain has residue (E) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
F5H838_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
F5H8J0_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
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hmmsearch and a domE cut off of 1e 0
F6R4Q5_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
F8VSA3_HUMAN/92. .152
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
F8VSK3_HUMAN/243..306
A |  0.2331 0.1862 0.0329 0.1150 0.9785 0.0256 0.3941 0.2947 0.2436
C |  0.2117 0.1101 0.0141 0.0001 0.0070 0.4410 0.0780 0.1906 0.2202
G |  0.1937 0.1722 0.0228 0.8471 0.0034 0.0585 0.3485 0.2694 0.3604
T |  0.3615 0.5314 0.9302 0.0378 0.0111 0.4749 0.1794 0.2454 0.1758
F8VU08_HUMAN/1. .24
A |  0.2381 0.1853 0.0670 0.7424 0.9831 0.0243 0.1367 0.5249 0.2129
C |  0.2325 0.2427 0.0621 0.0000 0.0071 0.1217 0.0921 0.0175 0.2535
G |  0.2352 0.1259 0.0533 0.1010 0.0035 0.0476 0.1374 0.4363 0.3466
T |  0.2942 0.4461 0.8175 0.1566 0.0063 0.8064 0.6338 0.0213 0.1871
F8VVX3_HUMAN/61. .121
A |  0.2445 0.2096 0.1271 0.4316 0.9587 0.0205 0.0569 0.5621 0.2182
C |  0.2330 0.1654 0.0897 0.0352 0.0052 0.0129 0.0985 0.0624 0.2992
G |  0.2606 0.1253 0.0550 0.0718 0.0090 0.0465 0.2375 0.3106 0.3115
T |  0.2620 0.4997 0.7282 0.4615 0.0271 0.9201 0.6071 0.0649 0.1712
F8VWZ5_HUMAN/8. .68
A |  0.2445 0.2096 0.1271 0.4316 0.9587 0.0205 0.0569 0.5621 0.2182
C |  0.2330 0.1654 0.0897 0.0352 0.0052 0.0129 0.0985 0.0624 0.2992
G |  0.2606 0.1253 0.0550 0.0718 0.0090 0.0465 0.2375 0.3106 0.3115
T |  0.2620 0.4997 0.7282 0.4615 0.0271 0.9201 0.6071 0.0649 0.1712
F8VWZ9_HUMAN/1. .21
A |  0.2583 0.2010 0.0372 0.7846 0.9828 0.0276 0.0965 0.6389 0.2062
C |  0.2227 0.1974 0.0304 0.0000 0.0080 0.0015 0.0579 0.0138 0.2991
G |  0.2488 0.1189 0.0163 0.0838 0.0026 0.0339 0.2749 0.3091 0.3027
T |  0.2703 0.4826 0.9161 0.1316 0.0066 0.9370 0.5707 0.0381 0.1920
F8VXG0_HUMAN/53. .113
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
F8VXG1_HUMAN/8. .68
A |  0.1987 0.3362 0.0584 0.9561 0.9824 0.0100 0.0806 0.3828 0.1706
C |  0.2379 0.2062 0.0127 0.0160 0.0105 0.0092 0.0670 0.0273 0.3544
G |  0.3166 0.1786 0.0059 0.0239 0.0009 0.0302 0.1323 0.5315 0.2907
T |  0.2468 0.2791 0.9230 0.0040 0.0062 0.9506 0.7201 0.0585 0.1843
F8VXJ2_HUMAN/127..187
A |  0.1987 0.3362 0.0584 0.9561 0.9824 0.0100 0.0806 0.3828 0.1706
C |  0.2379 0.2062 0.0127 0.0160 0.0105 0.0092 0.0670 0.0273 0.3544
G |  0.3166 0.1786 0.0059 0.0239 0.0009 0.0302 0.1323 0.5315 0.2907
T |  0.2468 0.2791 0.9230 0.0040 0.0062 0.9506 0.7201 0.0585 0.1843
F8VXY1_HUMAN/81. .137 No prediction made
The extracted domain has residue (H) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
A |  0.2452 0.1830 0.1529 0.7102 0.9874 0.0080 0.0318 0.6574 0.2954
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F8VYP0_HUMAN/218..278 C |  0.2423 0.2509 0.0212 0.0057 0.0063 0.0055 0.0256 0.0096 0.2252G |  0.2592 0.1444 0.0178 0.0416 0.0031 0.0211 0.1130 0.2999 0.3132
T |  0.2533 0.4217 0.8082 0.2424 0.0032 0.9655 0.8296 0.0330 0.1661
F8W0U5_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
F8W1B5_HUMAN/69. .118 No prediction made
The extracted domain has a gap at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
F8W7W6_HUMAN/218..278
A |  0.2452 0.1830 0.1529 0.7102 0.9874 0.0080 0.0318 0.6574 0.2954
C |  0.2423 0.2509 0.0212 0.0057 0.0063 0.0055 0.0256 0.0096 0.2252
G |  0.2592 0.1444 0.0178 0.0416 0.0031 0.0211 0.1130 0.2999 0.3132
T |  0.2533 0.4217 0.8082 0.2424 0.0032 0.9655 0.8296 0.0330 0.1661
F8W811_HUMAN/181..226 No prediction made
The extracted domain has a gap at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
F8WBG7_HUMAN/12. .72
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
G3V138_HUMAN/2128..2188
A |  0.2351 0.1770 0.0755 0.8644 0.9854 0.1264 0.6189 0.1422 0.1215
C |  0.2654 0.2520 0.0169 0.0187 0.0060 0.0136 0.1701 0.6182 0.2285
G |  0.2370 0.1027 0.0337 0.0968 0.0036 0.7031 0.0000 0.0275 0.5260
T |  0.2625 0.4683 0.8739 0.0200 0.0050 0.1570 0.2109 0.2121 0.1240
G3V138_HUMAN/2225..2285
A |  0.2519 0.1819 0.0275 0.8227 0.9853 0.0203 0.0536 0.6569 0.2579
C |  0.2418 0.2492 0.0408 0.0045 0.0075 0.0334 0.0530 0.0141 0.2140
G |  0.2715 0.1199 0.0276 0.1135 0.0019 0.0237 0.3889 0.2931 0.3775
T |  0.2348 0.4490 0.9041 0.0594 0.0052 0.9226 0.5044 0.0359 0.1507
G3V138_HUMAN/2604..2664
A |  0.2342 0.1668 0.0273 0.5568 0.9874 0.0101 0.0138 0.4708 0.2177
C |  0.2530 0.3389 0.0029 0.0000 0.0079 0.0084 0.0216 0.0118 0.2707
G |  0.2909 0.1231 0.0049 0.4184 0.0017 0.0107 0.0940 0.4760 0.3289
T |  0.2220 0.3711 0.9649 0.0247 0.0030 0.9708 0.8706 0.0414 0.1826
G3V138_HUMAN/2928..2988
A |  0.2399 0.1483 0.0321 0.9435 0.9809 0.0210 0.0287 0.5619 0.2547
C |  0.2461 0.3280 0.0106 0.0110 0.0072 0.0028 0.0488 0.0140 0.2428
G |  0.2837 0.1082 0.0044 0.0325 0.0037 0.0484 0.1220 0.3763 0.3085
T |  0.2304 0.4155 0.9529 0.0129 0.0083 0.9279 0.8005 0.0478 0.1940
G3V1R3_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
G3V222_HUMAN/36..70
A |  0.2421 0.2191 0.0447 0.6895 0.9791 0.0360 0.0390 0.3784 0.2049
C |  0.2282 0.1878 0.0643 0.0000 0.0070 0.0639 0.1742 0.0254 0.2888
G |  0.2438 0.1422 0.0597 0.0896 0.0042 0.0280 0.3170 0.5490 0.3218
T |  0.2859 0.4509 0.8313 0.2209 0.0097 0.8722 0.4698 0.0472 0.1844
G3V243_HUMAN/72..132
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
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G3V2N2_HUMAN/217..274
A |  0.2537 0.3059 0.0696 0.0818 0.9881 0.0268 0.7430 0.0787 0.1403
C |  0.2413 0.1870 0.1236 0.0211 0.0087 0.1361 0.2206 0.7112 0.4748
G |  0.2467 0.2303 0.0879 0.8057 0.0006 0.0668 0.0034 0.0544 0.2127
T |  0.2583 0.2768 0.7190 0.0915 0.0025 0.7703 0.0331 0.1557 0.1722
G3V2N3_HUMAN/93..153
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
G3V2N9_HUMAN/60..120
A |  0.2074 0.1845 0.0610 0.8782 0.9839 0.0062 0.0325 0.3769 0.2463
C |  0.2821 0.2124 0.0406 0.0097 0.0086 0.0161 0.0316 0.1065 0.1939
G |  0.2880 0.1005 0.0107 0.0617 0.0018 0.0151 0.0904 0.4114 0.3923
T |  0.2226 0.5026 0.8878 0.0505 0.0056 0.9626 0.8455 0.1051 0.1674
G3V2X8_HUMAN/184..244
A |  0.2191 0.1761 0.0263 0.9723 0.9856 0.0560 0.1117 0.3591 0.1986
C |  0.2675 0.3558 0.0072 0.0080 0.0073 0.0000 0.0736 0.0192 0.2784
G |  0.2983 0.1247 0.0020 0.0127 0.0030 0.0310 0.1989 0.5711 0.3360
T |  0.2151 0.3433 0.9644 0.0070 0.0041 0.9130 0.6158 0.0506 0.1870
G3V309_HUMAN/18..78
A |  0.2302 0.1742 0.0599 0.3944 0.9753 0.0104 0.0717 0.4626 0.2097
C |  0.2493 0.2014 0.0340 0.0104 0.0108 0.0410 0.0443 0.0158 0.2800
G |  0.2460 0.1514 0.0210 0.5221 0.0024 0.1015 0.1874 0.4727 0.3175
T |  0.2745 0.4730 0.8850 0.0731 0.0115 0.8471 0.6966 0.0490 0.1927
G3V309_HUMAN/93..151
A |  0.2372 0.1661 0.0463 0.3135 0.9856 0.0073 0.0133 0.4561 0.2499
C |  0.2490 0.2693 0.0091 0.0000 0.0076 0.0054 0.0175 0.0124 0.2019
G |  0.2650 0.1353 0.0085 0.6468 0.0024 0.0131 0.0804 0.5029 0.3823
T |  0.2487 0.4294 0.9361 0.0397 0.0044 0.9742 0.8888 0.0285 0.1659
G3V397_HUMAN/1. .47
A |  0.2366 0.2247 0.0435 0.6936 0.9794 0.0514 0.0436 0.3177 0.1926
C |  0.2288 0.1894 0.0640 0.0000 0.0071 0.0566 0.1835 0.0302 0.2993
G |  0.2452 0.1460 0.0603 0.0876 0.0041 0.0384 0.3025 0.5936 0.3241
T |  0.2894 0.4399 0.8321 0.2187 0.0094 0.8536 0.4705 0.0586 0.1840
G3V3J3_HUMAN/37..97
A |  0.2271 0.2000 0.0400 0.9635 0.9883 0.0002 0.0349 0.0327 0.1395
C |  0.2471 0.2969 0.0041 0.0098 0.0085 0.0051 0.9108 0.7577 0.3630
G |  0.3047 0.1251 0.0091 0.0116 0.0013 0.0741 0.0043 0.0403 0.2830
T |  0.2211 0.3780 0.9468 0.0151 0.0019 0.9206 0.0500 0.1693 0.2146
G3V3P9_HUMAN/45..105
A |  0.2271 0.2000 0.0400 0.9635 0.9883 0.0002 0.0349 0.0327 0.1395
C |  0.2471 0.2969 0.0041 0.0098 0.0085 0.0051 0.9108 0.7577 0.3630
G |  0.3047 0.1251 0.0091 0.0116 0.0013 0.0741 0.0043 0.0403 0.2830
T |  0.2211 0.3780 0.9468 0.0151 0.0019 0.9206 0.0500 0.1693 0.2146
G3V3Q9_HUMAN/164..224
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
G3V469_HUMAN No prediction made
No matches were found to the Homeobox.hmm Pfam model using the program
hmmsearch and a domE cut off of 1e-07
G3V471_HUMAN/38..98
A |  0.1987 0.3362 0.0584 0.9561 0.9824 0.0100 0.0806 0.3828 0.1706
C |  0.2379 0.2062 0.0127 0.0160 0.0105 0.0092 0.0670 0.0273 0.3544
G |  0.3166 0.1786 0.0059 0.0239 0.0009 0.0302 0.1323 0.5315 0.2907
T |  0.2468 0.2791 0.9230 0.0040 0.0062 0.9506 0.7201 0.0585 0.1843
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G3V4M3_HUMAN/38..98
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
G3V4N4_HUMAN/73..133
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
G3V4Q1_HUMAN/159..219
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
G3V4R6_HUMAN/46..93 No prediction made
The extracted domain has a gap at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
G3V567_HUMAN/8. .68
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
G3V5W7_HUMAN/73..133
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
G5E9C1_HUMAN/218..278
A |  0.2275 0.2398 0.0596 0.7268 0.9881 0.0157 0.1254 0.2813 0.2523
C |  0.2571 0.2797 0.0096 0.0030 0.0072 0.0173 0.2354 0.2483 0.1896
G |  0.3102 0.1459 0.0148 0.2523 0.0021 0.0099 0.1297 0.3206 0.4273
T |  0.2052 0.3345 0.9160 0.0179 0.0026 0.9571 0.5094 0.1498 0.1307
GBX1_HUMAN/260..320
A |  0.2234 0.1770 0.0728 0.8774 0.9850 0.0102 0.0588 0.5195 0.2173
C |  0.2655 0.3072 0.0302 0.0089 0.0058 0.0176 0.0460 0.0165 0.2762
G |  0.2906 0.1531 0.0144 0.0945 0.0043 0.0158 0.1151 0.4319 0.3286
T |  0.2206 0.3627 0.8826 0.0193 0.0049 0.9564 0.7801 0.0320 0.1779
GBX2_HUMAN/246..306
A |  0.2234 0.1770 0.0728 0.8774 0.9850 0.0102 0.0588 0.5195 0.2173
C |  0.2655 0.3072 0.0302 0.0089 0.0058 0.0176 0.0460 0.0165 0.2762
G |  0.2906 0.1531 0.0144 0.0945 0.0043 0.0158 0.1151 0.4319 0.3286
T |  0.2206 0.3627 0.8826 0.0193 0.0049 0.9564 0.7801 0.0320 0.1779
GSC2_HUMAN/125..185
A |  0.2271 0.2000 0.0400 0.9635 0.9883 0.0002 0.0349 0.0327 0.1395
C |  0.2471 0.2969 0.0041 0.0098 0.0085 0.0051 0.9108 0.7577 0.3630
G |  0.3047 0.1251 0.0091 0.0116 0.0013 0.0741 0.0043 0.0403 0.2830
T |  0.2211 0.3780 0.9468 0.0151 0.0019 0.9206 0.0500 0.1693 0.2146
GSC_HUMAN/159..219
A |  0.2271 0.2000 0.0400 0.9635 0.9883 0.0002 0.0349 0.0327 0.1395
C |  0.2471 0.2969 0.0041 0.0098 0.0085 0.0051 0.9108 0.7577 0.3630
G |  0.3047 0.1251 0.0091 0.0116 0.0013 0.0741 0.0043 0.0403 0.2830
T |  0.2211 0.3780 0.9468 0.0151 0.0019 0.9206 0.0500 0.1693 0.2146
GSX1_HUMAN/146..206
A |  0.2722 0.0944 0.0261 0.9366 0.9863 0.0208 0.0528 0.6940 0.1640
C |  0.2329 0.3918 0.0060 0.0127 0.0063 0.0498 0.0518 0.0237 0.2775
G |  0.3234 0.0880 0.0032 0.0256 0.0036 0.0337 0.2745 0.2522 0.3798
T |  0.1714 0.4259 0.9647 0.0251 0.0037 0.8958 0.6208 0.0301 0.1787
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GSX2_HUMAN/201..261
A |  0.2722 0.0944 0.0261 0.9366 0.9863 0.0208 0.0528 0.6940 0.1640
C |  0.2329 0.3918 0.0060 0.0127 0.0063 0.0498 0.0518 0.0237 0.2775
G |  0.3234 0.0880 0.0032 0.0256 0.0036 0.0337 0.2745 0.2522 0.3798
T |  0.1714 0.4259 0.9647 0.0251 0.0037 0.8958 0.6208 0.0301 0.1787
HDX_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
HESX1_HUMAN/107..167
A |  0.2141 0.1981 0.0597 0.9105 0.9847 0.0095 0.0563 0.3875 0.2324
C |  0.2651 0.3035 0.0226 0.0060 0.0060 0.0122 0.0522 0.0473 0.2407
G |  0.3031 0.1458 0.0108 0.0630 0.0039 0.0121 0.0863 0.4951 0.3563
T |  0.2176 0.3526 0.9068 0.0205 0.0054 0.9662 0.8052 0.0701 0.1706
HHEX_HUMAN/136..196
A |  0.2210 0.1638 0.0785 0.6865 0.9798 0.0475 0.1521 0.4341 0.1991
C |  0.2338 0.1882 0.1114 0.0000 0.0068 0.1009 0.0851 0.0203 0.2706
G |  0.2209 0.1197 0.1033 0.1052 0.0040 0.1031 0.1491 0.5147 0.3487
T |  0.3243 0.5283 0.7068 0.2083 0.0094 0.7486 0.6137 0.0309 0.1817
HLX_HUMAN/275..335
A |  0.2445 0.2096 0.1271 0.4316 0.9587 0.0205 0.0569 0.5621 0.2182
C |  0.2330 0.1654 0.0897 0.0352 0.0052 0.0129 0.0985 0.0624 0.2992
G |  0.2606 0.1253 0.0550 0.0718 0.0090 0.0465 0.2375 0.3106 0.3115
T |  0.2620 0.4997 0.7282 0.4615 0.0271 0.9201 0.6071 0.0649 0.1712
HMBX1_HUMAN/266..341
A |  0.2260 0.2126 0.1212 0.6215 0.9503 0.0503 0.1019 0.5213 0.2296
C |  0.2767 0.2221 0.1232 0.0477 0.0000 0.8548 0.3955 0.1597 0.1796
G |  0.2235 0.1424 0.0738 0.1213 0.0130 0.0000 0.0753 0.1542 0.4496
T |  0.2738 0.4229 0.6818 0.2096 0.0367 0.0949 0.4273 0.1648 0.1413
HME1_HUMAN/302..362
A |  0.2234 0.1770 0.0728 0.8774 0.9850 0.0102 0.0588 0.5195 0.2173
C |  0.2655 0.3072 0.0302 0.0089 0.0058 0.0176 0.0460 0.0165 0.2762
G |  0.2906 0.1531 0.0144 0.0945 0.0043 0.0158 0.1151 0.4319 0.3286
T |  0.2206 0.3627 0.8826 0.0193 0.0049 0.9564 0.7801 0.0320 0.1779
HME2_HUMAN/243..303
A |  0.2234 0.1770 0.0728 0.8774 0.9850 0.0102 0.0588 0.5195 0.2173
C |  0.2655 0.3072 0.0302 0.0089 0.0058 0.0176 0.0460 0.0165 0.2762
G |  0.2906 0.1531 0.0144 0.0945 0.0043 0.0158 0.1151 0.4319 0.3286
T |  0.2206 0.3627 0.8826 0.0193 0.0049 0.9564 0.7801 0.0320 0.1779
HMX1_HUMAN/202..262
A |  0.2401 0.1582 0.0836 0.9092 0.9833 0.0388 0.0116 0.1081 0.1841
C |  0.2438 0.1338 0.0473 0.0073 0.0093 0.0188 0.1793 0.0031 0.3333
G |  0.2630 0.1023 0.0325 0.0466 0.0017 0.1763 0.0612 0.8516 0.2754
T |  0.2531 0.6057 0.8366 0.0368 0.0057 0.7660 0.7479 0.0372 0.2072
HMX2_HUMAN/148..208
A |  0.2378 0.1675 0.0771 0.9271 0.9864 0.1035 0.0234 0.1104 0.1835
C |  0.2473 0.1396 0.0472 0.0000 0.0081 0.0794 0.2258 0.0094 0.2838
G |  0.2664 0.0909 0.0236 0.0397 0.0022 0.1250 0.0662 0.8468 0.3293
T |  0.2485 0.6020 0.8520 0.0331 0.0034 0.6921 0.6846 0.0335 0.2034
HMX3_HUMAN/226..286
A |  0.2401 0.1582 0.0836 0.9092 0.9833 0.0388 0.0116 0.1081 0.1841
C |  0.2438 0.1338 0.0473 0.0073 0.0093 0.0188 0.1793 0.0031 0.3333
G |  0.2630 0.1023 0.0325 0.0466 0.0017 0.1763 0.0612 0.8516 0.2754
T |  0.2531 0.6057 0.8366 0.0368 0.0057 0.7660 0.7479 0.0372 0.2072
HNF1A_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the program
hmmsearch and a domE cut off of 1e-07
HNF1B_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
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HNF6_HUMAN/384..443
A |  0.1931 0.1113 0.0222 0.2972 0.9745 0.0000 0.2299 0.4554 0.2274
C |  0.2696 0.1448 0.0114 0.0000 0.0157 0.3179 0.0929 0.1078 0.2631
G |  0.2480 0.1308 0.0526 0.6561 0.0000 0.0649 0.0780 0.3108 0.2899
T |  0.2893 0.6130 0.9138 0.0467 0.0099 0.6172 0.5991 0.1260 0.2195
HOP_HUMAN/3. .62 No prediction made
The extracted domain has residue (Q) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
HXA10_HUMAN/335..395
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
HXA11_HUMAN/240..300
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
HXA13_HUMAN/321..381
A |  0.2148 0.0476 0.0387 0.2264 0.9767 0.0135 0.1978 0.5543 0.0909
C |  0.1365 0.0246 0.0194 0.0161 0.0053 0.2529 0.0163 0.0215 0.2332
G |  0.1714 0.0213 0.0008 0.0326 0.0062 0.0432 0.4201 0.3712 0.5099
T |  0.4773 0.9065 0.9411 0.7249 0.0118 0.6904 0.3658 0.0531 0.1661
HXA1_HUMAN/228..288
A |  0.2388 0.1524 0.0789 0.8548 0.9809 0.0153 0.0341 0.6234 0.1776
C |  0.2408 0.2590 0.0302 0.0100 0.0064 0.0150 0.1060 0.0090 0.3514
G |  0.2657 0.1690 0.0330 0.0811 0.0039 0.0015 0.3173 0.3343 0.3038
T |  0.2547 0.4196 0.8580 0.0541 0.0088 0.9682 0.5426 0.0333 0.1672
HXA2_HUMAN/142..202
A |  0.2350 0.1336 0.0185 0.9687 0.9862 0.0056 0.0284 0.7018 0.1918
C |  0.2644 0.3754 0.0073 0.0092 0.0076 0.0315 0.0744 0.0197 0.3114
G |  0.2964 0.1184 0.0071 0.0189 0.0024 0.0112 0.4242 0.2305 0.3153
T |  0.2042 0.3725 0.9672 0.0032 0.0038 0.9517 0.4731 0.0480 0.1814
HXA3_HUMAN/190..250
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXA4_HUMAN/214..274
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXA5_HUMAN/194..254
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXA6_HUMAN/154..214
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
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HXA7_HUMAN/129..189
           
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
HXA9_HUMAN/205..265
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
HXB13_HUMAN/215..275
A |  0.2128 0.0493 0.0343 0.2878 0.9776 0.0112 0.1990 0.5397 0.1105
C |  0.1383 0.0440 0.0179 0.0066 0.0045 0.2568 0.0179 0.0165 0.2212
G |  0.1794 0.0343 0.0132 0.0310 0.0066 0.0218 0.3812 0.3905 0.4973
T |  0.4696 0.8724 0.9345 0.6746 0.0113 0.7103 0.4020 0.0533 0.1710
HXB1_HUMAN/203..262
A |  0.2336 0.1371 0.0596 0.8873 0.9778 0.0122 0.0420 0.6226 0.1879
C |  0.2396 0.2738 0.0441 0.0093 0.0064 0.0234 0.0696 0.0160 0.3422
G |  0.2672 0.1233 0.0366 0.0476 0.0047 0.0096 0.4171 0.3255 0.2770
T |  0.2596 0.4658 0.8597 0.0558 0.0111 0.9547 0.4713 0.0360 0.1929
HXB2_HUMAN/142..202
A |  0.2350 0.1336 0.0185 0.9687 0.9862 0.0056 0.0284 0.7018 0.1918
C |  0.2644 0.3754 0.0073 0.0092 0.0076 0.0315 0.0744 0.0197 0.3114
G |  0.2964 0.1184 0.0071 0.0189 0.0024 0.0112 0.4242 0.2305 0.3153
T |  0.2042 0.3725 0.9672 0.0032 0.0038 0.9517 0.4731 0.0480 0.1814
HXB3_HUMAN/187..247
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXB4_HUMAN/161..221
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXB5_HUMAN/193..253
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXB6_HUMAN/145..205
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
HXB7_HUMAN/136..196
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
HXB8_HUMAN/145..205
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
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HXB9_HUMAN/184..244
C |  0.181  0.0802 0.052  0.0226 0.0000 0.2461 0.062  0.0651 0.48 2
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
HXC10_HUMAN/267..327
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
HXC11_HUMAN/231..291
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
HXC12_HUMAN/213..273
A |  0.2252 0.0936 0.0511 0.3292 0.9699 0.0074 0.0978 0.6179 0.1175
C |  0.1636 0.0518 0.0120 0.0040 0.0041 0.3050 0.0519 0.0307 0.4384
G |  0.1837 0.0610 0.0177 0.0424 0.0082 0.0291 0.4848 0.2911 0.2165
T |  0.4275 0.7937 0.9192 0.6244 0.0178 0.6584 0.3655 0.0603 0.2276
HXC13_HUMAN/259..319
A |  0.2148 0.0476 0.0387 0.2264 0.9767 0.0135 0.1978 0.5543 0.0909
C |  0.1365 0.0246 0.0194 0.0161 0.0053 0.2529 0.0163 0.0215 0.2332
G |  0.1714 0.0213 0.0008 0.0326 0.0062 0.0432 0.4201 0.3712 0.5099
T |  0.4773 0.9065 0.9411 0.7249 0.0118 0.6904 0.3658 0.0531 0.1661
HXC4_HUMAN/155..215
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXC5_HUMAN/154..214
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXC6_HUMAN/140..200
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
HXC8_HUMAN/148..208
A |  0.2099 0.1346 0.0644 0.6483 0.9649 0.0164 0.0646 0.5106 0.1519
C |  0.2343 0.1484 0.0415 0.0154 0.0038 0.0809 0.0638 0.0341 0.4405
G |  0.2189 0.1171 0.0531 0.0376 0.0095 0.0172 0.3966 0.3866 0.1973
T |  0.3369 0.5998 0.8410 0.2987 0.0218 0.8856 0.4750 0.0687 0.2104
HXC9_HUMAN/191..251
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
HXD10_HUMAN/265..325
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
HXD11_HUMAN/265..325
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
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HXD12_HUMAN/201..261
A |  0.2252 0.0936 0.0511 0.3292 0.9699 0.0074 0.0978 0.6179 0.1175
C |  0.1636 0.0518 0.0120 0.0040 0.0041 0.3050 0.0519 0.0307 0.4384
G |  0.1837 0.0610 0.0177 0.0424 0.0082 0.0291 0.4848 0.2911 0.2165
T |  0.4275 0.7937 0.9192 0.6244 0.0178 0.6584 0.3655 0.0603 0.2276
HXD13_HUMAN/275..335
A |  0.2148 0.0476 0.0387 0.2264 0.9767 0.0135 0.1978 0.5543 0.0909
C |  0.1365 0.0246 0.0194 0.0161 0.0053 0.2529 0.0163 0.0215 0.2332
G |  0.1714 0.0213 0.0008 0.0326 0.0062 0.0432 0.4201 0.3712 0.5099
T |  0.4773 0.9065 0.9411 0.7249 0.0118 0.6904 0.3658 0.0531 0.1661
HXD1_HUMAN/229..288
A |  0.2388 0.1524 0.0789 0.8548 0.9809 0.0153 0.0341 0.6234 0.1776
C |  0.2408 0.2590 0.0302 0.0100 0.0064 0.0150 0.1060 0.0090 0.3514
G |  0.2657 0.1690 0.0330 0.0811 0.0039 0.0015 0.3173 0.3343 0.3038
T |  0.2547 0.4196 0.8580 0.0541 0.0088 0.9682 0.5426 0.0333 0.1672
HXD3_HUMAN/193..253
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXD4_HUMAN/153..213
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
HXD8_HUMAN/196..256
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
HXD9_HUMAN/284..344
A |  0.1976 0.0924 0.0713 0.3587 0.9481 0.0093 0.0841 0.4919 0.1006
C |  0.1817 0.0802 0.0527 0.0226 0.0000 0.2461 0.0627 0.0651 0.4872
G |  0.1645 0.0754 0.0438 0.0385 0.0179 0.0276 0.5222 0.3438 0.2068
T |  0.4561 0.7520 0.8322 0.5802 0.0340 0.7169 0.3309 0.0992 0.2053
I SL1_HUMAN/180..240
A |  0.2524 0.1439 0.0520 0.9014 0.9711 0.0836 0.1018 0.3286 0.2510
C |  0.2238 0.3478 0.0234 0.0054 0.0061 0.0148 0.0343 0.0514 0.2630
G |  0.3062 0.1284 0.0219 0.0829 0.0057 0.1413 0.3529 0.5412 0.2866
T |  0.2176 0.3800 0.9027 0.0104 0.0171 0.7603 0.5110 0.0789 0.1994
I SL2_HUMAN/190..250
A |  0.2524 0.1439 0.0520 0.9014 0.9711 0.0836 0.1018 0.3286 0.2510
C |  0.2238 0.3478 0.0234 0.0054 0.0061 0.0148 0.0343 0.0514 0.2630
G |  0.3062 0.1284 0.0219 0.0829 0.0057 0.1413 0.3529 0.5412 0.2866
T |  0.2176 0.3800 0.9027 0.0104 0.0171 0.7603 0.5110 0.0789 0.1994
I SX_HUMAN/81..141
A |  0.2185 0.1736 0.0641 0.8991 0.9846 0.0091 0.0574 0.3465 0.2224
C |  0.2672 0.3063 0.0229 0.0082 0.0075 0.0099 0.0477 0.0886 0.2461
G |  0.2917 0.1363 0.0105 0.0712 0.0032 0.0131 0.0908 0.4519 0.3464
T |  0.2227 0.3838 0.9025 0.0214 0.0048 0.9679 0.8041 0.1131 0.1851
LBX1_HUMAN/124..184
A |  0.2059 0.1908 0.0454 0.9553 0.9856 0.0293 0.1458 0.6771 0.2052
C |  0.2493 0.2771 0.0518 0.0190 0.0078 0.2258 0.1411 0.0375 0.2281
G |  0.3054 0.1065 0.0233 0.0179 0.0025 0.0660 0.2322 0.2629 0.3712
T |  0.2395 0.4255 0.8796 0.0078 0.0041 0.6790 0.4810 0.0225 0.1955
153
Appendix A-4 contd. 
 
 
 
 
LBX2_HUMAN/84. .144
A |  0.2059 0.1908 0.0454 0.9553 0.9856 0.0293 0.1458 0.6771 0.2052
C |  0.2493 0.2771 0.0518 0.0190 0.0078 0.2258 0.1411 0.0375 0.2281
G |  0.3054 0.1065 0.0233 0.0179 0.0025 0.0660 0.2322 0.2629 0.3712
T |  0.2395 0.4255 0.8796 0.0078 0.0041 0.6790 0.4810 0.0225 0.1955
LEUTX_HUMAN/1. .37
A |  0.2376 0.2048 0.0760 0.6848 0.9823 0.0094 0.1518 0.0243 0.1691
C |  0.2360 0.1920 0.0452 0.0000 0.0078 0.0278 0.7536 0.7188 0.3782
G |  0.2459 0.1531 0.0317 0.1196 0.0031 0.0328 0.0000 0.0735 0.2569
T |  0.2804 0.4501 0.8471 0.1956 0.0068 0.9301 0.0946 0.1834 0.1959
LHX1_HUMAN/179..239
A |  0.2443 0.2089 0.0512 0.9422 0.9841 0.0132 0.0474 0.6244 0.2746
C |  0.2498 0.2231 0.0479 0.0078 0.0077 0.0059 0.0327 0.0121 0.2351
G |  0.2533 0.1376 0.0275 0.0353 0.0029 0.0190 0.1259 0.3347 0.3081
T |  0.2526 0.4304 0.8733 0.0147 0.0054 0.9619 0.7940 0.0289 0.1822
LHX2_HUMAN/265..325
A |  0.2538 0.1440 0.0297 0.9307 0.9844 0.0031 0.0704 0.6998 0.2085
C |  0.2443 0.2930 0.0144 0.0090 0.0070 0.0453 0.0294 0.0101 0.1934
G |  0.2605 0.1008 0.0026 0.0354 0.0030 0.0078 0.1952 0.2659 0.4121
T |  0.2415 0.4623 0.9533 0.0250 0.0057 0.9438 0.7050 0.0241 0.1860
LHX3_HUMAN/156..216
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
LHX4_HUMAN/156..216
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
LHX5_HUMAN/179..239
A |  0.2443 0.2089 0.0512 0.9422 0.9841 0.0132 0.0474 0.6244 0.2746
C |  0.2498 0.2231 0.0479 0.0078 0.0077 0.0059 0.0327 0.0121 0.2351
G |  0.2533 0.1376 0.0275 0.0353 0.0029 0.0190 0.1259 0.3347 0.3081
T |  0.2526 0.4304 0.8733 0.0147 0.0054 0.9619 0.7940 0.0289 0.1822
LHX6_HUMAN/218..278
A |  0.2345 0.1541 0.0242 0.5016 0.9882 0.0068 0.0121 0.5322 0.2058
C |  0.2632 0.3621 0.0023 0.0019 0.0075 0.0041 0.0125 0.0084 0.2960
G |  0.3123 0.1258 0.0047 0.4749 0.0018 0.0058 0.0753 0.4280 0.3341
T |  0.1900 0.3580 0.9688 0.0216 0.0025 0.9833 0.9001 0.0314 0.1641
LHX8_HUMAN/224..284
A |  0.2345 0.1541 0.0242 0.5016 0.9882 0.0068 0.0121 0.5322 0.2058
C |  0.2632 0.3621 0.0023 0.0019 0.0075 0.0041 0.0125 0.0084 0.2960
G |  0.3123 0.1258 0.0047 0.4749 0.0018 0.0058 0.0753 0.4280 0.3341
T |  0.1900 0.3580 0.9688 0.0216 0.0025 0.9833 0.9001 0.0314 0.1641
LHX9_HUMAN/266..326
A |  0.2538 0.1440 0.0297 0.9307 0.9844 0.0031 0.0704 0.6998 0.2085
C |  0.2443 0.2930 0.0144 0.0090 0.0070 0.0453 0.0294 0.0101 0.1934
G |  0.2605 0.1008 0.0026 0.0354 0.0030 0.0078 0.1952 0.2659 0.4121
T |  0.2415 0.4623 0.9533 0.0250 0.0057 0.9438 0.7050 0.0241 0.1860
LMX1A_HUMAN/194..254
A |  0.2452 0.1830 0.1529 0.7102 0.9874 0.0080 0.0318 0.6574 0.2954
C |  0.2423 0.2509 0.0212 0.0057 0.0063 0.0055 0.0256 0.0096 0.2252
G |  0.2592 0.1444 0.0178 0.0416 0.0031 0.0211 0.1130 0.2999 0.3132
T |  0.2533 0.4217 0.8082 0.2424 0.0032 0.9655 0.8296 0.0330 0.1661
LMX1B HUMAN/195..255
A |  0.2452 0.1830 0.1529 0.7102 0.9874 0.0080 0.0318 0.6574 0.2954
C |  0.2423 0.2509 0.0212 0.0057 0.0063 0.0055 0.0256 0.0096 0.2252
G |  0 2592 0 1444 0 0178 0 0416 0 0031 0 0211 0 1130 0 2999 0 3132
154
Appendix A-4 contd. 
 
  
LMX B_HUMAN/ 95. .255 G |  0.2592 0.1444 0.0178 0.0416 0.0031 0.0211 0.1130 0.2999 0.3132
T |  0.2533 0.4217 0.8082 0.2424 0.0032 0.9655 0.8296 0.0330 0.1661
MEOX1_HUMAN/170..230
A |  0.2344 0.1869 0.0226 0.9033 0.9814 0.0073 0.0113 0.7340 0.1894
C |  0.2384 0.2464 0.0173 0.0095 0.0072 0.0342 0.0514 0.0071 0.3376
G |  0.2724 0.1015 0.0038 0.0480 0.0035 0.0164 0.4441 0.2224 0.2769
T |  0.2548 0.4652 0.9563 0.0392 0.0080 0.9421 0.4932 0.0365 0.1961
MEOX2_HUMAN/186..246
A |  0.2344 0.1869 0.0226 0.9033 0.9814 0.0073 0.0113 0.7340 0.1894
C |  0.2384 0.2464 0.0173 0.0095 0.0072 0.0342 0.0514 0.0071 0.3376
G |  0.2724 0.1015 0.0038 0.0480 0.0035 0.0164 0.4441 0.2224 0.2769
T |  0.2548 0.4652 0.9563 0.0392 0.0080 0.9421 0.4932 0.0365 0.1961
MIXL1_HUMAN/85..145
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
MNX1_HUMAN/240..300
A |  0.2256 0.2329 0.0320 0.9445 0.9838 0.0132 0.0465 0.4633 0.2032
C |  0.2579 0.2875 0.0050 0.0096 0.0080 0.0087 0.1394 0.0207 0.3161
G |  0.3030 0.1898 0.0023 0.0331 0.0024 0.0090 0.2441 0.4508 0.2789
T |  0.2135 0.2899 0.9607 0.0128 0.0058 0.9691 0.5701 0.0652 0.2018
MSX1_HUMAN/165..225
A |  0.2035 0.2496 0.0360 0.9101 0.9819 0.0093 0.0215 0.3239 0.1946
C |  0.2511 0.2627 0.0260 0.0253 0.0095 0.0029 0.0284 0.0150 0.2866
G |  0.2945 0.1800 0.0072 0.0332 0.0017 0.0097 0.0509 0.6125 0.3373
T |  0.2509 0.3077 0.9308 0.0313 0.0070 0.9781 0.8992 0.0485 0.1815
MSX2_HUMAN/141..201
A |  0.2035 0.2496 0.0360 0.9101 0.9819 0.0093 0.0215 0.3239 0.1946
C |  0.2511 0.2627 0.0260 0.0253 0.0095 0.0029 0.0284 0.0150 0.2866
G |  0.2945 0.1800 0.0072 0.0332 0.0017 0.0097 0.0509 0.6125 0.3373
T |  0.2509 0.3077 0.9308 0.0313 0.0070 0.9781 0.8992 0.0485 0.1815
NANG2_HUMAN/37. .97
A |  0.2184 0.2379 0.0271 0.9604 0.9834 0.0366 0.0387 0.4661 0.1915
C |  0.2319 0.2329 0.0092 0.0105 0.0081 0.1007 0.1784 0.0222 0.2702
G |  0.3183 0.1328 0.0103 0.0124 0.0025 0.0358 0.3706 0.4677 0.3421
T |  0.2314 0.3965 0.9534 0.0167 0.0060 0.8269 0.4122 0.0439 0.1962
NANGN_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
NANOG_HUMAN/94. .154
A |  0.2184 0.2379 0.0271 0.9604 0.9834 0.0366 0.0387 0.4661 0.1915
C |  0.2319 0.2329 0.0092 0.0105 0.0081 0.1007 0.1784 0.0222 0.2702
G |  0.3183 0.1328 0.0103 0.0124 0.0025 0.0358 0.3706 0.4677 0.3421
T |  0.2314 0.3965 0.9534 0.0167 0.0060 0.8269 0.4122 0.0439 0.1962
NANP8_HUMAN/94. .154
A |  0.2184 0.2379 0.0271 0.9604 0.9834 0.0366 0.0387 0.4661 0.1915
C |  0.2319 0.2329 0.0092 0.0105 0.0081 0.1007 0.1784 0.0222 0.2702
G |  0.3183 0.1328 0.0103 0.0124 0.0025 0.0358 0.3706 0.4677 0.3421
T |  0.2314 0.3965 0.9534 0.0167 0.0060 0.8269 0.4122 0.0439 0.1962
NKX11_HUMAN/258..318
A |  0.2191 0.1761 0.0263 0.9723 0.9856 0.0560 0.1117 0.3591 0.1986
C |  0.2675 0.3558 0.0072 0.0080 0.0073 0.0000 0.0736 0.0192 0.2784
G |  0.2983 0.1247 0.0020 0.0127 0.0030 0.0310 0.1989 0.5711 0.3360
T |  0.2151 0.3433 0.9644 0.0070 0.0041 0.9130 0.6158 0.0506 0.1870
 |          
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NKX12_HUMAN/162..222
A |  0.2191 0.1761 0.0263 0.9723 0.9856 0.0560 0.1117 0.3591 0.1986
C |  0.2675 0.3558 0.0072 0.0080 0.0073 0.0000 0.0736 0.0192 0.2784
G |  0.2983 0.1247 0.0020 0.0127 0.0030 0.0310 0.1989 0.5711 0.3360
T |  0.2151 0.3433 0.9644 0.0070 0.0041 0.9130 0.6158 0.0506 0.1870
NKX21_HUMAN/160..220
A |  0.2060 0.1792 0.0541 0.7949 0.9824 0.0017 0.1054 0.2634 0.0920
C |  0.2620 0.1057 0.3395 0.0024 0.0098 0.0087 0.0094 0.0028 0.3330
G |  0.2375 0.0509 0.1348 0.1574 0.0015 0.9296 0.0623 0.7215 0.3739
T |  0.2946 0.6641 0.4715 0.0453 0.0063 0.0600 0.8229 0.0123 0.2012
NKX22_HUMAN/127..187
A |  0.2060 0.1792 0.0541 0.7949 0.9824 0.0017 0.1054 0.2634 0.0920
C |  0.2620 0.1057 0.3395 0.0024 0.0098 0.0087 0.0094 0.0028 0.3330
G |  0.2375 0.0509 0.1348 0.1574 0.0015 0.9296 0.0623 0.7215 0.3739
T |  0.2946 0.6641 0.4715 0.0453 0.0063 0.0600 0.8229 0.0123 0.2012
NKX23_HUMAN/147..207
A |  0.2060 0.1792 0.0541 0.7949 0.9824 0.0017 0.1054 0.2634 0.0920
C |  0.2620 0.1057 0.3395 0.0024 0.0098 0.0087 0.0094 0.0028 0.3330
G |  0.2375 0.0509 0.1348 0.1574 0.0015 0.9296 0.0623 0.7215 0.3739
T |  0.2946 0.6641 0.4715 0.0453 0.0063 0.0600 0.8229 0.0123 0.2012
NKX24_HUMAN/188..248
A |  0.2060 0.1792 0.0541 0.7949 0.9824 0.0017 0.1054 0.2634 0.0920
C |  0.2620 0.1057 0.3395 0.0024 0.0098 0.0087 0.0094 0.0028 0.3330
G |  0.2375 0.0509 0.1348 0.1574 0.0015 0.9296 0.0623 0.7215 0.3739
T |  0.2946 0.6641 0.4715 0.0453 0.0063 0.0600 0.8229 0.0123 0.2012
NKX25_HUMAN/137..197
A |  0.2060 0.1792 0.0541 0.7949 0.9824 0.0017 0.1054 0.2634 0.0920
C |  0.2620 0.1057 0.3395 0.0024 0.0098 0.0087 0.0094 0.0028 0.3330
G |  0.2375 0.0509 0.1348 0.1574 0.0015 0.9296 0.0623 0.7215 0.3739
T |  0.2946 0.6641 0.4715 0.0453 0.0063 0.0600 0.8229 0.0123 0.2012
NKX26_HUMAN/131..191
A |  0.2060 0.1792 0.0541 0.7949 0.9824 0.0017 0.1054 0.2634 0.0920
C |  0.2620 0.1057 0.3395 0.0024 0.0098 0.0087 0.0094 0.0028 0.3330
G |  0.2375 0.0509 0.1348 0.1574 0.0015 0.9296 0.0623 0.7215 0.3739
T |  0.2946 0.6641 0.4715 0.0453 0.0063 0.0600 0.8229 0.0123 0.2012
NKX28_HUMAN/83. .143
A |  0.2060 0.1792 0.0541 0.7949 0.9824 0.0017 0.1054 0.2634 0.0920
C |  0.2620 0.1057 0.3395 0.0024 0.0098 0.0087 0.0094 0.0028 0.3330
G |  0.2375 0.0509 0.1348 0.1574 0.0015 0.9296 0.0623 0.7215 0.3739
T |  0.2946 0.6641 0.4715 0.0453 0.0063 0.0600 0.8229 0.0123 0.2012
NKX31_HUMAN/123..183
A |  0.2235 0.1651 0.0630 0.9099 0.9811 0.0198 0.0598 0.2550 0.1154
C |  0.2660 0.2142 0.0465 0.0123 0.0105 0.0000 0.0066 0.0071 0.2901
G |  0.2598 0.1060 0.0496 0.0451 0.0015 0.8713 0.0516 0.7340 0.4255
T |  0.2507 0.5147 0.8410 0.0326 0.0070 0.1089 0.8820 0.0040 0.1691
NKX32_HUMAN/205..265
A |  0.2131 0.1478 0.0635 0.9117 0.9805 0.0110 0.0618 0.2794 0.1347
C |  0.2745 0.2056 0.0559 0.0182 0.0119 0.0002 0.0075 0.0010 0.2881
G |  0.2658 0.1039 0.0534 0.0496 0.0002 0.8587 0.0694 0.7127 0.3851
T |  0.2467 0.5426 0.8273 0.0205 0.0074 0.1302 0.8613 0.0069 0.1921
NKX61_HUMAN/235..295
A |  0.3161 0.2891 0.0259 0.8317 0.9838 0.0151 0.0982 0.6754 0.1698
C |  0.1581 0.0691 0.0375 0.0011 0.0083 0.0000 0.0511 0.0194 0.3465
G |  0.2046 0.0789 0.0185 0.0779 0.0022 0.0362 0.3095 0.2825 0.3006
T |  0.3213 0.5630 0.9181 0.0892 0.0057 0.9487 0.5412 0.0227 0.1831
NKX62_HUMAN/147..207
A |  0.3161 0.2891 0.0259 0.8317 0.9838 0.0151 0.0982 0.6754 0.1698
C |  0.1581 0.0691 0.0375 0.0011 0.0083 0.0000 0.0511 0.0194 0.3465
G |  0.2046 0.0789 0.0185 0.0779 0.0022 0.0362 0.3095 0.2825 0.3006
T |  0 3213 0 5630 0 9181 0 0892 0 0057 0 9487 0 5412 0 0227 0 1831
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T |  0.3213 0.5630 0.9181 0.0892 0.005  0.948  0.5412 0.022  0.1831
NKX63_HUMAN/138..198
A |  0.3161 0.2891 0.0259 0.8317 0.9838 0.0151 0.0982 0.6754 0.1698
C |  0.1581 0.0691 0.0375 0.0011 0.0083 0.0000 0.0511 0.0194 0.3465
G |  0.2046 0.0789 0.0185 0.0779 0.0022 0.0362 0.3095 0.2825 0.3006
T |  0.3213 0.5630 0.9181 0.0892 0.0057 0.9487 0.5412 0.0227 0.1831
NOBOX_HUMAN/271..320 No prediction made
The extracted domain has a gap at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
NOTO_HUMAN/155..215
A |  0.2288 0.1814 0.0238 0.9578 0.9874 0.0057 0.0766 0.5059 0.2380
C |  0.2586 0.3085 0.0078 0.0099 0.0061 0.1279 0.1358 0.0746 0.1990
G |  0.2943 0.1224 0.0041 0.0153 0.0031 0.0411 0.2385 0.3457 0.4227
T |  0.2183 0.3876 0.9643 0.0170 0.0034 0.8253 0.5491 0.0738 0.1404
ONEC2_HUMAN/425..484
A |  0.1931 0.1113 0.0222 0.2972 0.9745 0.0000 0.2299 0.4554 0.2274
C |  0.2696 0.1448 0.0114 0.0000 0.0157 0.3179 0.0929 0.1078 0.2631
G |  0.2480 0.1308 0.0526 0.6561 0.0000 0.0649 0.0780 0.3108 0.2899
T |  0.2893 0.6130 0.9138 0.0467 0.0099 0.6172 0.5991 0.1260 0.2195
ONEC3_HUMAN/413..472
A |  0.1931 0.1113 0.0222 0.2972 0.9745 0.0000 0.2299 0.4554 0.2274
C |  0.2696 0.1448 0.0114 0.0000 0.0157 0.3179 0.0929 0.1078 0.2631
G |  0.2480 0.1308 0.0526 0.6561 0.0000 0.0649 0.0780 0.3108 0.2899
T |  0.2893 0.6130 0.9138 0.0467 0.0099 0.6172 0.5991 0.1260 0.2195
OTP_HUMAN/103..163
A |  0.2452 0.1830 0.1529 0.7102 0.9874 0.0080 0.0318 0.6574 0.2954
C |  0.2423 0.2509 0.0212 0.0057 0.0063 0.0055 0.0256 0.0096 0.2252
G |  0.2592 0.1444 0.0178 0.0416 0.0031 0.0211 0.1130 0.2999 0.3132
T |  0.2533 0.4217 0.8082 0.2424 0.0032 0.9655 0.8296 0.0330 0.1661
OTX1_HUMAN/37..97
A |  0.2271 0.2000 0.0400 0.9635 0.9883 0.0002 0.0349 0.0327 0.1395
C |  0.2471 0.2969 0.0041 0.0098 0.0085 0.0051 0.9108 0.7577 0.3630
G |  0.3047 0.1251 0.0091 0.0116 0.0013 0.0741 0.0043 0.0403 0.2830
T |  0.2211 0.3780 0.9468 0.0151 0.0019 0.9206 0.0500 0.1693 0.2146
OTX2_HUMAN/37..97
A |  0.2271 0.2000 0.0400 0.9635 0.9883 0.0002 0.0349 0.0327 0.1395
C |  0.2471 0.2969 0.0041 0.0098 0.0085 0.0051 0.9108 0.7577 0.3630
G |  0.3047 0.1251 0.0091 0.0116 0.0013 0.0741 0.0043 0.0403 0.2830
T |  0.2211 0.3780 0.9468 0.0151 0.0019 0.9206 0.0500 0.1693 0.2146
P5F1B_HUMAN/229..288
A |  0.3019 0.2505 0.0874 0.8705 0.9843 0.0063 0.0581 0.5512 0.3071
C |  0.2338 0.2215 0.0037 0.0060 0.0059 0.0072 0.0558 0.2614 0.1645
G |  0.2729 0.0959 0.0303 0.0190 0.0029 0.0265 0.5642 0.0837 0.4177
T |  0.1914 0.4321 0.8786 0.1044 0.0068 0.9600 0.3218 0.1038 0.1108
PAX3_HUMAN/218..278
A |  0.2275 0.2398 0.0596 0.7268 0.9881 0.0157 0.1254 0.2813 0.2523
C |  0.2571 0.2797 0.0096 0.0030 0.0072 0.0173 0.2354 0.2483 0.1896
G |  0.3102 0.1459 0.0148 0.2523 0.0021 0.0099 0.1297 0.3206 0.4273
T |  0.2052 0.3345 0.9160 0.0179 0.0026 0.9571 0.5094 0.1498 0.1307
PAX4_HUMAN/169..229
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239
G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
A |  0.2558 0.1352 0.0223 0.9726 0.9900 0.0053 0.3103 0.3134 0.1535
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PAX6_HUMAN/209..269 C |  0.2783 0.3110 0.0044 0.0101 0.0060 0.0141 0.0213 0.4853 0.0239G |  0.2932 0.0638 0.0021 0.0148 0.0033 0.0037 0.3739 0.0424 0.7676
T |  0.1728 0.4900 0.9712 0.0026 0.0008 0.9769 0.2945 0.1589 0.0550
PAX7_HUMAN/216..276
A |  0.2275 0.2398 0.0596 0.7268 0.9881 0.0157 0.1254 0.2813 0.2523
C |  0.2571 0.2797 0.0096 0.0030 0.0072 0.0173 0.2354 0.2483 0.1896
G |  0.3102 0.1459 0.0148 0.2523 0.0021 0.0099 0.1297 0.3206 0.4273
T |  0.2052 0.3345 0.9160 0.0179 0.0026 0.9571 0.5094 0.1498 0.1307
PBX1_HUMAN/232..295
A |  0.2331 0.1862 0.0329 0.1150 0.9785 0.0256 0.3941 0.2947 0.2436
C |  0.2117 0.1101 0.0141 0.0001 0.0070 0.4410 0.0780 0.1906 0.2202
G |  0.1937 0.1722 0.0228 0.8471 0.0034 0.0585 0.3485 0.2694 0.3604
T |  0.3615 0.5314 0.9302 0.0378 0.0111 0.4749 0.1794 0.2454 0.1758
PBX2_HUMAN/243..306
A |  0.2331 0.1862 0.0329 0.1150 0.9785 0.0256 0.3941 0.2947 0.2436
C |  0.2117 0.1101 0.0141 0.0001 0.0070 0.4410 0.0780 0.1906 0.2202
G |  0.1937 0.1722 0.0228 0.8471 0.0034 0.0585 0.3485 0.2694 0.3604
T |  0.3615 0.5314 0.9302 0.0378 0.0111 0.4749 0.1794 0.2454 0.1758
PBX3_HUMAN/234..297
A |  0.2331 0.1862 0.0329 0.1150 0.9785 0.0256 0.3941 0.2947 0.2436
C |  0.2117 0.1101 0.0141 0.0001 0.0070 0.4410 0.0780 0.1906 0.2202
G |  0.1937 0.1722 0.0228 0.8471 0.0034 0.0585 0.3485 0.2694 0.3604
T |  0.3615 0.5314 0.9302 0.0378 0.0111 0.4749 0.1794 0.2454 0.1758
PBX4_HUMAN/209..272
A |  0.2331 0.1862 0.0329 0.1150 0.9785 0.0256 0.3941 0.2947 0.2436
C |  0.2117 0.1101 0.0141 0.0001 0.0070 0.4410 0.0780 0.1906 0.2202
G |  0.1937 0.1722 0.0228 0.8471 0.0034 0.0585 0.3485 0.2694 0.3604
T |  0.3615 0.5314 0.9302 0.0378 0.0111 0.4749 0.1794 0.2454 0.1758
PDX1_HUMAN/145..205
A |  0.2263 0.1402 0.0485 0.9456 0.9829 0.0076 0.0573 0.5889 0.1826
C |  0.2661 0.3168 0.0059 0.0128 0.0073 0.0304 0.0505 0.0231 0.3520
G |  0.2886 0.1183 0.0086 0.0231 0.0033 0.0147 0.4736 0.3364 0.2637
T |  0.2191 0.4247 0.9370 0.0185 0.0065 0.9473 0.4186 0.0516 0.2017
PHX2A_HUMAN/89..149
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
PHX2B_HUMAN/97..157
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
PIT1_HUMAN/213..273
A |  0.2631 0.3989 0.1168 0.6712 0.9791 0.0144 0.0535 0.5957 0.4059
C |  0.2246 0.1544 0.0168 0.0445 0.0044 0.0063 0.0536 0.2864 0.1167
G |  0.2723 0.1050 0.0283 0.1157 0.0047 0.0021 0.4663 0.0446 0.3879
T |  0.2401 0.3418 0.8381 0.1687 0.0118 0.9772 0.4266 0.0733 0.0895
PITX1_HUMAN/88..148
A |  0.2324 0.1630 0.0267 0.9782 0.9888 0.0026 0.0191 0.0222 0.1627
C |  0.2392 0.2854 0.0077 0.0036 0.0066 0.0029 0.9491 0.8396 0.3991
G |  0.3303 0.0989 0.0011 0.0110 0.0028 0.0434 0.0012 0.0260 0.2300
T |  0.1981 0.4527 0.9645 0.0072 0.0018 0.9511 0.0306 0.1121 0.2083
PITX2_HUMAN/84..144
A |  0.2324 0.1630 0.0267 0.9782 0.9888 0.0026 0.0191 0.0222 0.1627
C |  0.2392 0.2854 0.0077 0.0036 0.0066 0.0029 0.9491 0.8396 0.3991
G |  0.3303 0.0989 0.0011 0.0110 0.0028 0.0434 0.0012 0.0260 0.2300
T |  0 1981 0 4527 0 9645 0 0072 0 0018 0 9511 0 0306 0 1121 0 2083
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T |  0.1981 0.4527 0.9645 0.0072 0.0018 0.9511 0.0306 0.1121 0.2083
PITX3_HUMAN/61..121
A |  0.2324 0.1630 0.0267 0.9782 0.9888 0.0026 0.0191 0.0222 0.1627
C |  0.2392 0.2854 0.0077 0.0036 0.0066 0.0029 0.9491 0.8396 0.3991
G |  0.3303 0.0989 0.0011 0.0110 0.0028 0.0434 0.0012 0.0260 0.2300
T |  0.1981 0.4527 0.9645 0.0072 0.0018 0.9511 0.0306 0.1121 0.2083
PO2F1_HUMAN/378..438
A |  0.2670 0.3899 0.1107 0.7971 0.9786 0.0187 0.0316 0.6638 0.3870
C |  0.2142 0.1971 0.0113 0.0073 0.0029 0.0003 0.0657 0.2101 0.0997
G |  0.3053 0.1073 0.0149 0.0115 0.0060 0.0103 0.4403 0.0463 0.4244
T |  0.2135 0.3057 0.8630 0.1841 0.0126 0.9707 0.4624 0.0798 0.0889
PO2F2_HUMAN/296..356
A |  0.2670 0.3899 0.1107 0.7971 0.9786 0.0187 0.0316 0.6638 0.3870
C |  0.2142 0.1971 0.0113 0.0073 0.0029 0.0003 0.0657 0.2101 0.0997
G |  0.3053 0.1073 0.0149 0.0115 0.0060 0.0103 0.4403 0.0463 0.4244
T |  0.2135 0.3057 0.8630 0.1841 0.0126 0.9707 0.4624 0.0798 0.0889
PO2F3_HUMAN/280..340
A |  0.2473 0.3513 0.1233 0.7905 0.9802 0.0121 0.0171 0.6505 0.3667
C |  0.2127 0.2208 0.0182 0.0067 0.0049 0.0036 0.0486 0.2373 0.0974
G |  0.3243 0.1216 0.0152 0.0176 0.0043 0.0067 0.4954 0.0479 0.4528
T |  0.2158 0.3063 0.8433 0.1853 0.0105 0.9775 0.4389 0.0643 0.0831
PO3F1_HUMAN/338..398
A |  0.2612 0.3687 0.1334 0.7055 0.9766 0.0135 0.0219 0.5028 0.4292
C |  0.2211 0.1796 0.0305 0.0041 0.0031 0.0082 0.0480 0.3732 0.1101
G |  0.2883 0.1232 0.0400 0.0230 0.0061 0.0037 0.4951 0.0383 0.3881
T |  0.2294 0.3284 0.7962 0.2673 0.0142 0.9745 0.4351 0.0857 0.0726
PO3F2_HUMAN/353..413
A |  0.2612 0.3687 0.1334 0.7055 0.9766 0.0135 0.0219 0.5028 0.4292
C |  0.2211 0.1796 0.0305 0.0041 0.0031 0.0082 0.0480 0.3732 0.1101
G |  0.2883 0.1232 0.0400 0.0230 0.0061 0.0037 0.4951 0.0383 0.3881
T |  0.2294 0.3284 0.7962 0.2673 0.0142 0.9745 0.4351 0.0857 0.0726
PO3F3_HUMAN/405..465
A |  0.2612 0.3687 0.1334 0.7055 0.9766 0.0135 0.0219 0.5028 0.4292
C |  0.2211 0.1796 0.0305 0.0041 0.0031 0.0082 0.0480 0.3732 0.1101
G |  0.2883 0.1232 0.0400 0.0230 0.0061 0.0037 0.4951 0.0383 0.3881
T |  0.2294 0.3284 0.7962 0.2673 0.0142 0.9745 0.4351 0.0857 0.0726
PO3F4_HUMAN/277..337
A |  0.2612 0.3687 0.1334 0.7055 0.9766 0.0135 0.0219 0.5028 0.4292
C |  0.2211 0.1796 0.0305 0.0041 0.0031 0.0082 0.0480 0.3732 0.1101
G |  0.2883 0.1232 0.0400 0.0230 0.0061 0.0037 0.4951 0.0383 0.3881
T |  0.2294 0.3284 0.7962 0.2673 0.0142 0.9745 0.4351 0.0857 0.0726
PO4F1_HUMAN/354..414
A |  0.3438 0.2235 0.0819 0.8454 0.9818 0.0101 0.0620 0.6215 0.2867
C |  0.2166 0.1917 0.0074 0.0091 0.0053 0.0150 0.0321 0.2077 0.1403
G |  0.2470 0.0853 0.0348 0.0344 0.0036 0.0097 0.6031 0.0630 0.4496
T |  0.1926 0.4995 0.8759 0.1111 0.0093 0.9652 0.3028 0.1077 0.1233
PO4F2_HUMAN/344..404
A |  0.3438 0.2235 0.0819 0.8454 0.9818 0.0101 0.0620 0.6215 0.2867
C |  0.2166 0.1917 0.0074 0.0091 0.0053 0.0150 0.0321 0.2077 0.1403
G |  0.2470 0.0853 0.0348 0.0344 0.0036 0.0097 0.6031 0.0630 0.4496
T |  0.1926 0.4995 0.8759 0.1111 0.0093 0.9652 0.3028 0.1077 0.1233
PO4F3_HUMAN/273..333
A |  0.3438 0.2235 0.0819 0.8454 0.9818 0.0101 0.0620 0.6215 0.2867
C |  0.2166 0.1917 0.0074 0.0091 0.0053 0.0150 0.0321 0.2077 0.1403
G |  0.2470 0.0853 0.0348 0.0344 0.0036 0.0097 0.6031 0.0630 0.4496
T |  0.1926 0.4995 0.8759 0.1111 0.0093 0.9652 0.3028 0.1077 0.1233
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PO5F1_HUMAN/229..289
A |  0.3019 0.2505 0.0874 0.8705 0.9843 0.0063 0.0581 0.5512 0.3071
C |  0.2338 0.2215 0.0037 0.0060 0.0059 0.0072 0.0558 0.2614 0.1645
G |  0.2729 0.0959 0.0303 0.0190 0.0029 0.0265 0.5642 0.0837 0.4177
T |  0.1914 0.4321 0.8786 0.1044 0.0068 0.9600 0.3218 0.1038 0.1108
PO5F2_HUMAN/209..266
A |  0.2529 0.2213 0.1093 0.5107 0.9663 0.1339 0.0631 0.5415 0.2454
C |  0.2452 0.1961 0.0639 0.0569 0.0059 0.4328 0.3338 0.1790 0.2473
G |  0.2668 0.1442 0.0457 0.1208 0.0072 0.0000 0.1223 0.1397 0.3659
T |  0.2351 0.4384 0.7811 0.3115 0.0206 0.4332 0.4808 0.1398 0.1415
PO6F1_HUMAN/233..293
A |  0.2774 0.4172 0.0795 0.7917 0.9789 0.0112 0.0421 0.8048 0.2034
C |  0.2227 0.1370 0.0124 0.0289 0.0057 0.0117 0.0326 0.1053 0.0576
G |  0.2710 0.1098 0.0138 0.0729 0.0034 0.0019 0.5778 0.0400 0.6060
T |  0.2289 0.3360 0.8943 0.1065 0.0119 0.9752 0.3475 0.0498 0.1330
PO6F2_HUMAN/606..666
A |  0.2607 0.3976 0.1200 0.7161 0.9777 0.0136 0.0254 0.5760 0.4088
C |  0.2257 0.1576 0.0225 0.0307 0.0040 0.0081 0.0466 0.3199 0.1088
G |  0.2789 0.1134 0.0320 0.0503 0.0052 0.0021 0.4992 0.0377 0.4068
T |  0.2347 0.3314 0.8256 0.2029 0.0131 0.9763 0.4288 0.0664 0.0756
PROP1_HUMAN/68..128
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
PRRX1_HUMAN/93..153
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
PRRX2_HUMAN/103..163
A |  0.2179 0.2059 0.0287 0.9560 0.9867 0.0062 0.0454 0.4502 0.2810
C |  0.2574 0.2964 0.0141 0.0108 0.0059 0.0139 0.0455 0.0537 0.1916
G |  0.3067 0.1247 0.0046 0.0216 0.0034 0.0067 0.0717 0.4088 0.3810
T |  0.2180 0.3731 0.9526 0.0116 0.0039 0.9732 0.8375 0.0873 0.1464
Q2KJ05_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
Q32M63_HUMAN/78..128 No prediction made
The extracted domain has residue (Q) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
Q3ZB87_HUMAN/495..556
A |  0.2093 0.1653 0.0865 0.6282 0.9833 0.0972 0.0798 0.2772 0.1611
C |  0.2440 0.1567 0.1058 0.0006 0.0076 0.0000 0.0622 0.0717 0.2572
G |  0.2283 0.1041 0.0790 0.2564 0.0028 0.7868 0.1105 0.5713 0.3955
T |  0.3184 0.5738 0.7287 0.1148 0.0063 0.1160 0.7475 0.0798 0.1862
Q494Z3_HUMAN/218..278
A |  0.2275 0.2398 0.0596 0.7268 0.9881 0.0157 0.1254 0.2813 0.2523
C |  0.2571 0.2797 0.0096 0.0030 0.0072 0.0173 0.2354 0.2483 0.1896
G |  0.3102 0.1459 0.0148 0.2523 0.0021 0.0099 0.1297 0.3206 0.4273
T |  0.2052 0.3345 0.9160 0.0179 0.0026 0.9571 0.5094 0.1498 0.1307
Q494Z4 HUMAN/217 277
A |  0.2275 0.2398 0.0596 0.7268 0.9881 0.0157 0.1254 0.2813 0.2523
C |  0.2571 0.2797 0.0096 0.0030 0.0072 0.0173 0.2354 0.2483 0.1896
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Q494Z4_HUMAN/217..277  |          G |  0.3102 0.1459 0.0148 0.2523 0.0021 0.0099 0.1297 0.3206 0.4273
T |  0.2052 0.3345 0.9160 0.0179 0.0026 0.9571 0.5094 0.1498 0.1307
Q49AQ3_HUMAN/81..137 No prediction made
The extracted domain has residue (H) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
Q53Y73_HUMAN/136..196
A |  0.1987 0.3362 0.0584 0.9561 0.9824 0.0100 0.0806 0.3828 0.1706
C |  0.2379 0.2062 0.0127 0.0160 0.0105 0.0092 0.0670 0.0273 0.3544
G |  0.3166 0.1786 0.0059 0.0239 0.0009 0.0302 0.1323 0.5315 0.2907
T |  0.2468 0.2791 0.9230 0.0040 0.0062 0.9506 0.7201 0.0585 0.1843
Q5SZE1_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
Q5SZE2_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
Q5SZE3_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
Q5SZE4_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
Q5VZ84_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
Q8IXZ1_HUMAN/195..255
A |  0.2198 0.1397 0.0578 0.7688 0.9711 0.0086 0.0609 0.5167 0.1622
C |  0.2431 0.1534 0.0278 0.0237 0.0056 0.0621 0.0507 0.0232 0.4097
G |  0.2330 0.1142 0.0312 0.0137 0.0071 0.0251 0.4372 0.3948 0.2140
T |  0.3041 0.5926 0.8831 0.1937 0.0162 0.9043 0.4512 0.0653 0.2141
RAX2_HUMAN/26..86
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
RHF2B_HUMAN/135..193
A |  0.2316 0.1860 0.0833 0.6866 0.9789 0.0000 0.0120 0.2694 0.1960
C |  0.2442 0.1896 0.0416 0.0000 0.0082 0.0511 0.2420 0.1181 0.3010
G |  0.2408 0.1600 0.0300 0.1421 0.0032 0.1144 0.2042 0.5649 0.3107
T |  0.2834 0.4644 0.8451 0.1713 0.0097 0.8345 0.5417 0.0476 0.1923
RHXF1_HUMAN/102..162
A |  0.2420 0.2234 0.0631 0.5942 0.9852 0.0117 0.1243 0.0418 0.1972
C |  0.2423 0.2577 0.0221 0.0000 0.0058 0.0111 0.7415 0.7322 0.3296
G |  0.2817 0.1467 0.0226 0.3469 0.0035 0.0387 0.0000 0.0673 0.2854
T |  0.2340 0.3722 0.8921 0.0589 0.0056 0.9385 0.1342 0.1587 0.1878
RHXF2_HUMAN/135..193
A |  0.2316 0.1860 0.0833 0.6866 0.9789 0.0000 0.0120 0.2694 0.1960
C |  0.2442 0.1896 0.0416 0.0000 0.0082 0.0511 0.2420 0.1181 0.3010
G |  0.2408 0.1600 0.0300 0.1421 0.0032 0.1144 0.2042 0.5649 0.3107
T |  0.2834 0.4644 0.8451 0.1713 0.0097 0.8345 0.5417 0.0476 0.1923
RX_HUMAN/135..195
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
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SATB1_HUMAN/643..704
A |  0.1989 0.1422 0.1056 0.7334 0.9902 0.0585 0.0615 0.3652 0.1648
C |  0.2936 0.3110 0.0467 0.0000 0.0068 0.0000 0.0436 0.0263 0.2376
G |  0.2584 0.1334 0.0676 0.2474 0.0021 0.8517 0.1338 0.6082 0.4324
T |  0.2491 0.4133 0.7801 0.0192 0.0009 0.0898 0.7610 0.0003 0.1651
SATB2_HUMAN/613..674
A |  0.2093 0.1653 0.0865 0.6282 0.9833 0.0972 0.0798 0.2772 0.1611
C |  0.2440 0.1567 0.1058 0.0006 0.0076 0.0000 0.0622 0.0717 0.2572
G |  0.2283 0.1041 0.0790 0.2564 0.0028 0.7868 0.1105 0.5713 0.3955
T |  0.3184 0.5738 0.7287 0.1148 0.0063 0.1160 0.7475 0.0798 0.1862
SEBOX_HUMAN/44..104 No prediction made
The extracted domain has residue (K) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
SHOX2_HUMAN/139..199
A |  0.2216 0.1799 0.0271 0.9614 0.9876 0.0035 0.0280 0.4998 0.2551
C |  0.2672 0.2974 0.0107 0.0123 0.0082 0.0037 0.0568 0.0421 0.2260
G |  0.2853 0.1350 0.0018 0.0161 0.0018 0.0203 0.0898 0.3923 0.3507
T |  0.2259 0.3877 0.9605 0.0102 0.0024 0.9725 0.8254 0.0657 0.1682
SHOX_HUMAN/116..176
A |  0.2216 0.1799 0.0271 0.9614 0.9876 0.0035 0.0280 0.4998 0.2551
C |  0.2672 0.2974 0.0107 0.0123 0.0082 0.0037 0.0568 0.0421 0.2260
G |  0.2853 0.1350 0.0018 0.0161 0.0018 0.0203 0.0898 0.3923 0.3507
T |  0.2259 0.3877 0.9605 0.0102 0.0024 0.9725 0.8254 0.0657 0.1682
S IX1_HUMAN/125..183
A |  0.2640 0.3129 0.0587 0.0593 0.9884 0.0137 0.8679 0.0974 0.1561
C |  0.2307 0.1840 0.1423 0.0176 0.0077 0.0693 0.1216 0.6202 0.4404
G |  0.2413 0.2526 0.0758 0.8463 0.0014 0.0340 0.0082 0.0985 0.2271
T |  0.2640 0.2505 0.7232 0.0767 0.0025 0.8831 0.0023 0.1840 0.1765
S IX2_HUMAN/125..183
A |  0.2640 0.3129 0.0587 0.0593 0.9884 0.0137 0.8679 0.0974 0.1561
C |  0.2307 0.1840 0.1423 0.0176 0.0077 0.0693 0.1216 0.6202 0.4404
G |  0.2413 0.2526 0.0758 0.8463 0.0014 0.0340 0.0082 0.0985 0.2271
T |  0.2640 0.2505 0.7232 0.0767 0.0025 0.8831 0.0023 0.1840 0.1765
S IX3_HUMAN/205..265
A |  0.2759 0.2541 0.0613 0.0757 0.9790 0.0151 0.7994 0.1441 0.1897
C |  0.2275 0.2023 0.1535 0.0283 0.0089 0.0645 0.1722 0.4797 0.3407
G |  0.2361 0.2890 0.0602 0.8106 0.0017 0.0170 0.0247 0.1612 0.2517
T |  0.2605 0.2546 0.7250 0.0855 0.0105 0.9035 0.0037 0.2150 0.2178
S IX4_HUMAN/225..282
A |  0.2537 0.3059 0.0696 0.0818 0.9881 0.0268 0.7430 0.0787 0.1403
C |  0.2413 0.1870 0.1236 0.0211 0.0087 0.1361 0.2206 0.7112 0.4748
G |  0.2467 0.2303 0.0879 0.8057 0.0006 0.0668 0.0034 0.0544 0.2127
T |  0.2583 0.2768 0.7190 0.0915 0.0025 0.7703 0.0331 0.1557 0.1722
S IX5_HUMAN/204..260
A |  0.2548 0.2795 0.0554 0.1369 0.9843 0.0119 0.7549 0.1121 0.1603
C |  0.2422 0.1899 0.1010 0.0000 0.0091 0.1279 0.1981 0.6441 0.4112
G |  0.2470 0.2323 0.0460 0.7659 0.0010 0.1392 0.0210 0.0714 0.2441
T |  0.2560 0.2982 0.7976 0.0971 0.0055 0.7209 0.0260 0.1724 0.1844
S IX6_HUMAN/127..187
A |  0.2759 0.2541 0.0613 0.0757 0.9790 0.0151 0.7994 0.1441 0.1897
C |  0.2275 0.2023 0.1535 0.0283 0.0089 0.0645 0.1722 0.4797 0.3407
G |  0.2361 0.2890 0.0602 0.8106 0.0017 0.0170 0.0247 0.1612 0.2517
T |  0.2605 0.2546 0.7250 0.0855 0.0105 0.9035 0.0037 0.2150 0.2178
TLX1_HUMAN/200..260
A |  0.2008 0.1962 0.0212 0.9709 0.9865 0.1785 0.1144 0.5041 0.2028
C |  0.2465 0.2269 0.0088 0.0065 0.0084 0.0788 0.1435 0.0106 0.2671
G |  0.2883 0.1034 0.0043 0.0053 0.0019 0.0565 0.2367 0.4559 0.3203
T |  0.2644 0.4735 0.9656 0.0173 0.0032 0.6862 0.5054 0.0294 0.2098
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TLX2_HUMAN/156..216
A |  0.2008 0.1962 0.0212 0.9709 0.9865 0.1785 0.1144 0.5041 0.2028
C |  0.2465 0.2269 0.0088 0.0065 0.0084 0.0788 0.1435 0.0106 0.2671
G |  0.2883 0.1034 0.0043 0.0053 0.0019 0.0565 0.2367 0.4559 0.3203
T |  0.2644 0.4735 0.9656 0.0173 0.0032 0.6862 0.5054 0.0294 0.2098
TLX3_HUMAN/165..225
A |  0.2008 0.1962 0.0212 0.9709 0.9865 0.1785 0.1144 0.5041 0.2028
C |  0.2465 0.2269 0.0088 0.0065 0.0084 0.0788 0.1435 0.0106 0.2671
G |  0.2883 0.1034 0.0043 0.0053 0.0019 0.0565 0.2367 0.4559 0.3203
T |  0.2644 0.4735 0.9656 0.0173 0.0032 0.6862 0.5054 0.0294 0.2098
UNC4_HUMAN/104..164
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
VAX1_HUMAN/99. .159
A |  0.2242 0.1402 0.0322 0.9710 0.9886 0.0282 0.1057 0.6090 0.2204
C |  0.2657 0.3534 0.0062 0.0095 0.0066 0.0122 0.0543 0.0226 0.2705
G |  0.3002 0.1290 0.0022 0.0144 0.0029 0.0205 0.3149 0.3164 0.3518
T |  0.2099 0.3774 0.9593 0.0051 0.0019 0.9391 0.5251 0.0520 0.1574
VAX2_HUMAN/101..161
A |  0.2242 0.1402 0.0322 0.9710 0.9886 0.0282 0.1057 0.6090 0.2204
C |  0.2657 0.3534 0.0062 0.0095 0.0066 0.0122 0.0543 0.0226 0.2705
G |  0.3002 0.1290 0.0022 0.0144 0.0029 0.0205 0.3149 0.3164 0.3518
T |  0.2099 0.3774 0.9593 0.0051 0.0019 0.9391 0.5251 0.0520 0.1574
VENTX_HUMAN/90. .150
A |  0.2213 0.2287 0.0296 0.9730 0.9858 0.0253 0.0249 0.2617 0.2181
C |  0.2571 0.2676 0.0045 0.0053 0.0066 0.0501 0.1803 0.0300 0.2467
G |  0.3055 0.1429 0.0033 0.0143 0.0032 0.0219 0.3492 0.6214 0.3657
T |  0.2161 0.3609 0.9626 0.0074 0.0044 0.9028 0.4457 0.0869 0.1695
VSX1_HUMAN/163..223
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
VSX2_HUMAN/147..207
A |  0.2377 0.1572 0.0336 0.9308 0.9875 0.0039 0.0375 0.5948 0.2849
C |  0.2492 0.3294 0.0224 0.0159 0.0079 0.0042 0.0238 0.0207 0.2028
G |  0.2792 0.1170 0.0158 0.0405 0.0020 0.0218 0.0738 0.3329 0.3384
T |  0.2340 0.3964 0.9282 0.0127 0.0027 0.9701 0.8649 0.0516 0.1739
ZEB1_HUMAN No prediction made No matches were found to the Homeobox.hmm Pfam model using the programhmmsearch and a domE cut off of 1e-07
ZFHX2_HUMAN/1594..1654
A |  0.2497 0.2247 0.0566 0.9201 0.9860 0.0070 0.0308 0.6598 0.2676
C |  0.2494 0.2419 0.0251 0.0094 0.0071 0.0112 0.0570 0.0146 0.2110
G |  0.2706 0.1490 0.0000 0.0235 0.0022 0.0288 0.3847 0.3034 0.3756
T |  0.2302 0.3844 0.9183 0.0469 0.0047 0.9530 0.5275 0.0222 0.1458
ZFHX2_HUMAN/1856..1916
A |  0.2497 0.2148 0.0239 0.4795 0.9877 0.0573 0.2147 0.5618 0.2241
C |  0.2443 0.2838 0.0320 0.0000 0.0073 0.0680 0.0101 0.0332 0.2709
G |  0.2773 0.1781 0.0219 0.4837 0.0021 0.0000 0.0907 0.3776 0.3267
T |  0.2287 0.3232 0.9222 0.0368 0.0029 0.8747 0.6845 0.0274 0.1783
ZFHX2_HUMAN/2064..2124
A |  0.2399 0.1483 0.0321 0.9435 0.9809 0.0210 0.0287 0.5619 0.2547
C |  0.2461 0.3280 0.0106 0.0110 0.0072 0.0028 0.0488 0.0140 0.2428
G |  0.2837 0.1082 0.0044 0.0325 0.0037 0.0484 0.1220 0.3763 0.3085
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T |  0.2304 0.4155 0.9529 0.0129 0.0083 0.9279 0.8005 0.0478 0.1940
ZFHX3_HUMAN/2144..2204
A |  0.2351 0.1770 0.0755 0.8644 0.9854 0.1264 0.6189 0.1422 0.1215
C |  0.2654 0.2520 0.0169 0.0187 0.0060 0.0136 0.1701 0.6182 0.2285
G |  0.2370 0.1027 0.0337 0.0968 0.0036 0.7031 0.0000 0.0275 0.5260
T |  0.2625 0.4683 0.8739 0.0200 0.0050 0.1570 0.2109 0.2121 0.1240
ZFHX3_HUMAN/2241..2301
A |  0.2502 0.2256 0.0619 0.9035 0.9831 0.0071 0.0308 0.6604 0.2658
C |  0.2486 0.2402 0.0224 0.0135 0.0064 0.0113 0.0569 0.0140 0.2083
G |  0.2701 0.1463 0.0053 0.0199 0.0032 0.0288 0.3847 0.3024 0.3783
T |  0.2311 0.3879 0.9104 0.0631 0.0073 0.9529 0.5276 0.0232 0.1477
ZFHX3_HUMAN/2640..2700
A |  0.2342 0.1668 0.0273 0.5568 0.9874 0.0101 0.0138 0.4708 0.2177
C |  0.2530 0.3389 0.0029 0.0000 0.0079 0.0084 0.0216 0.0118 0.2707
G |  0.2909 0.1231 0.0049 0.4184 0.0017 0.0107 0.0940 0.4760 0.3289
T |  0.2220 0.3711 0.9649 0.0247 0.0030 0.9708 0.8706 0.0414 0.1826
ZFHX3_HUMAN/2945..3005
A |  0.2399 0.1483 0.0321 0.9435 0.9809 0.0210 0.0287 0.5619 0.2547
C |  0.2461 0.3280 0.0106 0.0110 0.0072 0.0028 0.0488 0.0140 0.2428
G |  0.2837 0.1082 0.0044 0.0325 0.0037 0.0484 0.1220 0.3763 0.3085
T |  0.2304 0.4155 0.9529 0.0129 0.0083 0.9279 0.8005 0.0478 0.1940
ZFHX4_HUMAN/2083..2143
A |  0.2351 0.1770 0.0755 0.8644 0.9854 0.1264 0.6189 0.1422 0.1215
C |  0.2654 0.2520 0.0169 0.0187 0.0060 0.0136 0.1701 0.6182 0.2285
G |  0.2370 0.1027 0.0337 0.0968 0.0036 0.7031 0.0000 0.0275 0.5260
T |  0.2625 0.4683 0.8739 0.0200 0.0050 0.1570 0.2109 0.2121 0.1240
ZFHX4_HUMAN/2180..2240
A |  0.2519 0.1819 0.0275 0.8227 0.9853 0.0203 0.0536 0.6569 0.2579
C |  0.2418 0.2492 0.0408 0.0045 0.0075 0.0334 0.0530 0.0141 0.2140
G |  0.2715 0.1199 0.0276 0.1135 0.0019 0.0237 0.3889 0.2931 0.3775
T |  0.2348 0.4490 0.9041 0.0594 0.0052 0.9226 0.5044 0.0359 0.1507
ZFHX4_HUMAN/2559..2619
A |  0.2342 0.1668 0.0273 0.5568 0.9874 0.0101 0.0138 0.4708 0.2177
C |  0.2530 0.3389 0.0029 0.0000 0.0079 0.0084 0.0216 0.0118 0.2707
G |  0.2909 0.1231 0.0049 0.4184 0.0017 0.0107 0.0940 0.4760 0.3289
T |  0.2220 0.3711 0.9649 0.0247 0.0030 0.9708 0.8706 0.0414 0.1826
ZFHX4_HUMAN/2883..2943
A |  0.2399 0.1483 0.0321 0.9435 0.9809 0.0210 0.0287 0.5619 0.2547
C |  0.2461 0.3280 0.0106 0.0110 0.0072 0.0028 0.0488 0.0140 0.2428
G |  0.2837 0.1082 0.0044 0.0325 0.0037 0.0484 0.1220 0.3763 0.3085
T |  0.2304 0.4155 0.9529 0.0129 0.0083 0.9279 0.8005 0.0478 0.1940
ZHX1_HUMAN/465..523 No prediction made
The extracted domain has residue (D) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
ZHX1_HUMAN/663..719 No prediction made
The extracted domain has residue (D) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
ZHX2_HUMAN/440..498 No prediction made
The extracted domain has residue (D) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
ZHX2_HUMAN/532..586 No prediction made
The extracted domain has residue (E) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
ZHX3 HUMAN/495 553 N  i ti  
The extracted domain has residue (D) at position 51 but residue (N)
is required at this poisition in order to make a prediction
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ZHX3_HUMAN/495..553 No prediction made is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
ZHX3_HUMAN/612..669 No prediction made
The extracted domain has residue (E) at position 51 but residue (N)
is required at this poisition in order to make a prediction
(numbering is relative to the reference sequence, en_fly)
Download all predicted PFMs in a single file
Download the FASTA file used to make these predictions
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TTT 31 416 202 57 706 0.209 0.044 0.165 2.12E-02 1.28E-02 3.44E-02 4.96E-86 
TTC 78 130 572 24 804 0.209 0.097 0.112 2.54E-02 1.48E-02 4.22E-02 3.44E-67 
ATA 86 816 195 241 1338 0.142 0.064 0.077 1.31E-01 9.61E-02 1.76E-01 1.08E-45 
ATT 132 223 213 67 635 0.304 0.208 0.096 1.87E-01 1.29E-01 2.68E-01 6.38E-22 
TTA 21 293 119 215 648 0.105 0.032 0.072 1.30E-01 7.50E-02 2.16E-01 2.31E-19 
TAT 19 107 98 48 272 0.199 0.070 0.129 8.79E-02 4.54E-02 1.64E-01 1.10E-17 
CGC 37 265 243 396 941 0.095 0.039 0.056 2.28E-01 1.51E-01 3.36E-01 2.75E-16 
TGC 50 79 118 18 265 0.309 0.189 0.120 9.76E-02 4.96E-02 1.84E-01 1.21E-15 
TGA 20 303 34 39 396 0.111 0.051 0.061 7.65E-02 3.77E-02 1.52E-01 1.06E-14 
AAT 12 365 45 141 563 0.068 0.021 0.046 1.03E-01 4.84E-02 2.06E-01 4.39E-13 
TAA 8 282 37 95 422 0.073 0.019 0.054 7.34E-02 2.85E-02 1.67E-01 5.48E-13 
CAC 4 334 142 1151 1631 0.019 0.002 0.016 9.71E-02 2.59E-02 2.57E-01 3.78E-10 
TGT 19 266 37 76 398 0.101 0.048 0.053 1.48E-01 7.55E-02 2.81E-01 1.01E-09 
TTG 9 345 91 590 1035 0.033 0.009 0.024 1.69E-01 7.41E-02 3.42E-01 6.98E-09 
AAG 35 378 83 262 758 0.085 0.046 0.039 2.93E-01 1.85E-01 4.55E-01 2.27E-08 
AAA 31 517 67 319 934 0.062 0.033 0.028 2.86E-01 1.76E-01 4.55E-01 6.27E-08 
GCC 3 38 58 44 143 0.122 0.021 0.101 6.10E-02 1.13E-02 2.11E-01 6.44E-08 
TGG 13 190 26 68 297 0.090 0.044 0.046 1.80E-01 8.01E-02 3.87E-01 5.42E-06 
ACA 110 347 217 372 1046 0.137 0.105 0.031 5.44E-01 4.10E-01 7.19E-01 3.04E-05 
ACC 30 266 63 196 555 0.089 0.054 0.035 3.52E-01 2.11E-01 5.75E-01 3.80E-05 
TCG 19 204 86 327 636 0.058 0.030 0.028 3.55E-01 1.97E-01 6.09E-01 1.46E-04 
TAC 82 28 570 83 763 0.123 0.107 0.016 4.27E-01 2.57E-01 7.23E-01 3.22E-03 
GGG 3 155 27 246 431 0.026 0.007 0.019 1.77E-01 3.38E-02 5.90E-01 3.62E-03 
ACG 64 102 121 99 386 0.206 0.166 0.040 5.14E-01 3.33E-01 7.90E-01 3.87E-03 
CTC 20 69 84 123 296 0.106 0.068 0.038 4.26E-01 2.27E-01 7.72E-01 8.58E-03 
CTT 8 166 51 371 596 0.029 0.013 0.015 3.51E-01 1.41E-01 7.67E-01 1.01E-02 
CGG 8 117 32 155 312 0.051 0.026 0.026 3.32E-01 1.27E-01 7.71E-01 1.30E-02 
CCG 33 293 89 446 861 0.054 0.038 0.015 5.65E-01 3.57E-01 8.77E-01 1.97E-02 
CTA 15 279 69 610 973 0.026 0.015 0.011 4.76E-01 2.48E-01 8.58E-01 1.97E-02 
AGT 234 318 299 298 1149 0.223 0.204 0.019 7.34E-01 5.77E-01 9.32E-01 1.97E-02 
AAC 7 578 40 1234 1859 0.008 0.004 0.004 3.74E-01 1.40E-01 8.50E-01 2.27E-02 
GGT 14 399 40 526 979 0.023 0.014 0.009 4.62E-01 2.29E-01 8.81E-01 3.07E-02 
CGA 31 433 63 534 1061 0.039 0.029 0.010 6.07E-01 3.74E-01 9.67E-01 5.71E-02 
GTG 2 108 18 224 352 0.018 0.006 0.012 2.31E-01 2.56E-02 9.94E-01 8.37E-02 
ATC 17 20 57 137 231 0.051 0.074 -0.022 2.04E+00 9.28E-01 4.43E+00 1.02E-01 
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GGA 8 181 23 230 442 0.030 0.018 0.012 4.43E-01 1.67E-01 1.06E+00 1.05E-01 
AGG 85 341 57 326 809 0.092 0.105 -0.013 1.43E+00 9.72E-01 2.10E+00 1.11E-01 
TAG 11 386 12 183 592 0.026 0.019 0.007 4.35E-01 1.70E-01 1.10E+00 1.14E-01 
AGC 56 260 92 303 711 0.093 0.079 0.014 7.10E-01 4.80E-01 1.04E+00 1.27E-01 
GGC 2 54 17 127 200 0.027 0.010 0.017 2.78E-01 3.01E-02 1.24E+00 1.69E-01 
CCA 10 257 36 532 835 0.018 0.012 0.006 5.75E-01 2.51E-01 1.21E+00 2.26E-01 
GCG 2 93 13 200 308 0.015 0.006 0.009 3.32E-01 3.56E-02 1.51E+00 2.45E-01 
GTT 30 172 120 497 819 0.045 0.037 0.009 7.23E-01 4.50E-01 1.13E+00 2.57E-01 
CAA 1 422 13 1271 1707 0.002 0.001 0.001 2.32E-01 5.44E-03 1.55E+00 3.06E-01 
ACT 56 135 74 138 403 0.153 0.139 0.014 7.74E-01 4.96E-01 1.20E+00 3.44E-01 
TCC 4 65 31 262 362 0.018 0.011 0.007 5.21E-01 1.29E-01 1.55E+00 3.70E-01 
TCA 10 166 34 362 572 0.024 0.017 0.006 6.42E-01 2.76E-01 1.37E+00 4.12E-01 
CAT 23 770 79 2036 2908 0.010 0.008 0.002 7.70E-01 4.58E-01 1.25E+00 4.12E-01 
GCA 0 66 4 158 228 0.005 0.000 0.005 0.00E+00 0.00E+00 3.72E+00 4.25E-01 
GCT 8 101 25 201 335 0.032 0.024 0.008 6.38E-01 2.40E-01 1.52E+00 4.25E-01 
CCC 34 424 88 885 1431 0.027 0.024 0.004 8.07E-01 5.17E-01 1.23E+00 4.53E-01 
GAC 0 20 15 165 200 0.008 0.000 0.008 0.00E+00 0.00E+00 2.52E+00 4.57E-01 
ATG 42 282 50 276 650 0.071 0.065 0.006 8.22E-01 5.14E-01 1.31E+00 5.19E-01 
CTG 16 70 18 55 159 0.116 0.101 0.015 7.00E-01 3.03E-01 1.60E+00 5.19E-01 
TCT 1 88 14 428 531 0.005 0.002 0.003 3.48E-01 8.13E-03 2.34E+00 5.57E-01 
AGA 99 270 135 413 917 0.103 0.108 -0.005 1.12E+00 8.20E-01 1.53E+00 5.57E-01 
CAG 18 205 58 528 809 0.026 0.022 0.004 8.00E-01 4.32E-01 1.42E+00 5.62E-01 
CGT 13 277 13 365 668 0.017 0.019 -0.003 1.32E+00 5.53E-01 3.14E+00 6.04E-01 
GTC 8 51 41 187 287 0.035 0.028 0.007 7.16E-01 2.73E-01 1.68E+00 6.08E-01 
CCT 5 188 14 374 581 0.011 0.009 0.002 7.11E-01 1.97E-01 2.13E+00 6.67E-01 
GAG 7 141 17 265 430 0.019 0.016 0.003 7.74E-01 2.65E-01 2.02E+00 6.96E-01 
GAT 2 56 14 260 332 0.008 0.006 0.002 6.64E-01 7.13E-02 3.02E+00 7.72E-01 
GTA 17 169 70 614 870 0.021 0.020 0.002 8.82E-01 4.74E-01 1.57E+00 7.95E-01 
GAA 8 104 49 552 713 0.013 0.011 0.001 8.67E-01 3.44E-01 1.92E+00 8.50E-01 
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Appendix A-6: 
 
Final sequence cloned into pB1H2ω2-12En between NotI and XbaI to create 
pBIH2ω2-12En(SB): 
GCGGCCGCGGACTACAAGGATGACGACGACAAGTTCCGGACCGGCTCCAAGACCCCGCCGCACGGCACGGCGCGCCC
ATATGCTTGCCCTGTCGAGTCCTGCGATCGCCGCTTTTCTCGCTCGGATGAGCTTACCCGCCATATCCGCATCCACA
CAGGCCAGAAGCCCTTCCAGTGTCGAATCTGCATGCGTAACTTCAGTCGTAGTGACCACCTTACCACCCACATCCGC
ACCCACACCGGTACCGGCCGTGAGAAGCGTCCACGCACCGCGTTCTCCAGCGAGCAGTTGGCCCGCCTTAAGCGGGA
GTTCAACGAGAATCGCTATCTGACCGAGCGGAGACGCCAGCAGCTGAGCAGCGAGCTCGGCCTGAACGAGGCGCAGA
TCAAGATCTGGTTCCAGAACAAGCGGGCCAAGATCAAGAAGTCGGGATCCTAATCTAGA 
en K55 library: 
CGGCCTGAACGAGNNSCAGATCNNSNNSTGGTTCNNSAACAAGCGGNNSAAGATCAAGAAGTCGG 
en Library 5p comp: 
CTCGTTCAGGCCGAGCT 
en Library 3p comp: 
GATCCCGACTTCTTGATCTT 
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Appendix A-7: 
 
Barc
ode 
Barcode Strand 1 Sequence  
(no phosphorylation)  
Barcode Strand 2 Sequence  
no phosphorylation)  
     
AA aaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTttT 
CA caAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtgT 
GA gaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtcT 
TA taAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtaT 
AC acAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTgtT 
CC ccAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTggT 
GC gcAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTgcT 
TC tcAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTgaT 
AG agAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTctT 
CG cgAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcgT 
GG ggAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTccT 
TG tgAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcaT 
AT atAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTatT 
CT ctAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTagT 
GT gtAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTacT 
TT ttAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTaaT 
TTT aaaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtttT 
TGT acaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtgtT 
TCT agaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtctT 
TAT ataAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTtatT 
GTT gttAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcaaT 
GGT ggtAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTccaT 
GCT gctAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcgaT 
GAT ctaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTgatT 
CTT gaaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcttT 
CGT gcaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcgtT 
CCT ggaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcctT 
CAT gtaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTcatT 
ATT taaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTattT 
AGT tcaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTagtT 
ACT tgaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTactT 
AAT ttaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT ACACTCTTTCCCTACACGACGCTCTTCCGATCTaatT 
TTCT 
agaaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTttctT 
TGGA 
tccaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTtggaT 
TCAC 
gtgaAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTtcacT 
TATG 
cataAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTtatgT 
GTGC gcacAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG ACACTCTTTCCCTACACGACGCTCTTCCGATCTgtgcT 
169
T 
GGCG 
cgccAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTggcgT 
GCTT 
aagcAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTgcttT 
GAAA 
tttcAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTgaaaT 
CTAG 
ctagAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTctagT 
CGTC 
gacgAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTcgtcT 
CCCA 
tgggAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTcccaT 
CAGT 
actgAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTcagtT 
ATTA 
taatAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTattaT 
AGAT 
atctAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTagatT 
AACC 
ggttAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTG
T ACACTCTTTCCCTACACGACGCTCTTCCGATCTaaccT 
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Appendix A-8: 
 
The triplet binding site of the HD 
selection Barcode 
Restriction 
Site 
   
TTT TTCT BamHI 
TTG TGGA BamHI 
TTC TCAC BamHI 
TTA TATG BamHI 
TGT GTGC BamHI 
TGG GGCG BamHI 
TGC GCTT BamHI 
TGA GAAA BamHI 
TCT CTAG BamHI 
TCG CGTC BamHI 
TCC CAGT BamHI 
TCA CCCA BamHI 
TAT ATTA BamHI 
TAG AGAT BamHI 
TAC ACGG BamHI 
TAA AACC BamHI 
GTT TTT BamHI 
GTG TGT BamHI 
GTC TCT BamHI 
GTA TAT BamHI 
GGT GTT BamHI 
GGG GGT BamHI 
GGC GCT BamHI 
GGA GAT BamHI 
GCT CTT BamHI 
GCG CGT BamHI 
GCC CCT BamHI 
GCA CAT BamHI 
GAT ATT BamHI 
GAG AGT BamHI 
GAC ACT BamHI 
GAA AAT BamHI 
CTT TTCT XbaI 
CTG TGGA XbaI 
CTC TCAC XbaI 
CTA TATG XbaI 
CGT GTGC XbaI 
CGG GGCG XbaI 
CGC GCTT XbaI 
171
CGA GAAA XbaI 
CCT CTAG XbaI 
CCG CGTC XbaI 
CCC CCCA XbaI 
CCA CAGT XbaI 
CAT ATTA XbaI 
CAG AGAT XbaI 
CAC ACGG XbaI 
CAA AACC XbaI 
ATT TTT XbaI 
ATG TGT XbaI 
ATC TCT XbaI 
ATA TAT XbaI 
AGT GTT XbaI 
AGG GGT XbaI 
AGC GCT XbaI 
AGA GAT XbaI 
ACT CTT XbaI 
ACG CGT XbaI 
ACC CCT XbaI 
ACA CAT XbaI 
AAT ATT XbaI 
AAG AGT XbaI 
AAC ACT XbaI 
AAA AAT XbaI 
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Appendix A-9: 
 
ATA_LRWNS_Top 
CGAGctcCAGATCcgctggTGGTTCaatAACAAGCGGagc 
ATA_LRWNS_Bottom 
TCTTGCTCCGCTTGTTATTGAACCACCAGCGGATCTGGAG 
 
GCA_RHDRA_Top 
CGAGcggCAGATCcacgacTGGTTCcggAACAAGCGGgcc 
GCA_RHDRA_Bottom 
TCTTGGCCCGCTTGTTCCGGAACCAGTCGTGGATCTGCCG 
 
GCA_RYDRA_Top 
CGAGcggCAGATCtacgacTGGTTCcggAACAAGCGGgcc 
GCA_RYDRA_Bottom 
TCTTGGCCCGCTTGTTCCGGAACCAGTCGTAGATCTGCCG 
 
CTC_VMNRK_Top 
CGAGgttCAGATCatgaacTGGTTCcggAACAAGCGGaaa 
CTC_VMNRK_Bottom 
TCTTTTTCCGCTTGTTCCGGAACCAGTTCATGATCTGAAC 
 
GTC_YRRGA_Top 
CGAGtacCAGATCcgtcggTGGTTCggtAACAAGCGGgcc 
GTC_YRRGA_Bottom 
TCTTGGCCCGCTTGTTACCGAACCACCGACGGATCTGGTA 
 
GTC_YRRGF_Top 
CGAGtacCAGATCcgtcggTGGTTCggtAACAAGCGGttc 
GTC_YRRGF_Bottom 
TCTTGAACCGCTTGTTACCGAACCACCGACGGATCTGGTA 
 
AAG_RSQWH_Top 
CGAGcgtCAGATCagccagTGGTTCtggAACAAGCGGcac 
AAG_RSQWH_Bottom 
TCTTGTGCCGCTTGTTCCAGAACCACTGGCTGATCTGACG 
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Appendix A-10: 
 
# of HD_The triplet the HD 
variant was selected 
from_key residues of HD Sequencing Barcode 
Restriction Site 
for Illumina 
adaptor 
attachment 
   
1_TTT_RTVAA TTT BamHI 
2_TTT_RTVSA TGT BamHI 
4_TTC_VRVSA TCT BamHI 
5_TTC_TRVAA TAT BamHI 
6_TTA_VRVAA GTT BamHI 
7_TTA_RVLRA GGT BamHI 
8_TGT_RVVSQ GCT BamHI 
9_TGG_KTTQD GAT BamHI 
10_TGG_KSVMQ AA BamHI 
11_TGA_KSVAQ CA BamHI 
12_TGA_RGVAA GA BamHI 
13_TCT_ATVKA TA BamHI 
14_TCG_KGTQM AC BamHI 
15_TCC_RMIKS CC BamHI 
17_TAT_TRVSA GC BamHI 
18_TAG_RLTQA TC BamHI 
19_TAG_RMVSA AG BamHI 
20_TAC_QRVSA CG BamHI 
21_TAC_ERVSV GG BamHI 
22_TAA_RITAA TG BamHI 
23_GTT_GTRAY AT BamHI 
24_GTG_HLIQY CT BamHI 
25_GTA_YTRQV GT BamHI 
26_GGT_ALKNM TT BamHI 
27_GGT_LTKDQ TTCT BamHI 
28_GGG_RSKER TGGA BamHI 
29_GGC_TLKNQ TCAC BamHI 
30_GGA_LAKDQ TATG BamHI 
31_GCT_KITKF GTGC BamHI 
32_GCC_VRLKY GGCG BamHI 
33_GCA_ALRQQ GCTT BamHI 
34_GAT_RTMRY GAAA BamHI 
35_GAG_VMRWY CTAG BamHI 
36_GAC_ATRRF CGTC BamHI 
37_GAA_RFQKF CCCA BamHI 
38_CTA_LHYAK CAGT BamHI 
39_CTA_IFNAK ATTA BamHI 
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40_CGG_STRER CTT NcoI 
41_CGC_RVMSR CGT NcoI 
42_CGA_TFYAA CCT NcoI 
43_CCT_MTNGK CAT NcoI 
44_CCT_RGDSK ATT NcoI 
45_CCG_RCYEK AGT NcoI 
46_CCC_RLDSK ACT NcoI 
47_CCA_KMTQK AAT NcoI 
48_CCA_EHNAK AA NcoI 
49_CAT_LSQSR CA NcoI 
50_CAT_MMCSR GA NcoI 
51_CAG_MSHWR TA NcoI 
52_CAC_LGMRR AC NcoI 
53_CAC_ERVSR CC NcoI 
54_CAA_LMYQR GC NcoI 
55_CAA_LHYVR TC NcoI 
56_ATT_HRVQA AG NcoI 
57_ATG_LTYQW CG NcoI 
58_ATG_RVYQW GG NcoI 
59_ATC_TRMAF TG NcoI 
60_ATA_KTVQV AT NcoI 
61_AGT_KGKEW CT NcoI 
62_AGG_SHKEY GT NcoI 
63_AGC_QSRNV TT NcoI 
64_AGA_AFRAH TTCT NcoI 
65_AGA_GSRWY TGGA NcoI 
66_ACT_KTSHM TCAC NcoI 
67_ACT_MKYEK TATG NcoI 
68_ACG_SRYDR GTGC  NcoI 
69_ACG_VKYER GGCG NcoI 
70_ACC_KTSHM GCTT NcoI 
71_ACA_MTNNR GAAA NcoI 
72_AAT_KMSNF CTAG NcoI 
73_AAT_KLTAF CGTC NcoI 
74_AAG_STSAH CCCA NcoI 
75_AAC_SISRF CAGT NcoI 
76_AAA_RAQWF ATTA NcoI 
77_AAA_KEYVH AGAT NcoI 
168_ACG_SRYDR TGGA BamHI 
201_TGC_VRVSQ TCAC BamHI 
202_GTG_NAREF TATG BamHI 
203_GTC_VQKRF GTGC BamHI 
204_GCG_RTDRY GGCG BamHI 
177
205_GAA_TQRQW GCTT BamHI 
207_CTT_ITYGK GAAA BamHI 
208_CTC_HFNRK CTAG BamHI 
209_CGC_PRDSR CGTC BamHI 
210_CCG_RSNQK CCCA BamHI 
211_ATT_TKNQN CAGT BamHI 
212_ATA_RVTNA ATTA BamHI 
213_AGG_KMKES AGAT BamHI 
215_TTC_KRLAA AACC BamHI 
216_TGC_NRVMM TTT BamHI 
217_GGG_KSKEG TGT BamHI 
218_CTG_KQNQK TCT BamHI 
219_CTG_KVYER TAT BamHI 
220_CTG_LTYQK GTT BamHI 
221_CTG_RLYQK GGT BamHI 
222_CTC_SKYGK GCT BamHI 
223_CTC_RTFGK GAT BamHI 
224_CCC_IMNSK CTT BamHI 
225_AAC_SLQRF CGT BamHI 
226_TTT_KMISA ATT BamHI 
227_TTT_YRIAA AGT BamHI 
228_TTG_KMLQA ACT BamHI 
229_TTC_GRISA AAT BamHI 
230_TGC_ERISQ AA BamHI 
232_TCG_IKNQM CA BamHI 
233_TCG_VMNQQ GA BamHI 
234_TCA_AMVQR TA BamHI 
235_TAT_RAVSV AC BamHI 
236_TAG_KSTQM CC BamHI 
237_TAG_YAVNA GC BamHI 
238_TAC_QRISV TC BamHI 
239_TAA_RTVRA TTCT NcoI 
240_GTT_SSRGF TGGA NcoI 
241_GTT_GLRAF TCAC NcoI 
242_GTC_LQRGA TATG NcoI 
243_GGT_ATKSM GTGC NcoI 
244_GGT_KMKSV GGCG NcoI 
245_GCT_RAVKW GCTT NcoI 
246_GCT_ISVKY GAAA NcoI 
247_GCG_RTDRS CTAG NcoI 
249_GCA_QLKQS CGTC NcoI 
250_GAT_AGKTF CCCA NcoI 
251_CTT_VGYSR CAGT NcoI 
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252_CTC_LRYSK ATTA NcoI 
253_CGT_VANSR AGAT NcoI 
255_CCT_RADGK AACC NcoI 
256_CCA_RLYQK TTT NcoI 
257_CAT_KLCSR TGT NcoI 
258_ATT_RTVQQ TCT NcoI 
259_ATA_KMYAW TAT NcoI 
260_ATA_KAYNA GTT NcoI 
261_AGG_KSKEA GGT NcoI 
262_AGA_QFRAW GCT NcoI 
263_AGA_VRFAA GAT NcoI 
264_ACT_KVYHV CTT NcoI 
265_ACG_WYSKY CGT NcoI 
266_ACC_KACHS CCT NcoI 
267_ACA_RVSHT CAT NcoI 
268_AAT_KLQAF ATT NcoI 
269_AAT_KVTNF AGT NcoI 
270_AAG_RAQWF ACT NcoI 
271_AAC_KLQRF AAT NcoI 
272_AAC_VAQRC AG NcoI 
1_AAG_RSQWH TTCT NcoI 
2_ATA_LRWNS TGGA NcoI 
3_CTC_VMNRK TCAC NcoI 
4_CTG_TTNQK TATG NcoI 
5_GAT_VGRLY GTGC NcoI 
6_GCA_RHDRA GGCG NcoI 
7_GCA_RYDRA GCTT NcoI 
8_GCG_RLDRF_ GAAA NcoI 
9_GCG_RLDRY CTAG NcoI 
10_GTC_YRRGA CGTC NcoI 
11_GTC_YRRGF CCCA NcoI 
12_no_HD CAGT NcoI 
13_12-En(SB) ATTA NcoI 
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